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Abstract 
 
Campylobacter jejuni is a leading cause of bacterial gastroenteritis in humans. The 
ability of C. jejuni to invade human intestinal epithelial cells (IECs) is pivotal for 
pathogenicity. Two highly conserved fibronectin-binding proteins CadF & FlpA 
have been shown to play an important role in C. jejuni adhesion to IECs. CadF & 
FlpA are also associated with outer membrane vesicles (OMVs) and may play a 
role in the binding of OMVs to IECs. Mutation of cadF & flpA in 11168H & 81-176 
reduced binding to fibronectin in vitro and bacterial adhesion to and invasion of 
both Caco-2 & T84 IECs, however intracellular bacterial numbers increased over 
time between 3 and 24 hours. Both cadF & flpA mutants were able to translocate 
as efficiently as the wild-type strain across a T84 IEC monolayer, an event not 
associated with any change in membrane permeability as indicated by TEER 
values. Mutation of cadF reduced C. jejuni cytotoxicity in the Galleria mellonella 
larvae model of infection to a greater extent than mutation of flpA. OMVs isolated 
from cadF or flpA mutants were less immunogenic and cytotoxic than OMVs 
isolated from wild-type strains. Results from inhibitors studies showed that 
cytochalasin D, methyl-beta-cyclodextrin, colchicine and wortmannin all reduced 
11168H invasion of T84 IECs. However the invasion mediated by CadF and FlpA 
was shown to initiate different invasion pathways as wortmannin showed no effect 
on the ability of the 11168H cadF mutant to invade T84 IECs whilst colchicine 
showed no effect on the ability of the 11168H flpA mutant to invade T84 IECs. 
Using a 11168H strain expressing GFP at high levels, C. jejuni was shown to 
invade IECs, either residing within the Campylobacter containing vacuole (CCV), 
free within the cytoplasm and also in close proximity to parts of the trans-golgi 
network. A LAMP-1 stain showed co-localisation with late endosomal 
compartments in parts of the trans-golgi network. C. jejuni infection of IECs leads 
to actin cytoskeleton rearrangement as seen by the formation of filopodia, 
lamellapodia, membrane ruffles and F-actin stress fibres after 24 hours infection 
as a result of activation of the small GTPase Rac1. Mutation of cadF or flpA 
reduces Rac1 activation compared to wild-type strain. The significant finding of 
this study is that CadF and FlpA appear to initiate different invasion pathways to 
allow C. jejuni invasion of IECs. The results of this study support the view that both 
CadF and FlpA play equally important roles in C. jejuni pathogenesis. 
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1.1 Campylobacter  
 
Almost 30 years ago, Campylobacter species were recognised as a human 
pathogen causing gastroenteritis, long after this bacterial infection was first 
described in 1886 by Theodor Escherich (Kist, 1986). In the UK since 1981, 
Campylobacter species have been identified as the major cause of acute bacterial 
enteritis in humans (Richardson et al., 2001). 
Globally C. jejuni and C. coli are identified as a major cause of human 
gastroenteritis and are responsible for the majority of human cases of 
campylobacteriosis (Moore et al., 2005). Campylobacter species are the leading 
cause of human gastroenteritis compared to Salmonella species infections in 
many countries (Golz et al., 2014). The burden of the disease is important to 
human public health because of the clinical aspects emerging from the infection, 
such as Guillain-Barré Syndrome (GBS) and Miller Fisher Syndrome (MFS). Due 
to the association of C. jejuni with its natural host (poultry), the bacteria will always 
find their way into the food chain. As such, together with emerging trends in 
antibiotic resistance, this makes C. jejuni a significant foodborne human pathogen. 
At present, however, it is not feasible to eliminate Campylobacter species 
completely from poultry and thus the food chain. On-going research is aimed to 
understand the pathogenesis of C. jejuni.  
 
 
1.2 Campylobacter jejuni bacteriology 
 
C. jejuni is a Gram-negative bacterium which is curved or comma shaped, S or 
gull wing-shaped, or a spiral rod shape, 0.2 to 0.8 µm wide and 0.5 to 5 µm long. 
C. jejuni exhibits rapid darting motility with a corkscrew-like motion caused by a 
single polar flagellum at one or both ends of the cell. C. jejuni are microaerophilic 
and capnophilic, growing optimally in 5% O2, 10% CO2, 85% N2 at 42oC rather 
than at 37oC. However the bacteria cannot grow at temperatures below 30oC. C. 
jejuni is highly susceptible to drying and does not grow well on dry surfaces 
(Fernandez et al., 1985). However a study has reported that C. jejuni can survive 
up to 4 h on some clean or soiled food contact surfaces at 27oC and at around 
62% relative humidity (De Cesare et al., 2003). In comparison to Salmonella 
typhimurium and Listeria monocytogenes, C. jejuni is not tolerant to high osmotic 
stress. S. typhimurium and Listeria  monocytogenes can grow in the presence of 
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4.5% (w/v) and 10% (w/v) sodium chloride respectively, whilst C. jejuni cannot 
grow in the presence of 2% (w/v) sodium chloride (Doyle and Roman, 1982b). C. 
jejuni is able to grow in a pH range from 4.9 to 9.0, but the optimal growth pH is 
between 6.5 and 7.5 (Blaser and Wang, 1980, Blaser et al., 1980). C. jejuni can 
form biofilms and resist the impact of oxidative stress in the environment. Enzymes 
such as superoxide dismutase, catalase, peroxidase, gluthathione synthatase and 
gluthathione reductase play important roles in protecting C. jejuni from oxidative 
stresses (Pesci et al., 1994, Purdy and Park, 1994). 
Older Campylobacter cells become coccoid in shape and non-culturable. The state 
of viable but non-culturable (VBNC) has been reported to be associated with the 
change of morphology from spiral to coccoid (Rollins and Colwell, 1986, Moran 
and Upton, 1986). More recent studies however suggested no correlation exists 
between cell morphology and culturable status (Medema et al., 1992, Lazaro et 
al., 1999). Non-culturable cells at 20 and 116 days kept in PBS at 4oC were shown 
to contain the same intact DNA as fresh culturable control cells at day 0 (Lazaro 
et al., 1999). Furthermore, there are conflicting reports on the existence of the 
VBNC state in C. jejuni (Rollins and Colwell, 1986, Moran and Upton, 1986, Jones 
et al., 1991). 
C. jejuni motility is phase variable (Karlyshev et al., 2002, Hendrixson, 2006, 
Hendrixson, 2008) and also growth-phase dependent (Konkel et al., 1992c). 
During in vitro culturing, motility can be reduced or lost due to phase variation 
(Gaynor et al., 2004). However, during infection experiments, motility can be 
regained (Jones et al., 2004). At the late logarithmic growth phase, motility was 
observed to be maximal and diminished during stationary phase (Wosten et al., 
2004). 
In comparison to other enteric bacterial pathogens like Salmonella species, the C. 
jejuni genome is small (1.64 Mbps) and has a relatively low G+C content of around 
30% (Gaskin et al., 2009). A study in 2000 reported the complete circular genome 
of the C. jejuni NCTC 11168 wild-type strain has 1,641,481 base pairs (bp) 
encoding 1654 proteins. The C. jejuni NCTC 11168 genome contains many 
hypervariable gene sequences encoding different surface structures including lipo-
oligosaccharide (LOS), capsular polysaccharide and flagella (Parkhill et al., 2000). 
During replication, these hypervariable sequences which encode for bacterial 
surface structures such as LOS, capsule and flagella, can result in slip-strand 
mispairing and cause phase variation to occur that leads to antigenic variation in 
the bacterial population. As a result of phase variation, the protein expression 
changes and causes phenotypic variation. C. jejuni was shown to demonstrate 
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extensive genetic diversity between human isolates (Dorrell et al., 2001). Studies 
have demonstrated that several strains contain a plasmid encoding for antibiotic 
resistance and a type IV secretion system (T4SS) (Bacon et al., 2000, Louwen et 
al., 2006, Batchelor et al., 2004). A study reported that in 2016, the complete 
assembled genome sequences for 142 C. jejuni species jejuni genome were 
available at the National Centre for Biotechnology Information (NCBI) genome 
databases (Mund et al., 2016). However, there are thousands more sequences 
deposited in NCBI, but not assembled and/or not annotated. In the European 
Bioinformatic Institute (EBI) bacteria website, there are currently 23 C. jejuni 
genomes, with the sequences fully assembled and annotated (EBI, 2018). 
C. jejuni lacks the glycolytic enzyme phosphofructokinase and as such is not able 
to ferment glucose. However C. jejuni strains that have adapted to colonise 
livestock are able to utilise L-fucose (Zautner et al., 2012, Muraoka and Zhang, 
2011). C. jejuni is able to metabolise free amino acids and keto acids directly from 
a host or generated by other bacteria in the same ecological environment (Lee and 
Newell, 2006). The non-livestock adapted strains that are incapable to utilise L-
fucose and to metabolise amino acid (Zautner et al., 2011, Hofreuter et al., 2008). 
For respiration, C. jejuni is able to utilise many different electron donors such as 
D-lactate, formate, malate, succinate and NAD (P)H or hydrogen. In addition, C. 
jejuni has chemolithotropic characteristics so it is able to utilise inorganic sulphite 
as a respiratory electron donor (Tareen et al., 2011, Hoffman and Goodman, 1982, 
Kelly, 2001, Myers and Kelly, 2005). 
 
 
 
 
 
 
1.2.1Transmission in chickens and humans 
 
C. jejuni is found in the gastrointestinal tract of a wide range of animals particularly 
poultry (Gormley et al., 2014). The natural body temperature of poultry is around 
42oC and the microaerobic conditions in the gut are very favourable to C. jejuni 
colonisation (Gilbreath et al., 2011). Other animals can also harbour C. jejuni such 
as cats, dogs, pigs, cows and many wild animals (Gormley et al., 2014). As a 
natural host for C. jejuni, the poultry reservoir is linked to approximately 80% of all 
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campylobacteriosis infections (EFSA, 2011). C. jejuni colonises the chicken cecal 
mucosal crypts and numbers as high as 109 cfu/g of chicken ceacal contents can 
be found at any one time with chicks as young as 3 days old colonised (Shanker 
et al., 1990). Water, feed and litter gradually showed an increase of C. jejuni 
contamination as transmission within a flock increases (Shanker et al., 1990, 
Montrose et al., 1985). Other potential sources of transmission in broiler chicks 
were through contaminated fomites. These include farm workers clothing, 
transport such as trucks, tractors and forklifts as well as equipment such as crates 
and pallets (Ramabu et al., 2004).  
It was previously thought that C. jejuni is a commensal in chickens and a study 
showed that colonisation of chickens does not affect the ceacal mucosa 
suggesting that no disease occurs in infected chickens (Meade et al., 2009). 
However, more recent studies have reported that C. jejuni colonisation of chickens 
causes damage to the mucosa and increased intestine permeability (Humphrey et 
al., 2014). High colonisation levels allow C. jejuni to spread throughout a flock and 
result in very high levels of contamination. It was shown that the majority of broilers 
could be infected within a month of hatching (Patriarchi et al., 2009, Golz et al., 
2014). However, there was no evidence that vertical transmission occurs in 
commercial broiler production (Shanker et al., 1986, Cox et al., 2012). Another 
study in Sweden supported this, where 60,000 progeny parent breeders originating 
from Campylobacter-positive chickens were analysed and no evidence of vertical 
transmission was found (Callicott et al., 2006). In poultry processing, handling 
during slaughter and carcass processing pose the highest risk of contamination 
(Allen et al., 2007). Despite the hostile environment in the chicken gastrointestinal 
tract, C. jejuni thrives, indicating an adaptive ability to respond to in vivo stresses. 
One study has reported that the C. jejuni 81116 wild-type strain exhibits increased 
ability to colonise after one passage through chickens (Cawthraw et al., 1996). 
However C. jejuni can cause severe disease in humans. Major sources of C. jejuni 
infection are the consumption of undercooked poultry as well as contaminated 
meats, milk and water (Doyle and Roman, 1982a). Despite implementation of 
various strategies to control this pathogen in poultry, chicken meat remains the 
most important source of infection in humans. It was reported that 75% of poultry 
sold in major supermarkets in the UK were contaminated by Campylobacter 
species (EFSA, 2011). C. jejuni and Campylobacter coli are responsible for around 
85% and 15% of human infections respectively (Moore et al., 2005, Snelling et al., 
2005). For the highly invasive C. jejuni 81-176 wild-type strain, as little as 100 
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bacteria are able to cause disease in humans (Black et al., 1988). Studies have 
shown in humans that 400 to 10,000 bacteria are sufficient to cause inflammatory 
gastroenteritis (Black et al., 1988, Alter et al., 2011). Humans can also become 
infected by consumption of contaminated meat, unpasteurised milk as well as 
contaminated water (Nachamkin et al., 1993, Fernandes et al., 2015, Perkins-
Jones et al., 1982). The main infective route is through consumption of 
undercooked or raw poultry. Cross contamination to kitchen utensils also poses a 
significant risk during preparation of raw chicken products.  
Flies have also been reported to be a seasonal vector in transmitting 
Campylobacter species to humans after contact with contaminated surfaces, 
human, bird or animal faeces. Rainfall increase the fly population, which starts in 
the late spring and peaks around June (Nichols, 2005, Royden et al., 2016, Shane 
et al., 1985). Another study supported this observation and reported that C. jejuni 
infection outbreaks increase during summer months and decrease during winter 
months, however the reason behind this still unclear (Casey et al., 2017). 
Human to human transmission can occur, as reported in a study where an ill 
person contaminated a salad they prepared and caused an outbreak of 
gastrointestinal illness in a boys summer camp (Blaser et al., 1982). In another 
study, transmission between infected members of families was reported (Blaser et 
al., 1981). However, human-to-human transmission is thought to be a very 
infrequent event. 
 
 
1.2.2 Disease presentation 
 
Many host factors combine with the virulence factors expressed by C. jejuni to 
influence or determine the outcome of infection in humans. Acute symptoms are 
thought to be associated with C. jejuni invasion of the intestinal epithelium cells, 
which results in inflammatory bacterial diarrhoea. Symptoms range from mild 
diarrhoea with fever and abdominal pain to bacteraemia. These symptoms are not 
distinguishable from the gastrointestinal infections caused by other enteric 
bacterial pathogens such as Salmonella, Shigella or Yersinia species. 
Campylobacteriosis has an incubation period of 1 to 7 days and clinical symptoms 
will appear in most people after 3 to 7 days (Dasti et al., 2010) but these can last 
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far longer (5 to 21 days). More than 90% of patients reported fever of low grade or 
more than 40oC and the fever could last for 1 week (Allos, 2001). The diarrhoea 
can be short lived, prolonged or recurrent. The diarrhoea can be watery and non-
inflammatory or bloody and inflammatory. The frequency of diarrhoea can reach 
10 instances per day and a person with diarrhoea poses the highest risk to their 
contacts (Ashkenazi et al., 1987). 
Local complications can result from the direct spread of gastrointestinal infection 
including cholecystitis, pancreatitis, peritonitis and massive gastrointestinal 
haemorrhage. While systemic complications are rare, meningitis, arthritis, 
endocarditis and myocarditis have all been reported as manifestations of 
campylobacteriosis. In a rare case, C. jejuni mediated enterocolitis resulted in toxic 
megacolon in a 28 year old male (Schneider et al., 2000). In stools of healthy 
persons, C. jejuni is not commonly identified, as studies have shown up to 50% of 
infected persons during an outbreak are asymptomatic (Blaser et al., 1979).  
Bacteraemia with campylobacteriosis can occur in patients (less than 1%) who are 
immunocompromised or among the very young or very old and can lead to sepsis 
and death. Death due to sepsis after Campylobacter infection occurs in 50 out of 
1,000 cases (Allos, 2001). The duration of carriage may be quite long without 
treatment, however 90% of patients do become negative spontaneously within two 
months of infection. In the majority of cases, hospitalisation is not required, 
however death can occur in a minority of immunocompromised individuals.  
 
 
1.2.3 Post-sequelae syndromes 
 
Studies have shown that infection with C. jejuni can result in Guillain-Barré 
syndrome (GBS) (Rees et al., 1995, Yuki et al., 2004) or Miller Fisher syndrome 
(MFS) (Willison and O'Hanlon, 1999). GBS is an autoimmune disorder that causes 
a symmetrical ascending paralysis of the peripheral nervous system (PNS). GBS 
causes weakness of the limbs and weakness of the respiratory muscles (Ropper, 
1992). Evidence of prior infection with C. jejuni and subsequent link to GBS has 
been reported in several studies. Patients with GBS were found to have evidence 
of prior C. jejuni infections, however no particular strains were implicated. C. jejuni 
infection resulted in a poor or severe outcome of GBS (Rees et al., 1995). C. jejuni-
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positive patients showed significantly greater disability, such as requiring 
ventilation or walking aids and even death within one year after diagnosis. 
Only infection with certain C. jejuni serotypes is known to increase the risk of 
developing GBS. C. jejuni strains from patients with GBS belong mostly to Penner 
serogroup type 19 (Kuroki et al., 1993). Many researchers have indicated that a 
ganglioside-like surface structure, such as GM1, which is found in some C. jejuni 
strains LOS, can induce GBS. (Gregson et al., 1997, Ropper, 1992, Ropper and 
Adelman, 1992). An experimental study using chickens infected with C. jejuni 
showed similar symptoms to GBS (Li et al., 1996). Many serotypes of C. jejuni 
have been reported to be associated with GBS such as Penner type O:1 to O:5, 
O:10, O:16, O:23, O:37, O:44, and O:64 (Nachamkin et al., 1998). However, 
infection with C. jejuni Penner type O: 19 increases the risk of developing GBS. A 
study by Yuki et al. reported that type 0:19 was identified in 52% in GBS patients 
(Yuki et al., 1997). In South Africa, C. jejuni Penner type O: 41 isolates were found 
to be associated with GBS patients (Wassenaar et al., 2000). Molecular mimicry 
by the LOS on the surface of C. jejuni with the human gangliosides in the PNS 
causes production of autoreactive antibodies that lead to an ascending paralysis 
(Yuki et al., 2004). In a study with rabbits injected with C. jejuni LOS, the rabbits 
developed anti-GM1 IgG antibodies and exhibited limb weakness. The changes in 
the rabbit PNS appeared to be identical to that of GBS patients (Backert et al., 
2013). More recently it was reported that mice infected with C. jejuni developed 
GBS (St Charles et al., 2017).  
Another complication is MFS, a rare variant of GBS, but potentially fatal. The 
Penner type O:2 is associated with MFS (Yuki, 1997). The paralysis causes 
abnormal muscle co-ordination and paralysis of the eyes with unmoving pupils 
(Willison and O'Hanlon, 1999, Dingle et al., 2001). Other conditions are also 
implicated with C. jejuni infection. It was reported that septicaemia can occur in 
immunocompromised individuals and irritable bowel syndrome is also commonly 
associated with campylobacteriosis (Spiller, 2007). Reactive arthritis can develop 
as a result of C. jejuni infection (Hannu et al., 2002). Myocarditis associated with 
C. jejuni infection has also been reported in a number of studies (Cunningham and 
Lee, 2003, Obafemi and Douglas, 2017, Hessulf et al., 2016, Pena and Fishbein, 
2007, Westling and Evengard, 2001). 
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1.3 Campylobacter jejuni epidemiology 
 
C. jejuni is the major cause of bacterial gastroenteritis worldwide (Zilbauer et al., 
2008). C. jejuni infection is a significant public health problem globally because the 
number of cases of campylobacteriosis has surpassed by about 2-3 fold compared 
to the number of Salmonella infections (Figure 1.1) (Golz et al., 2014). Although 
other species of Campylobacter are also able to cause diseases in humans, such 
as C. lari and C. uppsaliensis, it is C. jejuni and C. coli that are responsible for 
around 85% and 15% of the human cases respectively (Moore et al., 2005). C. 
jejuni is responsible for as many as 400–500 million bacterial gastroenteritis cases 
per year worldwide (Boehm et al., 2011). In the USA it was estimated there are 1.3 
million cases per year (14 cases per 100,000 population) (CDC, 2015). In the 
European Union (EU) alone, there are approximately 9 million gastroenteritis 
cases per year with a total cost estimated at €2.4 billion due to campylobacteriosis. 
This is equivalent to 55.5 incidences per 100,000 population (EFSA, 2015). C. 
jejuni is the major cause of food poisoning in UK with an economic burden 
predicted to be around £900 million. Annually, there are approximately 280,000 
cases and there are over 100 deaths linked to campylobacteriosis (FSA, 2016).  
The self-limiting nature of the disease results in many cases been unreported 
(Samuel et al., 2004). Therefore, the actual number of cases is almost certainly 
higher (Golz et al., 2014). It is estimated that the actual number of cases would be 
around 10 times higher. It also appears to be sporadic and consistent with a peak 
during the summer season where the activity of barbequing is popular (Tauxe and 
Blake, 1992, Nichols, 2005). The peak month for Campylobacter species reporting 
in 2015 was June (Figure 1.2B) (PHE, 2016). 
Campylobacteriosis occurs in all age groups (Figure 1.2A). In developed countries, 
young children, young adults and the very elderly are susceptible, whereas in 
developing countries, young children are the high-risk individuals and many of the 
cases are fatal (Cody et al., 2012, Butzler and Skirrow, 1979a). Higher cases may 
occur in young children probably because of a lack of immunity and a lack of proper 
good hygiene practices as well as potentially higher contamination in food 
preparation (Cody et al., 2012). However, Campylobacter species were found in 
higher numbers in stool samples of young adults compared to young children, and 
higher in males than in females (Butzler and Lauwers, 1979, Butzler and Skirrow, 
1979b). In England, the 50 – 59 year age group was the highest number of cases 
infected with Campylobacter (PHE, 2016).  
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Figure 1.1. Campylobacteriosis causes more bacterial enteritis disease in 
humans compared to Salmonellosis. The underreporting of Campylobacter 
infections because of the self-limiting nature of disease would suggests that the 
true number of cases is probably higher. Report from human zoonoses cases and 
notification rates in EU in 2013. Reproduce from (EFSA, 2015). 
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Figure 1.2. Campylobacteriosis incidence showing distribution in age and 
sex and seasonal occurance. A. Age/sex distribution of laboratory reports of 
Campylobacter species and B. Seasonality of laboratory reports of Campylobacter 
species reported in England in 2015. Reproduced from Public Health England 
(PHE, 2016). 
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1.4 Intestinal epithelial cells 
 
Intestinal epithelial cells (IECs) form the first barrier in the intestine to harmful 
substances as well as offering a portal of entry for many enteric bacterial 
pathogens. Enteric bacterial pathogens ability to breach this barrier will potentially 
increase virulence and successful disease production (Wessler and Backert, 
2008). The integrity of an intact barrier of IECs is maintained by several features 
exhibited by polarised epithelial cells. Structures such as distinct apical and baso-
lateral surfaces, microvilli with a defined brush border, proper tight junctions (TJs) 
and adherence junctions (AJs), as well as a highly organised actin cytoskeleton, 
help form fully functional IECs (Laukoetter et al., 2008). The cell adhesion 
structures that are responsible for cell membrane integrity are the TJs, the AJs and 
in addition at the basal surface, the integrin-mediated cell matrix such as focal 
adhesions (FAs) and hemidesmosomes (HDs).  
TJs are maintained by junction adhesion molecules (JAMs), claudins and 
occludins, as well as other proteins. TJs are localised laterally at the apical side 
and are responsible for tight sealing of cell monolayers. TJs control movement of 
membrane proteins, lipids and paracellular ion influx. AJs are maintained by an E-
cadherin-based network of membrane proteins and associated molecules. AJs are 
localised basally to TJs and are responsible for mechanical adhesion between 
neighbouring cells. E-cadherin functions as an adhesive protein and also as a 
regulator of cell proliferation. In addition, E-cadherin is involved in transmitting a 
signal to the actin cytoskeleton via β-catenin via the intracellular domain of E-
cadherin. At the basal membrane of IECs, FAs are maintained by transmembrane 
receptor protein integrins α5β1. This integrin with two subunits of α and β chains 
binds to extracellular matrix (ECM) proteins at the plasma membrane via 
fibronectin and to microfilaments of the actin cytoskeleton in the cytoplasm via 
various adapter proteins such as vinculin and paxilin, and also signalling enzymes 
including focal adhesion kinase (FAK). These linkages are able to transmit various 
signals from outside the cell and result in various changes or reorganisation of the 
actin cytoskleton inside the cell. HDs also have a complex network of protein 
interactions that involve integrin α6β4, laminin and plectin (Backert et al., 2013).  
Previous studies have reported that C. jejuni is able to attach and invade both non-
polarised and polarised intestinal cells (IECs) in vitro including INT 407 (Monteville 
et al., 2003), Caco-2 (Everest et al., 1992) and T84 cells (Monteville and Konkel, 
2002). Although the adherence ability of different C. jejuni strains was similar to 
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some extent, invasion and transmigration capacities have been reported to be 
highly variable in different IEC lines. For translocation studies, polarised cells are 
widely used because the bacteria are required to cross tight polarised monolayer 
cells. Non-polarised cells express only FAs but polarised cells express TJs, AJs 
and HDs together with FAs. Typical polarised IECs include Caco-2, T84, MDCK-1 
and MKN-28. In addition some polarised IECs are able to produce a mucus layer 
such as HT29 MTXE-12 (Alemka et al., 2010), hence providing a better mimic of 
the intestinal natural environment and may produce more relevant results. 
Therefore, in order to impact, proliferate and survive in host cells, many enteric 
bacterial pathogens including C. jejuni employ various mechanisms to exploit and 
overcome TJs, AJs, HDs and FAs. Furthermore, studies have shown that C. jejuni 
invades cells of human origin more efficiently compared to non-human cells, 
indicating that C. jejuni is a successful human enteric bacterial pathogen (Konkel 
et al., 1992a). 
 
 
Figure 1.3 Schematic diagram showing characteristic of epithelial cell. 
Barrier function of the mucosa is largely determined by tight junctions. 
Reproduce from Antarnik.org 
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1.5 Campylobacter jejuni pathogenesis 
 
C. jejuni interaction with host cells is a multifactorial processes and involve various 
identified and unidentified virulence factors. These complex host-pathogen 
interactions require motility, adhesion, translocation, invasion, protein secretion, 
toxin production, as well as intracellular survival of C. jejuni to successfully impact 
host cells and cause disease. Studies have suggested (Hu et al., 2008, Konkel et 
al., 1992b) C. jejuni pathogenesis involves multiple steps but during the initial 
stages of infection, C. jejuni appears to interact with host cell protrusions. This was 
visualised using electron microscopy, showing the C. jejuni 81-176 wild-type strain 
to adhere, invade, translocate across and exit polarised Caco-2 IECs (Hu et al., 
2008). C. jejuni is reported to adhere to host cells via CadF and FlpA adhesins for 
maximal adherence (Konkel et al., 2010, Monteville et al., 2003). C. jejuni is 
capable of transcellular translocation across human polarised epithelial 
monolayers (Bras and Ketley, 1999). C. jejuni entry via the paracellular pathway 
was also reported and this involved no reduction in transepithelial electrical 
resistance (TEER). HtrA (high-temperature requirement A) protein has been 
shown to play a role in mediating the cleavage of E-cadherin (Boehm et al., 2012). 
In addition, a study reported an alternative entry pathway that C. jejuni may utilise 
referred to as subvasion. In the subvasion entry pathway, C. jejuni was suggested 
to enter host epithelial cells baso-laterally (Bouwman et al., 2013). Another study 
supported this showing C. jejuni preferentially entering T84 cells at the baso-lateral 
surface (Monteville and Konkel, 2002).  
Following invasion of IECs, C. jejuni secretes putative invasion effectors into host 
cells that activate host cell signalling pathways and trigger C. jejuni-induced 
changes in many host cell signalling proteins. Krause-Gruszczynska et al. reported 
C. jejuni-induced GTPase activation including Cdc42 (Krause-Gruszczynska et al., 
2011). Phosphorylation of host proteins as a prerequisite for C. jejuni invasion was 
also reported by studies using protein kinase inhibitors (Biswas et al., 2004, Hu et 
al., 2006). Internalised C. jejuni induces gastroenteritis through either inflammation 
or physical tissue damage (Young et al., 2007, Ketley, 1997). The ability of C. jejuni 
to induce pro-inflammatory cytokines in the host cells such as IL-8, is thought to 
be the major cause of gastroenteritis (Watson and Galan, 2005). HeLa cells 
infected with C. jejuni resulted in activation of the central immune modulator 
nuclear factor (NF-ĸB) (Mellits et al., 2002).  
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Previous studies have shown that the host cell cytoskeleton is reorganised to 
facilitate internalisation of C. jejuni with involvement of microfilaments (MFs) or 
microtubules (MTs) or both (Biswas et al., 2003, Kopecko et al., 2001). Hu & 
Kopecko reported that internalised C. jejuni moves along dynein (a molecular 
motor) in MTs to the perinuclear region of host cells (Hu and Kopecko, 1999). 
Moreover, C. jejuni 81-176 wild-type strain is able to replicate in a host cell vacuole 
and induce apoptosis via cytolethal distending toxin (CDT) (Hickey et al., 2005). 
CDT breaks double stranded DNA and causes cell cycle arrest (Lara-Tejero and 
Galan, 2000). 
Intracellular survival may facilitate the dissemination of C. jejuni locally. C. jejuni 
81-176 resides in a Campylobacter-containing vacuole (CCV) in T84 cells (Watson 
and Galan, 2008) and survives for several days in monocytes (Bouwman et al., 
2013, Kiehlbauch et al., 1985). In addition, it was shown that C. jejuni 81-176 can 
form microcolonies / biofilms on human intestinal epithelial tissue (Haddock et al., 
2010). Van Rhijn et al. reported that C. jejuni DNA was present circulating in 
myelomonocytic cells (Van Rhijn et al., 2003). 
Recently, it was reported that not only is C. jejuni colonisation dependent on the 
host microbiota, but that this can also cause changes to the composition of the 
intestinal microbiota (Awad et al., 2016). 
 
 
1.5.1 C. jejuni adhesion mechanisms 
 
Colonisation of host tissues is an important step in bacterial infection. One of the 
mechanisms involved in colonisation is attachment of bacteria to host cells via 
specific interactions between bacterial adhesins and host cell receptors. 
Adherence to IECs is a multifactorial event that is proposed to be fundamental to 
C. jejuni pathogenesis (Backert et al., 2013, O Croinin and Backert, 2012). 
However, many of the precise molecular mechanisms involved in the attachment 
of C. jejuni to eukaryotic cells are still unclear.  
Currently the hypothetical model of C. jejuni invasion involves two proposed 
pathways which are the zipper and trigger mechanisms (Figure 1.3) (O Croinin and 
Backert, 2012). The ‘zipper mechanism’ is commonly used by many pathogens 
that colonise the gastric intestinal tract. A high-affinity adhesin on the surface of 
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bacteria and a receptor on the host cell are required for the ‘zippering’ of the 
plasma membrane around the bacteria resulting in membrane engulfment. In the 
‘trigger mechanism’ used by Salmonella and Shigella species, various bacterial 
effector proteins injected by either a type III secretion system (T3SS) or a type IV 
secretion system (T4SS) will initiate and activate rearrangement of the host cell 
cytoskeleton and allow entry of the pathogen into host cells. 
                 
 
                         
                               
                                             
Figure 1.4 Primary mechanisms of bacterial invasion into non-phagocytic 
host cells. Schematic representation of the two different routes of entry by 
intracellular bacterial pathogens. The pathogens induce their own uptake into 
target cells by subversion of host cell signaling pathways using the “zipper” and 
“trigger” invasion mechanism, respectively. Reproduced from (O Croinin and 
Backert, 2012). 
Many studies have reported different proteins and carbohydrates to play important 
roles in adhesion of C. jejuni to hosts cells both in vivo and in vitro. (Table 1.1) 
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1.5.1.1 Flagella 
 
C. jejuni flagellin is thought to act as an adhesin for epithelial cells whilst motility is 
a virulence factor for C. jejuni (Guerry, 2007). FlaA and FlaB are the major and 
minor flagellins respectively and highly homologus (Guerry et al., 1991). A study 
reported that a flagellated and non-motile (flaA flaB+ Mot-) C. jejuni mutant showed 
similar ability in adherence to INT 407 cells when compared to a non-flagellated 
and non-motile (flaA flaB Mot-) mutant. However, the flaA flaB Mot- mutant showed 
a reduction in invasion compared to the flaA flaB+Mot- mutant (Grant et al., 1993). 
In addition, both mutants were inhibited in the ability to translocate across Caco-2 
monolayers compared to control strains. This data suggests that C. jejuni flagella 
play a role in internalisation but not in adherence to epithelial cells (Grant et al., 
1993). FlaC has sequence homology to the N- and C-terminal regions of the FlaA 
and FlaB flagellins but lacks the central domain (Song et al., 2004). However, a 
study showed that FlaC binds to Hep-2 cells and flaC mutants show a reduction in 
invasion of epithelial cells (Song et al., 2004). 
 
  
1.5.1.2 PEB1A 
 
One of the first proteins identified to play a role in C. jejuni adherence was PEB1A. 
PEB1A is a periplasmic binding protein component of an ABC transporter. PEB1A 
is a 28 kDa common antigen highly conserved and found in all C. jejuni and C. coli 
strains (Pei and Blaser, 1993, Pei et al., 1998). PEB1 from C. jejuni 81-176 wild-
type strain was suggested to be involved in binding to intestinal cells and also in 
transporting amino acids, hence the suggestion of a dual function (Pei and Blaser, 
1993). In another study, colonisation studies in a mouse model with a peb1A 
mutant showed a reduction in the rate and the duration of colonisation significantly 
lower and shorter compared to the wild-type strain (Pei et al., 1998). Peb1 in the 
C. jejuni F38011 wild-type strain was also reported to play a role in vivo in 
colonising broiler chicks (Flanagan et al., 2009). However in another study, a 81-
176 peb1A mutant was reported to show no difference in cellular adhesion (Novik 
et al., 2010). 
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1.5.1.3 PEB3 
 
PEB3 is a 30 kDa cell surface glycoprotein (Pei and Blaser, 1993) and was shown 
to be involved in E. coli interactions with host cell receptors (Batisson et al., 2003). 
PEB3 is required for binding of the C. jejuni 11168H wild-type strain to immobilised 
soya bean agglutinin (SBA) lectin (Rubinchik et al., 2014). Although the mutation 
of peb3 in C. jejuni 11168H wild-type strain resulted in a reduced binding, this was 
restored by complementation. In addition, it was also suggested that other C. jejuni 
glycoproteins may be involved in adhesion to host cells. However in another study, 
PEB3 was found to play more of a role as a transport protein (Min et al., 2009). In 
this study, the PEB3 structure was shown to have some homology to transport 
proteins and linked to 3-phosphoglycerate (3-PG) utilisation.   
PEB4 was thought initially to function as adhesion (Asakura et al., 2007), however 
a recent study demonstrated that PEB4 is a chaperone that transports other 
proteins such as CadF to the outer membrane (Kale et al., 2011). 
 
 
1.5.1.4 CapA 
 
In the genome of C. jejuni NCTC 11168, CapA (Campylobacter adhesion protein 
A) was identified as putative autotransporter protein (Ashgar et al., 2007). CapA 
was identified as an outer membrane protein of 116 kDa and the presence of a 
lipid attachment site suggested that CapA is also a lipoprotein. A capA mutant 
exhibited reduced adhesion to and invasion of Caco-2 cells (Ashgar et al., 2007). 
CapA has also been reported to play a role in the ability of C. jejuni to colonise 
chickens. The ability of capA mutants to colonise and persist in chickens was 
reduced (Ashgar et al., 2007, Jin et al., 2001). Further, C. jejuni CapA was reported 
to play a significant role in adherence to chicken epithelial cells in vitro (Flanagan 
et al., 2009). 
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1.5.1.5 Type VI Secretion System 
 
Recent studies have reported that some C. jejuni strains possess a functional type 
VI secretion system (T6SS) which plays roles in survival against bile salt 
(deoxycholic acid (DCA)) stress and also in adherence and invasion of host cells 
(Lertpiriyapong et al., 2012). The T6SS was demonstrated to play an important 
role in C. jejuni ability to bind to T84 cells and murine RAW 2657.7 macrophages 
(Lertpiriyapong et al., 2012). Interestingly however, the T6SS was demonstrated 
to have opposing functions in survival and in interactions with host cells. For 
survival, the T6SS was ‘not required’; as a T6SS mutant was able to resist the 
effect of DCA compared to the wild-type strain. When C. jejuni was exposed to 
DCA, cmeA was up-regulated in the wild-type strain but not in the T6SS mutant 
and as a result wild-type proliferation was inhibited. In contrast, during interactions 
with host cells, the T6SS was ‘required’; as a T6SS mutant showed reduced 
adherence to and invasion of T84 cells in vitro and also reduced ability to colonise 
mice in vivo. When T84 cells were infected with C. jejuni, a haemolysin co-
regulated protein was over-expressed in the wild-type strain, but not in the T6SS 
mutant and as a result the adherence and invasion abilities of the T6SS mutant 
was reduced. Furthermore, when C. jejuni was inoculated into B6.129P2-IL-10 
mice, the T6SS mutant demonstrated a reduced ability to colonise compared to 
the wild-type strain (Lertpiriyapong et al., 2012). 
 
 
1.5.1.6 JlpA 
 
C. jejuni lipoprotein A (JlpA) is a novel surface-exposed lipoprotein, which has a 
molecular mass of 42.3 kDa and 372 amino acids residues. JlpA is released by 
the C. jejuni TGH9011 strain into culture media. This study by Jin et al. also 
showed that JlpA has a lipoprotein processing site at the N-terminus. JlpA was 
easily extracted from OMVs using detergents such as Triton X-100. The mutation 
of jlpA by insertion and deletion was shown to reduce binding to Hep-2 cells 
compared to that of the TGH9011 wild-type strain (Jin et al., 2001). In contrast, in 
other studies, jlpA mutants were observed to be able to bind to T84 cells at levels 
similar to the wild-type controls (Novik et al., 2010). A further study by Flanagan et 
al. reported that jlpA mutants can colonise broiler chickens and bind to chicken 
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hepatocellular carcinoma epithelial cells (LMH) as efficiently as the wild-type strain 
(Flanagan et al., 2009). JlpA is highly conserved in C. jejuni and also identified in 
the genomes of C. coli RM 2228, C. lari RM2100 and C. upsaliensis RM3195 (Jin 
et al., 2001). The crystal structure showed that JlpA was composed of a single 
domain of a large β-sheet in the middle with 11 α-helices (Kawai et al., 2012). 
However, results from the study above demonstrated that the impact of JlpA on 
adhesion may be strain dependent and also the type of cells used that results in 
the inconsistency in the published data. 
 
1.5.1.7 MOMP 
 
A C. jejuni major outer membrane protein (MOMP) is encoded by the porA gene 
(Islam et al., 2010) and has been shown to bind to ECM components such as 
fibronectin (Moser et al., 1997). A 42 kDa MOMP in C. jejuni 10945 was shown to 
bind to INT 407 cells (Moser et al., 1997, Schroder and Moser, 1997). Recently, 
an O-linked glycosylated MOMP in NCTC 11168 was shown to bind to histo-blood 
group antigens (BsAgs) and also adhere to host cells. In this study, a 45 kDa 
MOMP was reported to promote cell to cell adhesion, adherence to Caco-2 cells, 
promote biofilm formation but was also required for optimal colonisation of 
chickens (Mahdavi et al., 2014). 
 
 
1.5.1.8 PldA 
 
Phospholipase A is a 35 kDa outer membrane protein. A pldA mutant showed 
reduced ability to colonised chicks ceacum (Ziprin et al., 2001). Another study 
suggested that PldA played role in C. lori virulence (Grant et al., 1997). 
 
 
1.5.1.9 pVir 
 
Some strains of C. jejuni carry a plasmid termed pVir which is 37 kb in size (Guerry 
et al., 2000). The C. jejuni 81-176 strain but not the NCTC 11168 strain contains 
pVir. pVir expresses proteins that show some homology to T4SS transport 
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proteins. Mutations of two of the pVir genes encoding ComB3 and VirBII that are 
involved in natural transformation and protein transport respectively, significantly 
reduced C. jejuni 81-176 wild-type strain adherence to and invasion of INT 407 
(Bacon et al., 2000). 
 
 
 
1.5.1.10 CadF and FlpA 
 
Probably the most established adhesion proteins and also the most highly 
conserved in C. jejuni are Campylobacter adhesion to fibronectin (CadF) (Konkel 
et al., 1997) and Fibronectin-like protein A (FlpA) (Flanagan et al., 2009). Both 
proteins are able to bind to fibronectin on host cell membranes that could possibly 
provide a linkage platform towards bacterial invasion (Eucker and Konkel, 2012). 
CadF and FlpA are described in more detail in Section 1.7.1 and 1.7.2 respectively. 
Table 1. 1. C. jejuni virulence factors reported to be involved in adhesion to 
intestinal epithelial cells. 
Virulence factor(s) Encoding 
gene(s) 
References 
 
CadF, outer membrane protein cadF (Konkel et al., 1997) 
 
CapA, Campylobacter adhesion 
protein A 
capA (Jin et al., 2001) 
 
Phospholipase A pldA (Ziprin et al., 2001, 
Dekker, 2000) 
 
JlpA, lipoprotein involved in 
adhesion to Hep-2 cells 
 
jlpA (Jin et al., 2001) 
PEB1, periplasmic binding protein peb1A (Pei and Blaser, 1993) 
 
PEB3, transport protein peb3 (Min et al., 2009) 
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PEB4, chaperone playing an 
important role in exporting proteins 
to the outer membrane 
 
peb4 (Kale et al., 2011) 
FlpA, fibronectin–like protein flpA (Flanagan et al., 2009) 
 
Type IV secretion system possibly 
involved in adhesion 
virB1 (Bacon et al., 2000, 
Dasti et al., 2010) 
 
 
Reported C. jejuni adhesion factors reproduced from (Bolton, 2015). 
 
 
1.5.2 C. jejuni invasion mechanisms 
 
Invasion of C. jejuni into IECs is well established as a result of many studies 
(Konkel et al., 2013, Kopecko et al., 2001). These studies have shown that C. jejuni 
is able to penetrate the IECs mucosal layer resulting in successful colonisation and 
invasion of IECs (Backert et al., 2013, Boehm et al., 2012, Corcionivoschi et al., 
2009). In studies using microscopy, C. jejuni was observed to invade polarised 
cells such as Caco-2 IECs in vitro from the baso-lateral surface (Bouwman et al., 
2013), where once internalised the bacteria will move towards the apical surface. 
Many routes of entry into intestinal cells have been reported for C. jejuni. Some 
are dependent on MTs and MFs (Kopecko et al., 2001, Monteville et al., 2003, Hu 
and Kopecko, 1999); others are independent of both (Bouwman et al., 2013). Table 
1.2 shows virulence factors reported to be involved in C. jejuni invasion into host 
cells. 
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Table 1.2. C. jejuni virulence factors reported to be involved in invasion of 
intestinal epithelial cells. 
Virulence factor(s) Encoding gene(s) References 
FlhA, FlhB, FliQ, Flip,FliO 
& FliR, components of 
the flagellar Type III 
secretion system 
flhA, flhB, fliQ, flip,fliO & 
fliR 
(Carrillo et al., 2004) 
FlaC, essential for 
colonisation and invasion 
flaC (Konkel et al., 2004, 
Carrillo et al., 2004) 
CiaB, involved in 
adhesion 
ciaB (Konkel et al., 2004) 
CiaC, required for full 
invasion of INT 407 cells 
ciaC (Eucker and Konkel, 
2012) 
CiaI, plays a role in 
intracellular survival 
ciaI (Buelow et al., 2011) 
IamA, invasion 
associated protein 
iamA (Rivera-Amill et al., 
2001) 
HtrA, protease involved 
in the proper folding of 
adhesins, cleaves E-
cadherin 
htrA (Baek et al., 2011, Elmi 
et al., 2016) 
VirK, may have a role in 
protection against 
antimicrobial proteins 
virK (Novik et al., 2009) 
FspA, role in apoptosis fspA (Poly et al., 2007) 
 
Proteins reported to be associated with C. jejuni invasion of IECs. Reproduced 
from (Bolton, 2015).  
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1.5.2.1 CiaB 
 
C. jejuni does not possess a T3SS like other enteropathogenic bacteria such as 
E. coli, Salmonella and Shigella to directly inject effector proteins into host cells. 
However, C. jejuni can utilise the flagellar apparatus to function as a secretion 
system to secrete virulence proteins into surrounding environments (Konkel et 
al., 2004). These proteins are termed Campylobacter invasion antigens (Cia) and 
have been identified to play a role in the invasion of and intracellular survival 
within host cells (Konkel et al., 1999b, Rivera-Amill and Konkel, 1999, Konkel et 
al., 2004). CiaB was reported to be important for internalisation of C. jejuni into 
INT 407 cells (Konkel et al., 1999c). A ciaB mutation in C. jejuni F38011 wild-type 
strain resulted in a non-invasive phenotype (Rivera-Amill and Konkel, 1999). 
However, Novik et al showed that C. jejuni 81-176 ciaB mutant does not exhibit 
reduced invasion into T84 cells (Novik et al., 2010).  
 
 
1.5.2.2 CiaC 
 
CiaC has been reported to play a role in C. jejuni invasion into INT 407 cells. The 
study showed that CiaC was delivered into the host cytosol upon C. jejuni adhering 
to epithelial cells via a flagellar hook complex that consisted of FlgE, FlgK and 
FlgL. Furthermore, the genes encoding the Cia proteins are up-regulated during 
C. jejuni infection of INT 407 cells. In addition, CiaC is also involved in host cell 
cytoskeleton rearrangements and causes membrane ruffling via activation of 
Rac1. However, a flgL mutant was not able to induce membrane ruffles in INT 407 
cells (Neal-McKinney and Konkel, 2012, Eucker and Konkel, 2012). 
 
 
 
1.5.2.3 CiaD 
 
CiaD is another a Cia effector protein identified in 2013 (Samuelson et al., 2013). 
The study reported that CiaD activated host cell MAP kinase signalling pathways  
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that involved p38 and Erk1/2. Activation of these pathways promotes invasion by 
C. jejuni and release of IL-8 from the host cell (Samuelson et al., 2013). 
 
 
1.5.2.4 CiaI  
 
Cial was reported to be involved in C. jejuni intracellular survival as a cial mutant 
exhibited reduced survival in INT 407 compared to the wild-type strain. In addition, 
epithelial cells infected with a cial mutant showed the Campylobacter-containing 
vacuole (CCV) to be more frequently co-localised with a lysosomal marker 
(Cathepsin D) compared to the cells infected with the wild-type strain (Buelow et 
al., 2011). 
 
 
1.5.3 Translocation 
 
Translocation is a virulence mechanism employed by pathogens to enable 
dissemination in the host cells. Enteropathogens such as Salmonella, Shigella and 
Listeria traverse host IECs using different translocation mechanisms including 
transcytosis of enterocytes or M cells and phagocytosis (Bras and Ketley, 1999). 
Transcytosis is apical endocytosis followed by basolateral exocytosis (Hu et al., 
2008). Although translocation in C. jejuni was suggested to involve passing both 
across and between cells, this is still not confirmed. However, studies suggest that 
penetration of the intestinal mucosa by C. jejuni may be the cause of inflammation 
and enteritis disease (Black et al., 1988, Blaser et al., 1983).  
IECs grown on Transwell filters can form polarised monolayers and exhibit 
characteristics of normal small intestine epithelial cells. Polarised cells exhibit a 
defined brush border and TJs that separate apical and baso-lateral surfaces which 
form a permeability barrier (Konkel et al., 1992c, Finlay and Falkow, 1990). These 
cells have been used in many studies to investigate the pathogenic potential in 
crossing cell barriers (Finlay and Falkow, 1990, Grant et al., 1993, Boehm et al., 
2012). Bacteria passing through IECs is termed the transcellular route and will not 
interrupt TEER. Bacteria passing between cells is termed the paracellular route 
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(Figure 1.4). In the paracellular pathway, TEER will decrease as a result of 
disruption of TJs and AJs caused by bacterial invasion. Some studies have shown 
data that supports C. jejuni translocation across IECs through the transcellular 
pathway while other studies have shown data that supports the paracellular 
pathway (Boehm et al., 2012, Monteville and Konkel, 2002, Wine et al., 2008, 
Louwen et al., 2012). 
C. jejuni translocation has been shown to be time-dependent and reached a 
maximum rate 4 h post-infection. This study also indicated that low temperature 
inhibited C. jejuni adherence to, invasion of and translocation across Caco-2 cells 
(Konkel et al., 1992c). Flagella are suggested to play a role in translocation 
because a study showed that non-flagellated non-motile C. jejuni mutants were 
not able to translocate across polarised Caco-2 cells compared to the wild-type 
strains. However, the non-flagellated non-motile mutants were found to adhere to 
INT 407 cells equally as well as flagellated non-motile mutants (Grant et al., 1993).  
 
 
 
Figure 1.5. Hypothetical model for C. jejuni transmigration across intestinal 
epithelial cells. Polarised cells such as Caco-2 and T84 exhibit defined apical and 
baso-lateral surfaces with TJs and AJs that provide tight monolayers when grown 
on a Transwell filter membrane. C. jejuni is suggested to use transcellular or 
paracellular routes or both to translocate into the lamina propria. Reproduced from 
(Backert and Hofreuter, 2013). 
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1.6 Intracellular survival 
 
Several studies have investigated the fate of C. jejuni after entering the host cell. 
In an earlier study, C. jejuni wild-type strains 2964 and 1702 were observed to be 
phagocytosed more successfully by human monocytes compared to murine 
macrophages (Kiehlbauch et al., 1985). The internalised C. jejuni appeared to be 
inside a vacuole, either as a single spiral bacterium or a mixture of spiral and 
coccoid bacteria in a larger vacuole. Once phagocytosed, C. jejuni changes shape 
from spiral to coccoid within 4 h to 6 h compared to within 24 h in controls 
(Kiehlbauch et al., 1985). Also in that study, C. jejuni was observed to survive 
intracellularly for up to 7 days, whereas a later study reported C. jejuni can only 
survive up to 48 h (Bouwman et al., 2013).   
In another study using Hep-2 cells, a strong lysosomal response was observed 
following invasion by C. jejuni (De Melo et al., 1989). Endosome-lysosome fusion 
was observed with acid phosphatase activity evident at the surface of the 
internalised bacteria, most of which then showed signs of degradation by changing 
to a coccoid form. A gentamicin protection assay indicated that bacterial viability 
declined after 6 h, with few bacteria remaining viable after 36 h. C. jejuni were also 
found in INT 407 cells up to 96 h post-inoculation if gentamicin treatment was 
reduced in steps and electron microscopy confirmed the presence of viable 
intracellular C. jejuni (Konkel et al., 1992b). Removal of the antibiotic resulted in a 
cytopathic effect after 48 h, which was coincident with an increase in extracellular 
bacteria.  
The bacterial and host factors important in determining the fate of intracellular C. 
jejuni are not clearly understood. Endosome acidification may not play a role as 
inhibition of acidification with monensin did not affect intracellular survival 
(Oelschlaeger et al., 1993). Reduction of the short-term intracellular survival in INT 
407 cells of a C. jejuni sodB mutant when compared to the wild-type strain, 
indicates that reactive oxygen species influence intracellular survival (Pesci et al., 
1994, Purdy and Park, 1994). The identification of a catalase KatA (Grant and 
Park, 1995) indicated that C. jejuni may have other determinants that form part of 
a defence system against oxidative stress as catalase was suggested to play a 
role in intracellular survival (Day et al., 2000). Interestingly, oxidative stress can 
increase the invasive potential of C. jejuni (Harvey and Leach, 1998). C. jejuni may 
not necessarily remain within membrane-bound vacuoles in the cytoplasm of 
tissue culture cells (Konkel et al., 1992a) although some reports did not observe 
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cytoplasmic bacteria (Oelschlaeger et al., 1993) (Konkel and Cieplak, 1992). In 
other studies, free C. jejuni within the cytoplasm were observed and were 
associated with a cytopathic effect (Ketley, 1997, Russell et al., 1993). 
In a study in 2008, C. jejuni was found to co-localise in a membrane-bound 
compartment (Watson and Galan, 2008). The compartment was termed the 
Campylobacter-containing vacuole (CCV) as it contains and is induced by C. jejuni 
bacteria just like previous studies that had observed C. jejuni inside a vacuole once 
internalised in host cells (Kiehlbauch et al., 1985, Konkel et al., 1992b, Hickey et 
al., 2005). By residing in this CCV, C. jejuni avoids being lysed by lysosome 
because the CCV somehow follows a different pathway instead of the lysosomal 
one (Watson and Galan, 2008). This phenomenon can also be seen with the 
Salmonella-containing vacuole (SCV) created by Salmonella upon entry into 
intestinal cells (Finlay et al., 1988, Steele-Mortimer, 2008, Knodler and Steele-
Mortimer, 2003, Steele-Mortimer et al., 2002, Steele-Mortimer et al., 2000). 
However, one study has shown that C. consicus co-localised with the 
autophagosome, which has a double membrane that subsequently will fuse with 
the lysosome for the continuing process of lysing the engulfed bacteria (Burgos-
Portugal et al., 2014). 
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Figure 1.6. Schematic model of C. jejuni intracellular survival within IECs. 
Following internalisation, C. jejuni resides in a CCV. The CCV has different 
markers from the markers for endocytic pathways, and is prevented from lysis by 
lysosome. Reproduced from (Watson and Galan, 2008). 
To date, many studies have shown that C. jejuni resides in a CCV and that being 
within that CCV or phagocytosed increases the intracellular survival of C. jejuni 
and may result in successful replication within the cells (Figure 1.5). 
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1.7 Outer membrane vesicles 
 
C. jejuni lacks the specific virulence-associated secretion systems of other enteric 
pathogens such as T3SS and T4SS, so an alternative method to deliver virulence 
factors is using outer membrane vesicles (OMVs). OMVs were first thought of as 
an artefact of bacterial growth. Since that initial discovery, it has become evident 
that almost all Gram-negative bacteria produce OMVs as part of their normal 
growth. Many pathogenic bacterial species have been reported to produce OMVs 
include E. coli, Shigella species, Salmonella species (Bae et al., 2014, Elhenawy 
et al., 2016), Helicobacter pylori (Turner et al., 2015, Fiocca et al., 1999), Vibrio 
species (Chatterjee and Chaudhuri, 2011), Pseudomonas aeruginosa (Bomberger 
et al., 2009, Bauman and Kuehn, 2006), Yersinia pestis (Eddy et al., 2014) and C. 
jejuni (Elmi et al., 2012, Lindmark et al., 2009, Jang et al., 2014).  
 
 
1.7.1 Biogenesis and composition of OMVs 
 
Most Gram-negative bacteria release OMVs (Bauman and Kuehn, 2006) and in all 
phases of growth (McBroom and Kuehn, 2005, Mayrand and Grenier, 1989). This 
was first observed when a cell free filtrate of Vibrio cholera was able to trigger an 
immune response in rabbits (Kulkarni and Jagannadham, 2014). OMVs were 
suspected to contain the immunogenic properties of the Outer Membrane (OM) 
components of Gram-negative bacteria that could somehow manage to leach into 
the medium. OMVs are now known to play roles in secreting virulence factors that 
increase bacterial survival in host cells (Kuehn and Kesty, 2005). 
Both Gram–negative pathogenic and non-pathogenic bacteria are known to 
release extracellular membrane–bound vesicles (Kulkarni and Jagannadham, 
2014) that have a size range from 20 to 500 nm (Kulp and Kuehn, 2010). OMVs 
are formed from a ‘pinched’ section of the OM (Klimentova and Stulik, 2015). 
OMVs are also known by other names such as ‘membrane vesicles’, ’blebs’ or 
‘outer membrane fragments’ (Ellis and Kuehn, 2010, Kulp and Kuehn, 2010). OMV 
production can be triggered when cross-linking between peptidoglycan and the 
OM is reduced. OMVs are released to relieve the turgor pressure exerted by PG 
during cell wall synthesis (Rolhion et al., 2005). Other suggested mechanisms for 
OMVs formation are increased phosphoslipids in OM, LPS and other proteins 
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result in curvature and leads to vasculation of OMVs from the OM. OMVs are not 
a product of cell lysis as they contain newly synthesised proteins. Bacteria produce 
OMVs on solid media, in liquid culture and during intracellular infections, also 
within biofilms (Klimentova and Stulik, 2015, Unal et al., 2011, Bjerre et al., 2002). 
Maximum OMV production was shown during exposure to physical and chemical 
stresses, as well as during the late log phase of bacterial growth (McBroom and 
Kuehn, 2007, Klimentova and Stulik, 2015). Other studies showed temperature, 
antibiotics and lack of nutrients increased release of OMVs by bacteria 
(Klimentova and Stulik, 2015, Collins, 2011). OMV composition and production can 
change as a result of host-pathogen interactions (Kuehn and Kesty, 2005). 
Generally, OMVs have similar components as the OM (Figure 1.6). OMVs have 
lipo-polysaccharides (LPS), phospholipids, peptidoglycan, outer membrane 
proteins (OMPs), proteins originating from periplasmic, cytoplasmic and 
membrane bound compartments, nucleic acids (DNA and RNA), ion metabolites, 
signalling molecules and cell wall components (Lindmark et al., 2009, Vanaja et 
al., 2016, Koeppen et al., 2016).  
 
             
                                     
Figure 1.7. Biogenesis of OMV production in Gram-negative bacteria. The 
OMVs composition reflects OM protein components such as LPS, 
glyserophospholipids, enclosed periplasmic components as well as OM proteins. 
Reproduced from (Jan, 2017). 
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1.7.2 Functions of OMVs  
 
With such a diverse composition from many aspects of cell interactions, OMVs will 
also have diverse functions depending on their composition. OMV roles can be 
offensive to the host cell or defensive to the bacterial cell as well as a tool for 
delivery of various effector molecules (Jan, 2017). OMVs have numerous functions 
that contribute to bacterial pathogenesis such as delivering bacterial virulence 
factors to host cells (Klimentova and Stulik, 2015), acting as metabolite and small 
molecule transporters, secreting toxins, as stress response mechanism promoters 
(McBroom and Kuehn, 2007), as a decoy or weapon for bacteriophages and 
initiation of biofilm formation (Yonezawa et al., 2009). 
OMVs act as delivery vehicle in P. aeruginosa to transport virulence factors such 
as β-lactamase, alkaline phosphatase, haemolytic phospholipase C and Cif. 
Fusion of the OMVs with lipid rafts in the plasma membrane facilitate virulence 
molecule entry directly into the host cytoplasm (Bomberger et al., 2009). H. pylori 
has also been reported to use OMVs to secrete the vacuolating cytotoxin VacA 
(Fiocca et al., 1999). 
It was hypothesised that C. jejuni may use OMVs to deliver bacterial virulence 
factors which promote the interaction with and invasion of IECs, as well as the 
modulation of the host response (Elmi et al., 2012, Klimentova and Stulik, 2015). 
One of the potent virulence mechanisms is vesicle-mediated toxin delivery. The 
CDT toxin including all subunits (CdtA, CdtB and CdtC) was found to be released 
by C. jejuni OMVs to the surrounding environment in infected host tissues 
(Lindmark et al., 2009). OMVs are reported to elicit inflammatory responses from 
infected host cell. OMVs from P. aeruginosa induced a significant IL-8 response 
from lung epithelial cells (Bauman and Kuehn, 2009). 
As a general stress response, OMVs have been found to be secreted more when 
the bacteria are under environmental stress (Klimentova and Stulik, 2015, 
McBroom and Kuehn, 2007). In non-pathogenic bacteria, the OMVs play protective 
roles by secreting properties that reduce toxic compound levels in the surrounding 
environment (Kuehn and Kesty, 2005). However, non-pathogenic bacteria produce 
less OMVs compared to pathogenic bacteria (Horstman and Kuehn, 2002). 
OMVs have many prospective applications such as drug delivery vehicles, 
communication tools, secretory systems, vaccines and adjuvants. Due to that, 
OMVs have the potential to become an agent for vaccine production.  
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1.7.3 C. jejuni outer membrane vesicles 
 
C. jejuni produces OMVs (Elmi et al., 2012). OMVs isolated from C. jejuni were 
shown to have different functions as described above. Proteomic analysis of C. 
jejuni OMVs isolated from the 11168H strain identified 151 proteins that included 
all three components of CDT (CdtA, CdtB and CdtC), the HtrA and Cj0511 
proteases, 16 N-linked glycoproteins including the major antigenic protein PEB3 
(Elmi et al., 2012). The fibronectin binding proteins CadF and FlpA were also 
identified in 11168H OMVs (Elmi et al., 2012) and in 81-176 OMVs (Watson et al., 
2014). In another study, proteomic analysis of OMVs from the C. jejuni NCTC 
11168 wild-type strain identified 134 vesicular proteins including some N-
glycoproteins (Jang et al., 2014).  
C. jejuni OMVs can trigger host innate immune responses from human T84 cells 
(Elmi et al., 2012). C. jejuni OMVs trigger production of IL-8, IL-6, TNF-α and hBD-
3 in a dose-dependent manner. IL-8 production depends on the concentration of 
11168H OMVs incubated with T84 cells. However, pre-treatment of host cells with 
methyl-beta-cyclodextrin prior to co-incubation with OMVs, resulted in a reduction 
in induction of IL-8, IL-6 and TNF-α (Elmi et al., 2012). This suggests that OMV 
entry into T84 cells is partially dependent on intact lipid rafts that require a 
cholesterol-rich microdomain. Studies have also shown a C. jejuni mutant lacking 
the CDT toxin exhibits reduced ability to induce IL-8 (Hickey et al., 2000), however 
other studies have shown OMVs isolated from a cdtA mutant induce IL-8 
production to the same extent as wild-type OMVs, suggestive that IL-8 production 
by OMVs is CDT-independent (Elmi et al., 2012). 
OMVs are also cytotoxic to cell lines as seen after Caco-2 cell exposure to OMVs 
which results in an increase of extracellular LDH released by the cells. Using G. 
mellonella as a model of C. jejuni infection showed that OMVs caused mortality to 
infected G. mellonella larvae. However, heat-treated OMVs showed reduced 
cytotoxicity in infected larvae (Elmi et al., 2012).  
In another study, OMVs isolated from the 81-176 strain were shown to play a role 
in adhesion and biofilm formation. In this study, the outer and inner membranes of 
81-176 were analysed. In addition CadF was up-regulated and a cadF mutant 
showed reduced adhesion to inert surfaces in oxygen-enriched conditions (19% 
O2) (Sulaeman et al., 2012). 
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Recently OMVs isolated from the 81-176 wild-type strain were shown to have 
protective properties in chicks challenged with C. jejuni by reducing ceacal 
colonisation. CjaA is a glycosylated extracytoplasmic highly immunogenic protein 
and conserved in different Campylobacter serotypes (Godlewska et al., 2016). In 
this study, OMVs from the 81-176 wild-type strain and OMVs that contained a high 
amount of CjaA were used as a vaccine in 18 day old chicken embryos. The 
immunisation showed a significant effect a week after infection, but this effect was 
short lived and was lost 2 weeks after infection (Godlewska et al., 2016).  
 
 
1.8 Galleria mellonela model of infection  
 
The human and insect immune systems, both humoral and cellular, share many 
similarities (Harding et al., 2013, Senior et al., 2011, Hoffmann, 1995). These 
include humoral immune responses via antibacterial peptides, coagulation, 
melanisation and production of reactive oxygen species (ROS), as well as cellular 
responses via the process of encapsulation and phagocytosis (Lavine and Strand, 
2002). Even though insect immune systems lack an acquired immune system 
mediated by B and T lymphocytes, insects have a well-developed innate immune 
system that reacts rapidly to infectious agents (Lavine and Strand, 2002). Insects 
have cells known as haemocytes that function to phagocytose pathogens and form 
aggregates that encapsulate and neutralise bacteria. Insect haemolymph detects 
LPS from bacteria and results in a rapid coagulation response. In addition, 
haemolymph also contains inhibitors and antibacterial peptides which are 
produced and released to eliminate the bacteria (Hoffmann, 1995). Foreign 
antigens are recognised by receptors on haemocyte surfaces or through 
opsonisation. Activation of the haemocytes will trigger a phenoloxidase (PO) which 
results in melanisation and production of anti-microbial compounds (Senior et al., 
2011, Lavine and Strand, 2002). Melanisation is an important cellular mechanism 
as a result of phagocytosis and encapsulation. The melanogenesis in insects 
produces cytotoxic molecules which are capable to interact with ROS, thus 
providing an effective immune response against foreign invaders (Nappi and 
Christensen, 2005).  
Many studies have established a good correlation between insect infection and the 
pathogenicity of several microorganism such as Listeria species, Legionella 
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species, Streptoccoccus pyogenes and several pathogenic fungi (Harding et al., 
2012, Mukherjee et al., 2010).   
Although several animal models have been used in Campylobacter research 
including primates (Russell et al., 1993), ferrets (Yao et al., 1997), mice (Watson 
et al., 2007), piglets (Babakhani and Joens, 1993), chicks (Flanagan et al., 2009, 
Nachamkin et al., 1993) and chick embryos (Field et al., 1986), all come with 
limitations and showed limited success (Chang and Miller, 2006). An alternative 
needed to be found and due to the lack of a convenient small animal model 
available to study C. jejuni pathogenesis, investigators turned to the use of insects 
as a model of infection.  
Galleria mellonella larvae are from the greater wax moth. The larvae are bred as 
live food for domestic reptiles and readily available commercially. Some of the 
advantages of using G. mellonella larvae include: 1. Easy to maintain as feeding 
is minimal, usually the wood chips that come with the box suffice; 2. Larvae can 
survive and be kept at 37oC before and during infection; 3. The larvae are small 
around 1-2 cm long so easy to handle; 4. Larvae can live for up to 3 weeks before 
turning into pupae; 5. Injection of a bacterial inoculum can be performed without 
anaesthetic (Harding et al., 2012) but simply by putting the larvae on ice for 20 
minutes renders them easy to handle. G. mellonella larvae have been used to 
study many aspects of pathogenesis such as cytotoxicity and antibiotic toxicity. G. 
mellonella larvae have become widely adopted as an insect model of infection to 
study a wide range of bacteria such as Yersinia pseudotuberculosis (Champion et 
al., 2009), Legionella pneumophilla (Harding et al., 2013), Listeria monocytogenes 
(Mukherjee et al., 2010), Shigella (Barnoy et al., 2017), E. coli (Heitmueller et al., 
2017) and C. jejuni (Champion et al., 2010). Larvae of G. mellonella have been 
shown to be susceptible to C. jejuni infection as previously described (Champion 
et al., 2010, Senior et al., 2011). Some studies have even successfully recovered 
C. jejuni 24 h post-infection (Senior et al., 2011).  
 
 
1.9 Role of the fibronectin binding proteins 
 
Fibronectin is a non-integral protein found on the surfaces of cells and in the 
extracellular matrix (ECM) (Henderson et al., 2011). Fibronectin is an essential 
large multi-domain glycoprotein that functions as a host adhesion (Pankov and 
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Yamada, 2002). Fibronectin links the cell through integrins to the extracellular 
environment, thus becoming a common major target for bacterial pathogens 
(Pankov and Yamada, 2002). Fibronectin also binds to many biologically important 
molecules including collagen, heparin and fibrin. In addition, fibronectin plays 
important roles in cell development such as growth, differentiation, adhesion and 
transmigration (Pankov and Yamada, 2002). 
Fibronectin is a major component of the ECM of epithelial cells. Fibronectin is a 
dimer of two very similar 220 kDa subunit glycoproteins linked by a pair of 
disulphide bonds present at regions of cell-to-cell contact between IECs (Konkel 
et al., 2010, Pankov and Yamada, 2002). Each monomer has three types of 
repeating units (Fibronectin repeats): type I, type II or type III. Type I contains two 
disulphide bonds and is about 40 amino acids in length; type II contains two intra-
chain disulphide bonds and is about 60 amino acids in length; type III has no 
disulphide bonds but is about 90 amino acids in length. Almost 90% of fibronectin 
sequences are made up of 12 type I repeats, 2 type II repeats and 15-17 type III 
repeats (Pankov and Yamada, 2002).  
Fibronectin acts as an adhesion molecule that anchors cells to ECM components 
via molecules called integrins. Integrins are cell-surface receptors that link the 
intracellular cytoskeleton to the ECM. Fibronectin acts as a ligand for many integrin 
receptors including the fibronectin classic receptor α5β1. The location for α5β1 
binding receptor can be found at FnIII9 and FnIII10, FnI1-9 and FnII1-2 (Pankov and 
Yamada, 2002). Many cellular interactions including tissue repair, blood clotting 
and cell migration and adhesion are facilitated by fibronectin.  
Cells rely on the surface protein fibronectin to interact with the cells surroundings, 
but many pathogens can also bind to this molecule and hijack the host cell 
signalling pathway mechanisms for the bacteria’s advantage (Cossart and 
Sansonetti, 2004). The binding to fibronectin will trigger signal molecular pathways 
and result in subsequent formation of focal adhesion complexes that rearrange the 
cytoskeleton of the cells and that allow bacterial uptake by the host cells. During 
the infectious process, C. jejuni must interact with receptors of the human IECs. It 
was suggested that the ability of C. jejuni to bind to fibronectin increases the 
probability of bacterial virulence proteins to come into closer contact with host cell 
factors and promote bacterial internalisation (Konkel et al., 1992c). There are 
numerous C. jejuni proteins that mediate the interaction between the multiple 
components of the IECs including fibronectin. The two most characterised are 
54 
 
Campylobacter adhesion to fibronectin (CadF) and Fibronectin-like protein A 
(FlpA) (Konkel et al., 2010, Konkel et al., 1999c). Substantial evidence exists that 
mutation of C. jejuni cadF or flpA results in a reduction in host cell invasion 
(Monteville et al., 2003, Ashgar et al., 2007). 
                        
 
 
Figure 1.8. Hypothetical model of C. jejuni entry into host cell mediated by 
CadF and FlpA. C. jejuni adheres to host cells via numerous reported and 
unknown factors. Several indicated host cell receptors have been proposed to play 
a role in the uptake of the bacteria. This potentially causes localised F-actin and/or 
microtubule rearrangements at the site of C. jejuni entry, resulting in engulfment 
and bacterial uptake. Several indicated host cell signaling molecules and pathways 
including the intracellular survival in CCVs have been reported in in vitro infection 
models and may play a role during pathogenesis in vivo. Reproduced from (O 
Croinin and Backert, 2012). 
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1.9.1 CadF 
 
The most extensively characterised C. jejuni fibronectin binding protein is CadF. 
CadF was first identified in 1997 (Konkel et al., 1997). CadF is a member of the 
microbial surface components recognising adhesive matrix molecules 
(MSCRAMMs) family. CadF has a molecular mass of 37 kDa and is an outer 
membrane protein that comprises 106 amino acid residues (Konkel et al., 1997). 
CadF is highly conserved amongst C. jejuni and C. coli strains which was initially 
confirmed by immunoblot analysis of 58 C. jejuni isolates of human and animal 
origin (Konkel et al., 1999a, Krause-Gruszczynska et al., 2007b). C. jejuni CadF 
showed 2 bands at a 37 kDa (p37) and 32 kDa (p32) whilst in C. lori the sizes were 
larger at 39 kDa (p39) and 34 kDa (p34) respectively. Four amino acids at position 
134-137 exposed on the surface of C. jejuni CadF have been shown to be 
responsible for the binding to fibronectin (Konkel et al., 2005). C. coli cadF has an 
extra 39 base pair insertion and as a result the binding to fibronectin was inhibited 
(Konkel et al., 1999a). Infection assays revealed that C. jejuni bound and invaded 
INT 407 epithelial cells much more efficiently than C. coli and that this difference 
was considerably reduced in C. jejuni cadF mutants compared to the wild-type 
strains (Monteville et al., 2003, Monteville and Konkel, 2002). More recent work by 
Neveda Naz (LSHTM PhD student, Personal communication) has also established 
that CadF from C. jejuni strain 81-176 plays a role in C. jejuni adhesion to human 
IECs (Caco-2 and T84 cells). Substantial evidence exists that mutation of C. jejuni 
adhesin genes results in a reduction in host cell invasion (Monteville et al., 2003, 
Ashgar et al., 2007). It was shown that CadF was required for maximal adherence 
to and invasion of INT 407 cells through binding to fibronectin. As a result, the 
binding activated the paxillin-mediated pathway and transmitted signals that cause 
cell cytoskeleton rearrangement through microfilament reorganisation (Monteville 
et al., 2003). 
Mamelli et al. attempted to purify CadF but this was found to be difficult and time 
consuming. They managed to purify small amount of CadF protein by extraction 
using mild detergent from the outer membrane of C. jejuni (Mamelli et al., 2006). 
A structural study analysis of the full length of the C. lori CadF was performed. This 
showed in comparison to the C. jejuni maximal fibronectin binding sequences that 
contain the residues phenylalanine-arginine-leucine-serine (FRLS) (Konkel et al., 
2005), C. lori CadF had the residues phenylalanine-alanine-leucine-glycine 
(FALG) instead (Hirayama et al., 2009). In addition, a CadF-like protein in C. lori 
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is 9 amino acids larger than the one in C. jejuni (Hirayama et al., 2009). A previous 
study has also suggested that CadF can be cleaved into smaller polypeptides but 
still able to bind to fibronectin. However, CadF was shown to be immunogenic as 
a full length structure, but not as the cleaved variant (Scott et al., 2010). 
A recent study reported that CadF was expressed in culture which is viable but 
non-culturable (VBNC) while incubated in fresh water at 4oC for 48 days. This 
suggests the potential role of CadF in combating oxidative impact in environmental 
stress and increased survival (Patrone et al., 2013). In another study, CadF in the 
C. jejuni 81–176 strain was up-regulated in the outer membrane of oxygen-
acclimatised cells, and a cadF mutant showed a reduction in adhesion to inert 
surfaces compared to the wild-type strain (Sulaeman et al., 2012). 
These results demonstrate that CadF is one of the many pathogenicity factors that 
C. jejuni possesses. CadF mediates the binding of C. jejuni to fibronectin, 
promotes bacterium-host interactions, and facilitates the bacterial colonisation of 
chickens. 
 
 
1.9.2 FlpA  
 
A second fibronectin binding protein was identified and named FlpA for fibronectin-
like protein A (Flanagan et al., 2009). In the study, it was reported that FlpA plays 
a role in colonising epithelial cells of chicks in vivo and a flpA mutant showed a 
reduction in adherence to chicken LMH hepatocellular carcinoma epithelial cells in 
vitro (Flanagan et al., 2009). Another study identified the amino acid sequence of 
C. jejuni NCTC 11168 FlpA (Cj1279c) that contained at least three Fibronectin type 
III domains which are surface-exposed domains (Konkel et al., 2010, Flanagan et 
al., 2009). In another study, FlpA was reported to be composed of three Fibronectin 
III-like repeats D1, D2 and D3, and binds the fibronectin-binding domain via a motif 
within the D2 repeat (Larson et al., 2013). FlpA binding affinity to fibronectin was 
reduced compared to CadF as shown by mutation in the C. jejuni F38011 strain 
(Konkel et al., 2010). It was reported that in addition to binding to fibronectin, FlpA 
also adheres to INT 407 cells. flpA mutants showed a reduction in adherence 
compared to wild-type strain, however, complemented strains restored the C. 
jejuni binding to INT 407 cells (Konkel et al., 2010). Further studies showed that 
the flpA mutant was completely prevented from colonising the chicken epithelium. 
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Accordingly, C. jejuni lacking a functional FlpA proved considerably less virulent 
than wild-type bacteria in a rodent model of infection, confirming the importance of 
this interaction. 
In a study by Larson et al., a residue of the Fibronectin-binding linear motif (FBLM) 
was identified in FlpA as a fibronectin binding domain (Larson et al., 2013). In 
addition, the study also reported that FlpA induced disease in a germ-free mouse 
model. FlpA is also required for maximal binding to intestinal epithelial cells and 
was able to activate Erk1/2 (Larson et al., 2013). Further, a C. jejuni cadF flpA 
double mutant was impaired in the activation of epidermal growth factor receptor 
(EGFR) and Rho GTPase Rac1 (Larson et al., 2013). Although these observations 
establish a role for fibronectin-binding proteins during C. jejuni invasion, their 
contribution to invasion mechanisms are unclear. Recent studies have highlighted 
the probability that FlpA and CadF may act collaboratively in targeting fibronectin 
on host cells (Eucker and Konkel, 2012). The resulting interaction from binding 
triggers a series of signalling events, including mechanisms that enable bacteria 
to penetrate the intestinal cell 
 
 
1.10 Visualisation of C. jejuni expressing GFP interaction with host cells 
 
Green fluorescent protein (GFP) usage in molecular microbiology has become 
increasingly common. GFP has been expressed in bacteria (Chalfie et al., 1994), 
yeast (Kahana et al., 1995), mould (Moores et al., 1996), plants (Casper and Holt, 
1996) and mammalian cells (Ludin et al., 1996). GFP can function as a protein tag 
and allows the host protein fused to maintain native function (Cubitt et al., 1995). 
In mammalian cells, GFP is typically distributed throughout the cytoplasm and 
nucleus. GFP as a non-invasive real-time marker allows enormous flexibility during 
applications in research including investigation in cell, developmental and 
molecular biology such as linage tracer, reporter of gene expression and proteins 
interaction (Valdivia et al., 1996, Miller et al., 2000). 
GFP is a 27 kDa protein isolated from the Pacific jellyfish Aequorea victoria. The 
protein is a monomer consisting of 238 amino acids and naturally fluorescent 
(Chalfie et al., 1994, Cody et al., 1993). GFP transduces the blue 
chemiluminecence of another protein, aequorin, into green fluorescence light, by 
energy transfer. The wild-type absorbance/excitation peak is at 395 nm and the 
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peak emission at 508 nm. The protein crystal structure is shaped as a cylinder, 
consisting of 11 strands of β-sheet wrapping around an α-helix. The protein fold 
cylinder is called ‘β-can’ and the fluorophores are protected within (Yang et al., 
1996). GFP requires no substrate or any cofactors, with addition of near UV or 
blue light will detect the protein readily. GFP requires oxygen to be in oxidised to 
fluoresce (Heim et al., 1994). GFP is thermosensitive, with maximal fluoresce at 
15oC and decreasing to 75% levels at temperatures greater than 30oC. Although 
GFP is a peptide, it is very resistant to denaturation. Partial or total denaturation 
can occur at a pH less than 4.0 or above 12.0 within minutes or with a strong 
oxidising agent such as 6 M of guanidine hydrochloride (GuHCL) at 90oC, but this 
is reversible (Yang et al., 1996). Thus, once produced expression of GFP is stable 
and resistant to photo bleaching (Chalfie et al., 1994). Incorporation of GFP into 
cells of wide variety of organisms does not seem to have toxic effects on the cells 
(Chalfie et al., 1994, Valdivia et al., 1996). 
Some studies have reported C. jejuni expressing GFP visualised in infected IECs. 
The first study showed C. jejuni expressing GFP fluorescence using flow cytometry 
and demonstrated that bacterial infection caused cell death (Konkel and Mixter, 
2000). This was followed by a study by Miller et al. who constructed C. jejuni 
expressing GFP with two different plasmids. It was found that GFP transformed 
into C. jejuni, fluoresce strongly and can be detected on plant tissue, chicken skin 
and inside infected Caco-2 cells (Miller et al., 2000).  
In 2003, a study by Mixter et al. reported that C. jejuni F38011 expressing GFP 
was readily detectable in vivo using fluorescence microscopy and flow cytometry. 
They constructed a shuttle vector pMEK91 using an ompE promoter with a 
tetracycline resistance cassette and gfp cloned into an EcoRI site. In the study, the 
C. jejuni GFP strain was injected into mice and the bacterial association was 
tracked with a marker for selected granulocytes (Mixter et al., 2003). 
In 2015, a study by Jervis et al. reported that C. jejuni 11168 expressing GFP was 
visualised invading HeLa cells. In the study, they constructed a plasmid pCJC1 
that contained a chloramphenicol resistance cassette (cat), with upstream and 
downstream sites. A region of C. jejuni pseudogene Cj0223 flanked both sites. 
Three different promoters were cloned into the pCJC1 upstream of the cat gene, 
namely porA from C. jejuni, ureI from H. pylori and flaA from Helicobacter pullorum. 
In addition, a GFP reporter gene were inserted downstream of each of the different 
promoters. The porA promoter produced the highest fluorescence, whilst the ureI 
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promoter produced the lowest. Following that, strains constructed with porA /GFP 
were investigated for in vitro invasion ability with HeLa cells. The results showed, 
the strains were readily visualised within the actin following staining and viewed 
with fluorescence microscopy. In addition, no significant effect on growth between 
strains expressing GFP and controls were observed (Jervis et al., 2015). 
GFP as a reporter protein is very versatile because it inherently fluoresces without 
the need for extra cofactors or substrates. This make it possible to visualise the 
fluorescence in live cells. 
 
 
1.11 Aims  
 
The aim of this study was to investigate the role of the CadF and FlpA fibronectin 
binding proteins during C. jejuni interactions with and invasion of human intestinal 
epithelial cells, comparing different wild-type strains and mutants. The effect of 
host immune responses to C. jejuni infection will also be investigated. Data from a 
previous study showed both cadF and flpA mutants had reduced interaction and 
invasion activity compared to the 81-176 wild-type strain (Neveda Naz, PhD 
Thesis, LSHTM, 2014). These studies showed that whilst 81-176 cadF and flpA 
mutants both exhibit reduced ability to adhere to IECs, the 81-176 flpA mutant 
exhibits a more significant reduction in invasion of IECs. This would suggest that 
FlpA plays a more important role in C. jejuni invasion than CadF. Therefore, this 
study aims to investigate whether the same phenotypic characteristics are 
observed in the 11168H wild-type strain, cadF and flpA mutants.  
Specific objectives: 
1. Investigation into the effects of mutation of cadF or flpA in the 11168H wild-
type strain and comparison with the same mutations in the 81-176 wild-
type strain; 
2. Investigation into the role of CadF and FlpA in the C. jejuni interactions with 
intestinal epithelial cells; 
3. Visualising C. jejuni 11168H wild-type expressing GFP during interactions 
with intestinal epithelial cells. 
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2.1 Bacterial strains and growth techniques 
 
2.1.1 Bacterial strains 
 
In this study, two C. jejuni wild-type strains and isogenic cadF and flpA mutants 
were used. The C. jejuni 11168H wild-type strain is a hypermotile derivative of 
NCTC 11168 (Karlyshev et al., 2002) which shows higher levels of colonisation of 
the GI tract of chicks and as such is considered a better strain to use to investigate 
host-pathogen interactions (Jones et al., 2004). The 11168H GFP strain was kindly 
provided by Dr Dennis Linton (University of Manchester). The 11168H cadF 
mutant and the 11168H cadF mutant expressing GFP were constructed in this 
study. The 11168H flpA mutant was from a previous study by Neveda Naz (a 
LSHTM PhD student), whilst the 11168H flpA mutant expressing GFP was 
constructed in this study. The C. jejuni 81–176 wild-type strain was isolated from 
a patient with gastroenteritis (Korlath et al., 1985). This strain has been verified to 
infect human volunteers and promote commensal colonisation of chicks (Black et 
al., 1988). The C. jejuni 81–176 wild-type strain is probably the most widely studied 
laboratory strain. The 81-176 cadF and flpA mutants were from the previous study 
by Neveda Naz. A list of all strains and plasmids used in this study is provided in 
Table 2.1.  
  
Table 2.1 Bacterial strains, mutants and plasmids used in this study 
Bacteria strains/ 
mutants/plasmids 
Descriptions  References 
C. jejuni 11168H Hypermotile derivative of the 
original sequenced strain NCTC 
11168 
(Karlyshev et al., 
2002, Jones et 
al., 2004) 
C. jejuni 11168H 
expressing GFP 
Hypermotile derivative of the 
original sequenced strain NCTC 
11168 expressing green 
fluorescent green under strong 
porA promoter control 
(Jervis et al., 
2015) 
C. jejuni 81-176 Highly invasive wild-type 
laboratory passaged strain. A 
(Korlath et al., 
1985) 
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strain isolated during outbreak in 
USA. 
C. jejuni 11168H cadF 
mutant 
Isogenic mutant, Cj1478 (cadF) 
gene function disrupted with 
insertion of 1.4kb KmR cassette. 
This study 
C. jejuni 11168H cadF 
mutant expressing GFP 
Isogenic mutant, Cj1478 (cadF) 
gene function disrupted with 
insertion of 1.4kb KmR cassette 
and expressing green fluorescent 
green under strong porA promoter 
control 
This study 
C. jejuni 11168H flpA 
mutant 
Isogenic mutant, Cj1279c (flpA) 
gene function disrupted with 
insertion of 1.4kb KmR cassette. 
Neveda Naz 
(PhD Thesis, 
LSHTM, 2014) 
C. jejuni 11168H flpA 
mutant expressing GFP 
Isogenic mutant, Cj1279c (flpA) 
gene function disrupted with 
insertion of 1.4kb KmR cassette 
and expressing green fluorescent 
green under strong porA promoter 
control 
This study 
C. jejuni 81-176 cadF 
mutant 
Isogenic mutant, Cjj1471 (cadF) 
gene function disrupted with 
insertion of 1.4kb KmR cassette. 
Neveda Naz 
(PhD Thesis, 
LSHTM, 2014) 
C. jejuni 81-176 flpA 
mutant 
Isogenic mutant, Cjj81176- (flpA) 
gene function disrupted with 
insertion of 1.4kb KmR cassette. 
Neveda Naz 
(PhD Thesis, 
LSHTM, 2014) 
E. coli DH5α competent 
cells 
E. coli cells used for 
transformation by electroporation 
Invitrogen, 
Thermo Fisher 
Scientific, 
Paisley, UK 
XL2-BLUE MRF high 
efficiency 
competent cells 
E. coli cells used for 
transformation by electroporation 
Agilent 
Technologies 
LDA, 
Cheadle,UK 
SCS110 competent 
cells 
E. coli cells used for 
transformation by electroporation 
 Agilent 
Technologies 
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LDA, Cheadle, 
UK 
pGEM-T easy Commercial TA cloning vector 
with ampicillin resistance cassette 
Promega, 
Southampton, 
UK 
pGEMT+Cj1478 
11168H 
pGEMT-easy vector with inserted 
0.96 kb 11168H cadF gene 
disrupted by insertion of KmR 
cassette 
This study 
pJMK30 Plasmid containing a gene 
encoding for Kanamycin 
resistance (aphA3) (1.4 kb) 
(Trieu-Cuot et 
al., 1985) 
pCJC1 Plasmid contains a 
chloramphenicol resistance 
cassette (cat) 
(Jervis et al., 
2015) 
 
 
 
 
2.1.2 Bacterial growth conditions  
 
C. jejuni wild-type strains and mutants were routinely grown on Columbia Blood 
Agar (CBA) plates (Fisher Scientific, Basingstoke, UK) supplemented with 
Campylobacter selective supplement (Oxoid, Basingstoke, UK) and 7% (v/v) horse 
blood (TCS Microbiology, Botolph Claydon, UK). Where appropriate CBA plates 
were supplemented with 50 µg/ml kanamycin or 10 µg/ml chloramphenicol (Sigma-
Aldrich, Poole, UK). For broth cultures, bacterial strains were cultured in Brucella 
broth (BB) or Muller Hinton broth (MH) (Oxoid). Both plates and broth cultures were 
incubated in microaerobic conditions in a Variable Atmosphere Incubator (VAIN) 
(Don Whitley Scientific, Sheffield, UK) that was supplied with a mixture of 5% 
Oxygen, 10% Carbon Dioxide and 85% Nitrogen to produce microaerobic 
conditions. 
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Escherichia coli DH5α and XL2 were grown on Luria–Bertani (LB) agar or in LB 
broth containing 100 μg/ml ampicillin, 100 μg/ml kanamycin or 15 μg/ml 
chloramphenicol as appropriate.  
 
 
2.1.3 Bacterial glycerol stocks 
 
C. jejuni were grown on CBA plates for 24 h. Bacteria were harvested with a sterile 
10 µl plastic loop (VWR, Lutterworth, UK), and resuspended in media consisting 
of BB supplemented with 10% (v/v) Foetal Calf Serum (FCS) (Sigma-Aldrich) and 
10% (v/v) glycerol (Sigma-Aldrich). The suspension was then aliquoted (100 µl) 
into 1.5 ml tubes (Starlab, Hamburg, Germany). Tubes were snap-frozen in a dry 
ice and 100% (v/v) ethanol mixture for 5 min in a polystyrene tray. Frozen bacterial 
suspensions were stored at -80°C in a New Brunswick Scientific Innova ultra-low 
temperature freezer (Eppendorf, Stevenage, UK). All E. coli strains were stored at 
−80°C in media consisting of LB broth supplemented with 20% (v/v) glycerol. 
 
 
2.1.4 Bacterial resuscitation 
 
To resuscitate C. jejuni from frozen stocks, a vial of glycerol stock containing the 
desired bacterial strain was thawed on ice. Once thawed, the contents were 
transferred onto a CBA plate and spread using a sterile loop in a circular motion 
over the plate. The plate was then placed into the VAIN incubator for 48 h. After 
48 h of growth, a single colony was picked, subcultured onto a new CBA plate and 
then incubated for further 24 h.  
 
 
2.1.5 Passaging of bacteria 
 
C. jejuni strains were routinely passaged onto a fresh CBA plate for 3-4 days up to 
a maximum of 10 passages. Passages were routinely checked for contamination 
by streaking in a fashion aimed at obtaining single colony forming units (CFUs) 
and the morphology of individual CFUs examined, as extended passage can lead 
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to the development of a mucoidy colony phenotype. If a mucoidy phenotype was 
observed, the line was discontinued, and fresh bacteria resuscitated from the 
stocks as described in Section 2.1.4. 
 
 
2.1.6 Bacterial suspension for assays 
 
To prepare suspensions of C. jejuni for assays, bacteria were harvested from a 24 
h CBA plate and mixed in 1 ml of BB or phosphate-buffered saline (PBS) in a 1.5 
ml Eppendorf tube. The suspension was vortexed to obtain a homogenous 
suspension. The concentration of bacterial cells was then determined by 
measuring the OD600. Briefly, 100 µl of bacterial suspension was diluted in 900 µl 
of BB or PBS in a cuvette (10 mm path length, Kartell, Noviglio, Italy). As a control, 
1 ml of BB or PBS alone was prepared in another cuvette. The OD600 of the 
bacterial suspension was determined using a spectrophotometer at OD600 
(S200UV/Vis Spectrophotometer, Jencons-VWR, Leighton Buzzard, UK). The 
formula below was used to obtain the required volume of the original suspension 
to add to a volume of media (Final volume) to produce a starting concentration of 
OD600 0.1: 
Volume required = Inoculum required at OD600 (e.g. 0.1) x Final volume x 1000  
                                            (10 x OD600 reading)       
    
 
2.1.7 Bacterial competent cells 
 
Bacteria were cultured under microaerobic conditions at 37°C for 16 h. When the 
OD600 reached 0.8, the culture was transferred into a 50 ml falcon tube and 
centrifuged at 4,000 rpm for 20 min. The supernatant was removed, and the pellet 
resuspended in 10 ml of ice cold EBF buffer until no clumps were visible. For 100 
ml EBF buffer, it was made by mixing 10 ml 10% (w/v) sucrose and 15 ml 100% 
(v/v) glycerol in Milli-Q water. The bacterial cell suspension was centrifuged at 
4,000 rpm at 4oC for 15 min. The supernatant was removed, and the bacterial 
pellet was resuspended with the same volume of ice-cold EBF buffer. The 
centrifugation step was repeated twice more for a total of three washes. After the 
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last spin, the pellet was resuspended in 1 ml of ice cold EBF buffer and 100 µl 
aliquots were made and kept at -80oC until required. 
 
 
2.1.8 Bacterial colony forming unit quantification  
 
100 µl of bacterial culture was serially diluted 1:10 in either PBS or BB. 200 µl of 
each dilution were plated onto a CBA plate and spread using a L-shaped spreader 
(Fisher Scientific). Each dilution was performed in triplicate. Plates were incubated 
for 24-48 h. Plates with between 50 to 300 colonies were selected for counting.
  
 
2.1.9 Bacterial growth curves 
 
For the growth curve assay, 10 ml of BB in a 25 cm3 tissue culture flask was pre-
incubated for 18 h on a shaking orbital platform in the VAIN. Broth was then 
inoculated with a bacterial suspension to a final OD600 of 0.1 and further incubated 
for 24 h in the VAIN with shaking at 75 rpm. At intervals of every 2 h starting at 0 
h, the OD600 readings of a 1 ml sample of the inoculated broth were recorded as 
an indication of bacterial growth. 
 
 
2.1.10 Bacterial motility 
 
Bacteria were cultured for 24 h then harvested in 1 ml PBS (Sigma Aldrich) and 
adjusted to an OD600 of 1.0, and 5 µl of this suspension was pipetted into the centre 
of a semi soft agar plate made by adding 0.4% (w/v) bacteriological agar (Oxoid) 
to BB. Plates were incubated under microaerobic conditions at 37oC. At intervals 
of 24 h, 48 h and 72 h, plates were checked for growth indicated by a halo growing 
from the centre of injection site. Measurement of the diameter of the halo or growth 
zone was recorded, and images were captured using a Gene Genius Bio Imaging 
System (Syngene, Cambridge, UK). 
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2.2 Cell culture techniques 
 
2.2.1 T84 and Caco-2 cultures 
 
Two types of human IECs were used in this study: Caco-2 cells, a human 
enterocyte-like cell line (HTB37™) and T84 cells, a human colonic epithelial cell 
line (CCL-248™). Both cell lines were able to form polarised monolayers and 
displayed distinct apical and basolateral surfaces. Both lines were routinely 
cultured at 37oC in a MCO15-AC humidified atmosphere containing air enriched 
with 5% CO2 at 37oC (Sanyo, Loughborough, UK).  
 
 
2.2.2 Tissue culture media 
 
The Caco-2 cell-line (HTB37™) was cultured in Dulbecco's Modified Eagle 
Medium (DMEM) (Fisher Scientific). The T84 cell-line (CCL-248™) was cultured 
in Dulbecco's Modified Eagle's Medium Nutrient Mixture F12 HAM with GlutaMAX- 
I (DMEM/F12) (Fisher Scientific). Both cell culture media were supplemented 10% 
(v/v) heat-inactivated FCS, 5% (v/v) essential amino acids and 5% (v/v) antibiotics 
that consists of streptomycin and penicillin (Fisher Scientific). 
 
  
2.2.3 Storage of IEC cells  
 
IECs cells were grown for 5-7 days until the cell density reached 80-90 % 
confluence. This was followed by washing and detaching the cells. Cells were 
pelleted and resuspended in media without antibiotics but supplemented with 5% 
(v/v) Dimethy sulfoxide (DMSO) to act as a cryoprotectant. 1 ml aliquots of this 
suspension was transferred into cryovials (Nunc, Roskilde, Denmark) and allowed 
to cool down slowly to -80oC overnight using a Naglene Mr Frosty™ freezing box 
(Nunc). Cryovials containing IECs were placed in a liquid nitrogen storage tank 
(Statebourne, Washington, Tyne & Wear, UK). 
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2.2.4 Resuscitation of IECs  
 
A cryovial of cryopreserved IECs cells (≈1 × 107 cells/ml) was taken out from the 
liquid nitrogen tank. The cryovial was immediately immersed in a water bath at 
37oC for 30–45 s. The surface of the cryovial was wiped dry and disinfected by 
spraying it with 70% (v/v) ethanol. Using a 1 ml pipette, the partially melted cells 
were mixed gently and carefully in order to melt the remaining frozen cells. The 
cells were aseptically transferred into 10 ml of pre-warmed complete media in a 25 
cm2 flask. The flask was then incubated in a MCO15-AC humidified atmosphere 
containing air enriched with 5% CO2 at 37oC. The culture media was changed 
every 2-3 days until the cells reach 90% confluence. Cells were subcultured at 
around 90% confluence. All work was performed in a biological safety hood 
(Envair, Haslingden, UK). 
 
 
2.2.5 Splitting and seeding cells  
 
Cells were sub-cultured at around 80-90% confluence. First, the culture medium 
was removed, and cells were washed three times in 10 ml of PBS (Fisher 
Scientific). 5 ml of Trypsin-EDTA (0.25%) phenol red (Fisher Scientific) were then 
added to cover the cell layers and flasks were incubated for 10 min. The action of 
trypsin was stopped by adding 20 ml of fresh culture medium. The suspension of 
cells was transferred into a 50 ml falcon tube. The cells were pelleted by 
centrifuging at 1,400 rpm for 10 min. The supernatant was removed and cells were 
resuspended in fresh complete media. Cells were seeded at a density of 
approximately 1 x 105 cells per well in a 24-well tissue culture plate (Fisher 
Scientific), containing 1 ml of complete medium per well. Plates were incubated for 
5-7 days to obtain fully differentiated cell layers. During this period, the medium 
was changed every 2 days. Before use for virulence assays, cell layers were 
washed three times in PBS and 3 ml of fresh complete culture medium without 
gentamicin was added. 
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2.2.6 Counting cell with haemocytometer 
 
To estimate the cell count for use in experiments, cells were enumerated using a 
haemocytometer (Weber Scientific, Teddington, UK). 100 µl of a cell suspension 
was mixed with 100 µl of trypan blue and 800 µl of cell media. 10 µl of the mix was 
filled into the glass chamber by capillary action onto the haemocytometer. The 
average number of cells present in the suspension was determined by counting 
the number of cells per square using an inverted microscope (Leica Microsystems, 
Milton Keynes, UK). The formula for concentration calculations is based on the 
volume underneath the cover slip.  
A small square has a volume of length x width x height = 1 x 1 x 0.1 = 0.1 mm3 = 
0.0001 ml.  
The cell concentration is calculated as follows: 
Cell concentration per ml = Average cells per small square X dilution factor 
                                                            Volume of a small square (ml) 
 
 
2.2.7 Measurement of the Trans-Epithelial Electrical Resistance (TEER) of 
IECs  
 
IECs were grown on a Transwell (Fisher Scientific) insert filter (3.0 µm pore size) 
in a 12 well plate and allowed to differentiate and form monolayers. Media was 
changed every 3 days from both apical and basolateral compartments. The TEER 
of Caco-2 and T84 monolayers were monitored using an electro volt ohm meter 
(EVOM) (World Precision Instruments, Sarasota, Florida, USA) with ‘chopstick 
type’ electrodes. Two voltage-sensing AgCl electrodes were placed close to the 
cell monolayer on apical and basolateral sites of the filter, passing a current 
through two further electrodes placed at the two distal ends of the insert and 
reading the voltage necessary to keep the current flowing. Resistance was 
calculated according to Ohm's law (R = V/I, where R = resistance, V = voltage, and 
I = current) and multiplied by the surface area of the monolayers (1.12 cm2). 
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2.2.8 Sensitivity assay with Triton X-100 and gentamicin 
 
1 ml of bacterial cells (≈1 × 108) from 24 h plate were incubated in 0.2% (v/v) Triton 
X-100 (Sigma-Aldrich) or gentamicin (150 µg/ml) for 20 min and 2 h respectively. 
Serial dilutions were performed down to 10-7 and 200 µl of the final dilution was 
plated in triplicates on CBA plates. Plates were incubated for 48 h and then the 
colonies counted. Sensitivity assays were performed on all the mutants and 
respective wild-type strains. 
 
 
2.2.9 Pre-treatment of IECs with eukaryotic inhibitors and OMVs 
 
Inhibitors of eukaryotic cell processes were added to the monolayer 1 h prior to 
the addition of bacteria. In this study, the inhibitors were then removed and not 
maintained throughout the 3 h infection period. The infected monolayers were then 
washed and incubated for another 3 h in fresh culture medium containing 250 
µg/ml of gentamicin to kill extracellular bacteria. Subsequently, the monolayers 
were washed and internalised bacteria were enumerated by plate count as 
described in Section 2.1.8. 
1 h prior to infection with C. jejuni, monolayers were treated with 1 ml of the 
required inhibitor and incubated for 1 h at 37oC in the CO2 incubator. After 
incubation, the medium containing the inhibitor was removed and the cells were 
infected with 1 ml of C. jejuni suspension (MOI 100:1) and further incubated for the 
required length of infection. The list of inhibitors used in this study is provided in 
Table 2.2. All inhibitors were diluted in culture medium without antibiotics prior to 
addition to monolayers. The highest concentration of each inhibitor used was 
chosen for the maximal inhibitory effect without affecting the epithelial cell 
monolayers and following the protocol of a previous study by Neveda Naz (LSHTM 
PhD student). The absence of growth inhibition of inhibitors against bacteria was 
confirmed by inoculating the bacteria with culture media with 10% (v/v) FCS and 
with or without inhibitors at 37oC in a humidified 5% CO2 incubator at the same 
condition as controls. The viable bacteria in both groups were compared. 
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Table 2.2. Inhibitors of eukaryotic cell processes used in this study 
Inhibitors  Stocks Concentration used 
(µM) 
Methyl-β-cyclodextrin 
(MβCD) 
10 mM in H2O 5 µM 
Cytochalasin D (CytoD) 0.2 mM in DMSO 3 µM 
Colchicine 10 mM in DMSO 10 µM 
Wortmannin 10 mM in DMSO 1 µM 
 
 
 
2.3 Molecular techniques 
 
2.3.1 Genomic DNA isolation 
 
For experiments that required genomic DNA extraction from bacterial cells, a Pure 
Link Genomic DNA Mini Kit (Invitrogen, Carlsbad, USA) was used following the 
manufacturers’ instruction for Gram-negative bacteria. Briefly, bacteria were grown 
on a CBA plate for 24 h under microaerobic conditions. A sterile loop was used to 
remove bacteria and re-suspended in 1 ml of PBS in a 1.5 ml Eppendorf tube. The 
suspension was centrifuged at 13,000 rpm for 1 min and the resulting supernatant 
was removed. After this time 180 µl of PureLink Genomic Digestion buffer was 
added to resuspend the pellet. 20 µl of Proteinase K at 20 mg/µl was then added 
and vortexed to lyse the cells. The sample was incubated at 55oC for 30 min in a 
heat block and vortexed occasionally during this period. Then 20 µl of RNaseA 
was added, vortexed and incubated for 2 min at room temperature (RT). After that, 
200 µl of PureLink Genomic Lysis/Binding buffer was added and vortexed. This 
was followed by addition of 200 µl of 100% (v/v) ethanol to the tube, and vortexed 
for 5 sec to form a homogenous solution. All of the lysate was transferred to a 
PureLink spin column and centrifuged at 10,000 rpm for 1 min. The column was 
then placed in a new collection tube and 500 µl of Wash Buffer 1 was added to the 
column and centrifuged at 10,000 for 1 min. In a new collection tube, the process 
was repeated with Wash Buffer 2, but this time centrifuged at 13,000 rpm for 3 
min. Finally, the spin column was placed in a 1.5 ml Eppendorf tube. 50 µl of Milli-
Q water was added to the centre of the column membrane and incubated for 1 min 
at RT, and then centrifuged at 13,000 rpm for 90 sec. The isolated DNA 
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concentration was quantified using a NanoDrop ND-1000 spectrophotometer 
(NanoDrop Technologies, Wilmington, USA) as described in Section 2.3.4. The 
genomic DNA samples were stored at -20oC. 
 
 
2.3.2 Plasmid DNA isolation from E. coli 
 
A QIAprep Spin Miniprep Kit (Qiagen) was used to isolate plasmid DNA from 
overnight cultures of E. coli strains following the manufacturers’ instructions. 
 
 
2.3.3 DNA quantification  
 
DNA was quantified using a NanoDrop 2000 platform. 1.5 µl of Milli-Q water was 
used to blank the initial measurement. Then, 1.5 µl of a DNA sample was pipetted 
onto the NanoDrop 2000 platform pedestal and the arm on top of the pedestal was 
closed, this resulted in the liquid sample contacting both ends of the fibre optic 
cable in the spectrophotometer. A ratio between absorbance readings at 260 nm 
and 280 nm was evaluated for DNA purity in samples. A ratio of 1.8 was 
considered as good quality DNA. Presence of proteins or other contaminants 
resulted in lower ratios that indicate poor quality DNA. DNA was stored at -20oC 
for further use. RNA was also quantified using the NanoDrop. A ratio of 2.0 
between absorbance reading at 260nm and 280 nm was considered as good 
quality RNA.  
 
 
 
2.3.4 RNA isolation 
 
Bacteria were grown on a CBA plate for 24 h in the VAIN and 10 ml BB was pre-
incubated overnight under microaerobic conditions with shaking at 75 rpm. The 
next day, the pre-incubated broth was inoculated with a bacterial suspension from 
the 24 h plate at an OD600 of 0.1. The broth was further incubated for 18 h under 
microaerobic conditions with shaking at 75 rpm at 37oC. After 18 h, 4 ml of the 
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culture was added to 8 ml of RNAprotect Bacteria Reagent (Qiagen, Manchester, 
UK), vortexed for 5 sec then incubated at RT for 5 min to stabilise the RNA. The 
stabilised RNA was then centrifuged for 10 min at 4,000 rpm at 4oC and the 
supernatant discarded. 
The following solutions were prepared prior to RNA isolation using buffers from an 
RNeasy Mini Kit (Qiagen): 
Tris-EDTA (TE) buffer - 1 part of lysozyme (1 mg/ml) added to 9 parts of TE 
buffer (Qiagen) 
RLT buffer  - 10 µl of 14.4 M β-mercaptoethanol added to 1 ml 
of RLT buffer (Qiagen)  
RDD buffer    - 10 µl of DNase I (1 U/µl) added to 70 µl of RDD 
buffer (Qiagen)  
In the tube with the stabilised RNA, 200 µl of TE buffer was added and the pellet 
was resuspended for 1 min using a P1000 Gilson pipette (Anachem Ltd, Luton, 
UK). The suspension was incubated for 10 min at RT and vortexed every 2 min. 1 
ml of RLT buffer was then added to the suspension and vortexed vigorously, 
followed by 500 µl of 100% (v/v) ethanol and mixed by pipetting. 700 µl of the 
suspension was then transferred into an RNeasy Mini spin column. The spin 
column was centrifuged at 10,000 rpm for 15 sec. The step was repeated with the 
remaining suspension. Then 350 µl of RW1 buffer was added and the spin column 
was centrifuged at 10, 000 rpm for 15 sec and the flow through discarded. 80 µl of 
RDD buffer was added to the centre of the spin column and incubated for 15 min 
at RT. After the incubation, 350 µl of RW1 buffer was added to the spin column, 
centrifuged at 10,000 rpm for 15 sec and the flow through discarded. This step was 
repeated with 500 µl of RPE buffer added to the spin column and the flow through 
discarded. Another 500 µl of RPE buffer was added and the spin column was 
centrifuged at 10,000 rpm for 2 min. To remove any remaining RPE buffer, the spin 
column was placed in a 2 ml collection tube and centrifuged at 13,000 rpm for 1 
min. The spin column was then transferred to a 1.5 ml Eppendorf tube. To elute 
the RNA, 50 µl of RNase-free water was added directly to the centre of the 
membrane in the spin column and centrifuged at 13,000 rpm for 1 min. A 
NanoDrop was used to quantify the RNA concentration as described in Section 
2.3.4. RNA samples were stored at -80oC. 
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2.3.5. DNase treatment  
 
Following RNA isolation, DNase treatment was performed to completely remove 
any traces of DNA present in the RNA samples using the TURBO DNA-free kit 
(Fisher Scientific). 
The reactions were prepared as follows: 
5 µl of 10X TURBO DNase Buffer 
1 µl of TURBO DNase 
x µl of RNA sample (2 µg) 
Nuclease-free water (to 50 µl) 
Mixed solutions were incubated at 37oC for 30 min. Then, 5 µl of DNase 
Inactivation Reagent was added to each reaction and further incubated at RT for 
5 min with occasional mixing to disperse the DNase Inactivation Reagent 
throughout the reaction mix. Tubes were centrifuged for 90 sec at 10,000 rpm. The 
concentration obtain for each sample was 40 ng/µl. The resulting supernatants 
containing pure RNA were carefully transferred to new tubes and stored at -80oC. 
 
  
2.3.5.1 Conversion of RNA to cDNA 
 
The SuperScript III First-Strand Synthesis System for RT-PCR (Invitrogen) was 
used to convert total bacterial RNA to cDNA. 
The reactions were prepared as follows:  
2.5 µl of RNA sample (40 ng/µl) 
1 µl of Random hexamers (50 ng/µl) 
1 µl of 10 mM dNTP mix 
5.5 µl of RNase-free water 
Samples were incubated for 5 min at 65oC, followed by 1 min on ice. Then 10 µl of 
the cDNA synthesis mix was prepared at the following concentration per sample: 
2 µl of 10X RT buffer 
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4 µl of 25 mM MgCl2 
2 µl of 0.1 M DTT 
1 µl of RNase OUT (40 U/µl) 
1 µl of SuperScript III RT (200 U/µl) 
As a control, a no RT reaction tube was prepared to analyse the reverse 
transcriptase enzyme efficiency and to check for any contamination by DNA. 
Samples were prepared in duplicate with one tube without the addition of 
SuperScript III RT. To each RNA sample, 10 µl of cDNA synthesis mix was added, 
mixed and incubated in a Thermal Cycler DNA Engine Tetrad 2 Peltier (Bio-Rad, 
Hemel Hempstead, UK) using the following program: 
Step 1 at 25oC for 10 min 
Step 2 at 50oC for 50 min and 
Step 3 at 85oC for 5 min 
Once the program was finished, tubes were taken out and incubated for 1 min on 
ice. Reactions were briefly centrifuged and then 1 µl of RNase H was added and 
incubated for 20 min at 37oC to degrade the remaining RNA. Finally, cDNA 
samples were stored at -20oC until further use. 
 
 
2.3.6 Primers design 
 
Primers listed below were used in this study. All primers were designed manually 
based on the C. jejuni NCTC 11168 genomic sequence, then checked using Oligo 
analyser 3.1 software on the Intergrated DNA Technologies website 
(http://eu.idtdna.com/analyser/applications/oligoanalyser/) to confirm the 
percentage of G+C content, melting temperature, the absence of self-dimers and 
hairpin loops. The primers were then synthesised by Invitrogen. Primer 
suspensions were prepared by reconstituting the powder in Milli-Q water to 
produce 100 µM stock solutions. Each primer was used at a concentration of 15 
pmol/µl in a PCR reaction. Primers were aliquoted and kept at -20oC until required. 
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Table 2.3 Primers used in this study 
 
Gene 
 
Primers 
 
Sequence 5’-3’ 
 
cadF 
 
Cj1478cR 
 
 
GAAGAGTGGATGCTAA 
 
cadF 
 
Cj1478cF 
 
ATATTCTTATGTTTAGG 
 
flpA 
 
Cj1279cR 
 
CTTTGCTTGAAGGTTCT 
 
flpA 
 
Cj1279F 
 
ATTTCGCTTGAGTTT 
 
 
KanR 
 
Kan R 
 
TGGGTTTCAAGCATTAGTCCATGCAAG 
 
KanR 
 
Kan F 
 
GTGGTATGACATTGCCTTCTGCG 
 
gyrA 
 
R 
 
CCTACAGCTATACCAC 
 
gyrA 
 
F 
 
GGTCGTTATCACCCACATGGAG 
 
 
 
2.3.7 Polymerase Chain Reaction 
 
All PCR reaction mixes were prepared in a dedicated UV cabinet free of nucleic 
acid templates. All PCR reactions was routinely performed using MyTaq™ Red 
Mix (Bioline, London, UK). For complementation of desired genes, a high-fidelity 
DNA polymerase Accuprime Pfx supermix (Invitrogen) was used. The PCR 
mixtures were set up as follows: 
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All reactions were set-up on ice. 
Template DNA 200 ng  
Primers (20 µM each) 1 µl 
MyTaq Red Mix, 2x 25 µl 
Water (ddH2O) to 50 µl 
 
Reactions were mixed in 0.6 ml Eppendorf tubes and placed into a Thermal Cycler 
DNA Engine Tetrad 2 Peltier and a PCR program cycle was run as follows:  
Step 1: Denature at 94oC for 15 sec 
Step 2: Anneal at 55oC for 1 min  
Step 3: Extension at 72oC for 1 min 
34 cycles of step 1 to step 3 were repeated and ends with one cycle of step 4.  
Step 4: End at 72oC for 4 min  
Steps 2 and 3 were varied to optimise PCR amplification conditions / amplification 
of larger products (usually 1 minute per Kb). Modifications to PCR reaction 
conditions were also dependent on the melting temperature (Tm) of the primers 
used. 
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2.3.8 Reverse transcription polymerase chain reaction (RT-PCR) 
 
RT-PCR was used to investigate expression of cadF and flpA in the 11168H wild-
type strain and mutants. This was a semi quantitative assay using the 
housekeeping gene gyrA as a control. RT-PCR reactions were performed using 
list of primers in Table 2.3. A minimum of three biological replicates were 
performed. PCR products were analysed and images were captured and recorded 
as described in Section 2.3.9. Image J software (NIH Image, Bethseda, USA) was 
used to analyse the images for band intensities. 
 
 
2.3.9 Electroporation of C. jejuni 
 
50 µl aliquots of electrocompetent C. jejuni cells were thawed on ice and 1 µl of 
plasmid (0.5 – 1.0 µg) DNA was added and mixed gently. The mix was kept chilled 
on ice for 30 min. Following incubation, the mixture was transferred to a pre-chilled 
2 mm gap electroporation cuvette (Gene Pulser, Biorad, CA, USA). The settings 
for electroporation using a Gene PulserXcell electroporation system (Bio-Rad) 
were: 2.5 kV and 200 Ω. Immediately after electroporation, 1 ml of SOC media 
(Invitrogen) at RT was added into the cuvette and mixed using a pipette. The 
mixture was then pipetted onto a CBA plate, spread and incubated for 24 h at 37oC 
in the VAIN. The next day, a sterile loop was used to collect the bacteria. The 
bacteria were then resuspended in 1 ml of BB. 200 µl of the suspension was plated 
onto an antibiotic supplemented CBA plate and incubated for 48 – 72h. The 
resulting colonies were restreaked and gDNA isolated as a boilate followed by 
PCR analysis to confirm homologous recombination of the correct construct. 
 
 
2.3.10 DNA analysis by agarose gel electrophoresis 
 
Agarose gels were prepared by dissolving 1.5 g agarose (Bioline) in 150 ml of 1 x 
Tris-acetate-EDTA (TAE) (40 mM Tris-acetate, 1 mM EDTA pH 8) buffer to obtain 
a desired concentration of 0.7% (w/v). The solution was heated for 3 min using a 
microwave. After cooling to 55oC, 0.5 µg/ml ethidium bromide (Fisher Scientific) 
was added. The gel was swirled around to mix the contents, and then immediately 
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poured into a gel casket with the appropriate comb attachment. The gel was left to 
solidify for 20 min. To perform gel electrophoresis, the comb attachment was 
removed, and the gel immersed into 1X TAE buffer in an electrophoresis tank 
(AGE electrophoresis tank; Biorad, Hemel Hempstead, UK). 10 µl of each PCR 
sample was loaded into a gel well. 5 μl of Hyperladder 1 kb marker (Bioline) was 
also added to a separate well. Gel electrophoresis was performed at 120 mV for 
30-45 min. PCR products were visualised using a transilluminator (UVP, 
Cambridge, UK) and gel images recorded using a Gene Genius Bio Imaging 
System (UVP). 
 
 
2.3.11 Purification of PCR amplicons 
 
PCR products were purified using a QIAquick PCR purification kit (Qiagen). Briefly, 
20 µl of the PCR reaction was transferred to a 1.6 ml Eppendorf and 100 µl of 
binding buffer BP1 was added. The solution was mixed gently by pipetting and 
then transferred to a QIAquick spin column in a 2 ml collection tube. The tube was 
centrifuged at 13,000 rpm for 1 min and the flow-through discarded. The tube was 
placed back into the 2 ml collection tube, 750 µl of RPE buffer added to the tube, 
and centrifuged again at 13,000 rpm for 1 min. The QIAquick column was placed 
into a fresh 1.6 ml Eppendorf tube, 20 µl of sterile Milli-Q water was added to the 
centre of the QIAquick spin column and left to stand for 1 min at RT, followed by 
centrifuging at 13,000 rpm for 1 min to elute the DNA. The sample was incubated 
on ice and the purity of DNA was quantified using the NanoDrop. The purified PCR 
products were stored at -20oC.  
 
 
2.3.12 Restriction enzyme digestion 
 
Prior to ligation with the kanamycin cassette, the plasmid DNA containing the gene 
to be mutated was digested and purified. Briefly, 2 µg of PCR product or plasmid 
DNA was added to 5 µl of 10X reaction buffer and 1 µl (10 U/µl) of the appropriate 
restriction endonuclease (New England Biolabs, England, UK) in a 1.5 ml 
Eppendorf tube, and then made up to a total volume of 48 µl with Milli-Q water. 
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The reaction tubes were incubated for 60-90 min in a 37oC water bath, followed by 
purification using the QIAquick PCR purification kit. Samples were checked for 
purity using the NanoDrop. Purified samples were stored at -20oC. 
 
 
2.3.13 Plasmid DNA dephosphorylation  
 
To avoid vector self-ligation, 8 µl of digested plasmid DNA was added to 1 µl of 
10X dephosphorylating buffer and 1 µl of Antarctic phosphatise enzyme (10U/µl) 
in a 0.6 ml Eppendorf tube. The reaction was incubated for 15 min at 37oC and 
then further incubated for 5 min at 65oC in a heat block to inactivate the enzyme. 
 
 
 2.3.14 Insertion of a Kanamycin cassette 
 
A BamHI digested fragment of plasmid pJMK30 containing the Kan cassette was 
ligated into the digested plasmid using the following procedures: 
2 µl of plasmid DNA with unique restriction enzyme digested (250 µg/µl) 
5 µl of digested Kanamycin cassette (29 ng/µl) 
1 µl of Ligase buffer 
2 µl of T4 DNA Ligase (3 U/µl) 
The ligation reaction was mixed gently by pipetting, briefly centrifuged and 
incubated overnight at 4oC. The ligation reaction was transformed into DH5α cells 
and plated onto LB amp-kan plates. Plates were then incubated overnight at 37oC. 
Colonies from positive transformants were picked and restreaked onto fresh LB 
amp-kan plates and incubated as before. Boilates were prepared and used for 
PCR screening reactions. Gene specific primers were used to confirm the 
presence of a larger band due to the insertion of the KmR cassette. Combinations 
of Kanamycin forward out or Kanamycin reverse out and gene specific forward or 
gene specific reverse primers were used to check that the Km cassette was in the 
correct orientation. 
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2. 3.15 Cloning PCR products into a plasmid vector 
 
Ligation reactions were prepared with a ratio of insert to vector of either 1:1 or 3:1 
and the amount of plasmid to insert was calculated using the following equation:  
Insert size (kb) /vector size (kb) x ng of vector = ng of insert. 
Three 0.6 ml tubes were prepared and labelled as test sample, negative control 
and positive control. The following were added into all tubes. 
5 µl of 10 X ligation buffer 
1 µl of pGEM T-easy vector (50 ng/µl) 
0.4 µl of T4 DNA ligase (10 U/µl) 
1 µl of water 
Then either:- 
2 µl of PCR products into the tube labelled test sample; 
2 µl of water into the tube labelled negative control; 
2 µl of control insert into tube labelled positive control  
The reactions were gently mixed by pipetting and incubated overnight for 16 h at 
4oC. 
 
 
2.3.16 Transformation of E. coli cells 
 
E. coli cells were transformed with ligated plasmid from the above reactions. 100 
µl of electrocompetent E. coli cells were thawed and mixed with 2 µl of β-
mercaptoethanol for 10 min on ice with occasional gentle mixing. In pre-chilled 1.6 
ml Eppendorf tubes, 2 µl of ligated plasmid were added to 50 µl of thawed 
electrocompetent E. coli cells. A control tube was set up and contained 2 µl of 
uncut plasmid DNA in 50 µl of electrocompetent E. coli cells. The tubes were 
incubated for 30 min on ice, heat shocked for 45 sec at 42oC in a water bath, and 
then immediately incubated for 2 min on ice. Next, 950 µl of SOC broth (Bioline) 
was added to each tube and further incubated for 90 min at 37oC with shaking at 
250 rpm. Finally, 200 µl of transformant reactions were plated onto LB-amp plates 
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that contained 0.5 mM Isopropyl-B-thio-galactoside (IPTG) (Promega, 
Southampton, UK) and 80 µg/ml of X-Gal (Promega). Plates were incubated for 
16 h overnight at 37oC. 
 
 
2.3.17 PCR screening of transformants 
 
Fresh individual colonies from transformation plates were picked and restreaked 
onto fresh LB-amp plates and incubated overnight at 37oC. After 16 h incubation, 
boilates were prepared by making a suspension of bacterial cells in 100 µl of Milli-
Q water. The suspension was heated for 10 min at 95oC, briefly chilled on ice and 
centrifuged for 5 min at 13,000 rpm. 1 µl of the supernatant was used as template 
in a 25 µl PCR reaction. 
 
 
2.3.18 Construction of C. jejuni mutants expressing Green Fluorescent 
Protein Fusion (GFP)  
 
C. jejuni 11168H cadF and flpA mutants expressing GFP were constructed by 
electroporation of the plasmid (pCJC1) that contains the gfp gene encoding the 
green fluorescent protein (GFP) under control of the strong C. jejuni porA promoter 
(Jervis et al., 2015). Briefly, competent cadF mutant or flpA mutant cells were 
prepared from a 24 h CBA plate as described in Section 2.1.7. Then, 50 µl of 
competent cells was mixed with 5 µl of GFP plasmid DNA and incubated on ice for 
30 min. Electroporation was performed as described in Section 2.3.8. 
Electroporated bacterial cells were plated immediately onto CBA plates and 
incubated for less than 24 h. Colonies were picked and resuspended in 1 ml of BB. 
400 µl and 200 µl of this bacterial suspension were spread onto separate CBA 
plates supplemented with kanamycin and chloramphenicol. Plates were incubated 
for 24 h to 72 h in the VAIN. The resulting colonies were collected, gDNA isolated 
as boilates, then analysed by PCR to screen for homologous recombination of the 
correct construct. 
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2.4 Assays 
 
2.4.1 BCA assay 
 
Bicinchoninic acid (BCA) kit (Fisher Scientific) protein assay was used to quantify 
protein concentrations according to the manufacturer's recommendations. Briefly, 
diluted albumin (BSA) standards were prepared at different concentrations in PBS, 
followed by the working reagent (WR). The volume of the WR needed was 
prepared by mixing 50 parts of reagent A with 1 part of reagent B from the kit. 25 
µl of albumin standards and the unknown samples were added to microplate wells 
in duplicates, and then 200 µl of WR was added into each well. The plate was then 
incubated at 37°C in the dark for 30 min. The absorbance was measured at 562 
nm using a SpectraMax M3 microplate reader (SpectraFluorPlus, Tecan, 
California, USA). From the absorbance reading output, a standard curve was 
generated. The average OD562 reading for each concentration replicate of the BSA 
standards was plotted against concentration in µg/ml. Protein concentration of the 
samples was then determined using the standard curve. Samples were diluted to 
the required concentration prior to performing the assays. 
 
 
2.4.2 Enzyme-linked immunosorbent assay (ELISA) 
 
T84 IECs were seeded into 24 well plates (≈ 1 x 105 cells per well) and grown for 
5-7 days until confluent. A suspension of C. jejuni from a 24 h plate was prepared 
and adjusted to OD600 0.1. T84 cells were incubated with 1 ml of the bacterial 
suspension for 24 h. The next day, supernatants were gently removed so as not 
to disturb the cells. The collected supernatants were probed for any cytokines 
present. The levels of Interleukin 8 (IL8 or chemokine (C-X-C motif) ligand 8, 
CXCL8) and Tumor necrosis factor alpha (TNFα) secretion were assessed using 
an ELISA kit according to manufacturer’s instructions (Peprotech, London, UK). 
Detection was performed at an absorbance of 405 nm using a 96-well plate reader 
Dynex MRX II (Dynex, USA). 
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2.4.3 Lactate Dehydrogenase (LDH) Assay  
 
Caco-2 and T84 IECs were seeded into 24 well plates (≈ 1 x 105 cells per well). 
IECs were grown for 5-7 days until confluent, then washed three times with PBS 
followed by the addition of the appropriate concentration of each inhibitor as well 
as a control without inhibitor. The IECs were incubated for 1 h with the inhibitor, 
and then the supernatants were removed and the IECs washed three times with 
pre-warmed PBS. This was followed by the addition of 1 ml fresh culture medium 
and the IECs were incubated for a further 24 h. After 24 h, the supernatant was 
collected, and extracellular lactate dehydrogenase levels were measured with the 
CytoTox 96 nonradioactive cytotoxicity assay kit (Promega) according to the 
manufacturer's recommendations. Total lysis of IECs following treatment with 1% 
(v/v) Triton X-100 represented the 100% cytotoxicity control. Medium without cells 
and inhibitors represented a 0% cytotoxicity control.  
 
 
2.4.4 Rac1 activation with G-LISA assay 
 
To determine Rac1 activation in infected IECs G-LISA™Rac1- activation assay 
(Cytoskeleton) (Cytoskeleton Inc., Denver, CO) was used according to the 
manufacturer's recommendations. Briefly, IECs were grown to 70% confluency in 
a 24 well tissue culture plate in DMEM/F12 containing 10% (v/v) heat-inactivated 
FCS, 5% (v/v) essential amino acids and 5% (v/v) antibiotics that consists of 
streptomycin and penicillin incubated in a 5% CO2 incubator at 37oC. The cells 
were serum-depleted, washed with DMEM once and incubated with DMEM 
containing 5% (v/v) FCS for 24 h. The next day, the procedure was repeated but 
this time the cells were incubated serum-free with DMEM and incubated for a 
further 24 h. The serum-depleted cells were then infected with C. jejuni for the 
indicated time per experiment. Subsequently, cells were washed with PBS, 
resuspended in the appropriate volume of G-LISA lysis buffer per well then 
harvested from the wells using a cell scraper. The lysate was clarified by 
centrifugation at 14,000 rpm at 4oC for 2 min. The total protein concentration of 
each lysate was determined by the protein assay reagent of the kit. The 
concentrations of cell lysates were then normalised and equal amounts were 
added to a 96-well dish coated with Rac1. The plate was placed on a microplate 
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shaker at 400 rpm, 4oC for 30 min. Wells were then washed three times with wash 
buffer before adding 50 μl anti-Rac1 primary antibody (1:250). The plate was 
incubated on an orbital microplate shaker at 400 rpm, room temperature for 45min. 
The primary antibody was removed and wells were washed three times with wash 
buffer at room temperature. 50 μl diluted secondary horseradish peroxidase 
conjugate (HRP)-linked antibody (1:200) was added to each well before shaking 
the plate on a microplate shaker at 400 rpm, room temperature for 45 min. The 
plate was then washed three times with RT wash buffer before adding 50 μl HRP 
detection reagent into each well and incubate at RT for 20 min. Finally, 50 µl of 
HRP Stop Buffer was added into each well. The luminescence signal was 
quantified using a SpectraMax M3 microplate reader (SpectraFluorPlus, Tecan). 
  
 
2.4.5 Interaction assay 
 
For bacterial interaction assays, cells were cultured in either DMEM or DMEM/F-
12 medium supplemented with 10% (v/v) heat-inactivated FCS, 5% (v/v) essential 
amino acids and 5% (v/v) antibiotics that consists of streptomycin and penicillin 
incubated in a 5% CO2 incubator at 37oC. Interaction (adhesion and invasion) 
assays were performed in 24-well tissue culture plates with T84 cells which had 
reached at least 80% confluency. One day prior to infection, cells were washed 
once with 1 ml PBS and incubated overnight with antibiotic-free growth medium. 
On the day of infection, bacteria grown to mid-log phase were collected, 
resuspended in 1 ml of medium and adjusted to OD600 of 0.1 (≈1 x 108 cfu/ml). 
The monolayers were infected with 1 ml of the bacterial suspension in each well, 
which is equivalent to multiplicity of infection (MOI) of 100:1 in pre-warmed DMEM, 
and then incubated in a humidified 5% CO2 incubator at 37oC. After 3 h or 24 h, 
monolayers were rinsed 3 times with 1 ml of PBS each time, and then 500 µl of 
0.2% (v/v) Triton X-100 in PBS was added and incubated for 20 min to lyse the 
IECs. The lysate was then serially diluted 1:10 down to 104. 200 µl of the diluted 
suspension was plated on CBA plates in triplicate. Plates were then incubated in 
the VAIN for 48 to 72 h. The number of interacting bacteria was determined by 
counting the resulting colonies. 
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2.4.6 Intracellular survival and gentamicin protection assays 
 
The gentamicin protection assay was performed in a similar manner as above. 
Briefly, after incubating the cells with bacteria for the desired time point, cells were 
washed with 1 ml of PBS to remove non-adherent bacteria. The cells were then 
added with 1 ml of culture medium containing 150 μg/ml gentamicin sulfate and 
incubated under aerobic conditions for 2 h to kill extracellular bacteria. The cells 
were washed three times with 1 ml of PBS and lysed with 300 μl of 0.1 % (v/v) 
Triton X-100 in PBS for 15 min at 37oC. Finally, serial tenfold dilutions of this lysate 
was performed and 200 μl of each dilution was spread on CBA plates using a 
sterile inoculation spreader. The plates were incubated for 72 h at 37oC under 
microaerobic conditions, after which bacterial colony-forming units were formed, 
and the number of colony-forming units per ml was enumerated. 
Intracellular survival assays were performed using the same protocol as 
gentamicin protection assay. However, after the first incubation with 150 µg/ml of 
gentamicin sulfate for 2 h, the monolayers were washed with 1 ml of PBS and 
further incubated with reduced concentration of gentamicin sulfate (10 µg/mL) for 
19 h. Following incubation, the gentamicin-containing medium was removed, cells 
were washed three times with PBS, and lysed as described above. 
 
2.4.7 Fibronectin and laminin binding assay 
 
Fibronectin binding assays were performed as described previously (Konkel et al., 
2010). Briefly, the wells of a 96-well flat-bottom plate (Fisher Scientific) were 
coated with a 1 mg/ml solution of fibronectin (Sigma-Aldrich) in PBS and then 
incubated overnight at 4oC. For control, wells were also coated with 1% (w/v) BSA 
in PBS. C. jejuni was harvested from 24 h cultures on CBA plate and re-suspended 
in PBS at an OD600 of 2. Wells were rinsed with PBS and 50 µl of the bacterial 
suspension was added to each well and incubated at 37°C in a CO2 incubator for 
1 h. The wells were washed three times with PBS and adherent bacteria were 
removed by the addition of 0.05% (w/v) Trypsin / 0.02% (w/v) EDTA in Hanks’ 
Balanced Salt Solution and incubated for 10 min at 37oC. To enumerate the 
number of adherent bacteria, serial dilutions of the trypsin suspension were plated 
on CBA plates as described previously. 
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Pre-treatment of fibronectin with OMVs was performed as above, however OMVs 
(10 µg) were added to the fibronectin coated wells and incubated overnight at 4oC 
prior to the addition of bacteria. 
 
 
2.4.8 Galleria mellonella model of infection 
 
G. mellonella larvae were purchased from Live Foods Direct (Sheffield, UK) and 
kept on wood chips in the dark at RT for maximum of 2 weeks. Experiments were 
performed as described previously (Harding et al., 2013). Bacterial suspensions of 
OD600 1 and OD600 0.1 were prepared in PBS. 10 µl of suspension was injected into 
the right foremost leg of the larvae using a micro-syringe (Hamilton, Nevada, USA). 
The same procedure was also performed using 5 µg or 0.5 µg of OMVs isolated 
from the C. jejuni 11168H wild-type strain, cadF or flpA mutant. The larvae were 
incubated at 37°C. Larvae untreated with no injection or PBS only injection were 
also included as controls. Live C. jejuni-infected, OMV-injected, PBS-injected, and 
uninfected larvae in vented Petri dishes were incubated at 37oC under aerobic 
conditions. For each experiment, 10 G. mellonella larvae were infected and this 
was repeated at least three times. Survival was observed and recorded over 72 h. 
Cytotoxicity was determined by appearance of black pigmentation and 
unresponsiveness upon contact. Larvae that changed colour from white to dark 
brown or black were recorded as dead.  
 
 
2.4.9 Translocation assay 
 
T84 cells were seeded on Transwell 3.0 µm pore size filters in a 12-well plate 
(Fisher Scientific) at ≈ 1 x 105 cells per well and allowed to form a polarised 
monolayer for about 10 to 16 days. The media in both the apical and basolateral 
compartments were replaced with fresh media every 2-3 days. Once the cells had 
polarised, the cells were washed gently three times with 500 µl PBS. All media 
from the apical and basolateral compartment were then replaced with fresh media 
without antibiotics and incubated overnight. The following day, cells on the apical 
side were washed three times with PBS. Treated cells were infected with GFP 
expressing 11168H wild-type, cadF or flpA mutants at a MOI of 100:1. Control 
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wells were left untreated. At time intervals, the supernatant was collected from both 
apical and basolateral compartments and RFU read in 96 well black/opaque 
bottom to detect bacterial translocation using SpectraMax M3 microplate reader 
(SpectraFluorPlus Tecan). TEER values were taken before and after treatment at 
specified time points. Basolateral supernatants were collected to detect bacterial 
translocation from apical to basolateral side. For CFU counts, the basolateral 
supernatant was serially diluted, plated onto CBA plates and incubated in the 
VAIN. Bacterial CFUs were enumerated after 48 h incubation. 
 
 
2.5 OMV isolations 
 
OMVs were isolated as described previously (Elmi et al., 2012) . Briefly, C. jejuni 
strains were grown on CBA plates for 24 h, and harvested cells were re-suspended 
in 1 ml BB and adjusted to an OD600 of 0.1. This suspension was inoculated into 
50 ml of BB which had been pre-incubated overnight in a 150 cm3 tissue culture 
flask (Corning Incorporated, New York, USA) at 37oC with shaking at 75 rpm. For 
every strain used, two flasks of 50 ml BB were prepared. The inoculated flasks 
were placed into the VAIN on an orbital shaker at 75 rpm for 16 h to achieve mid-
log phase, and then transferred into 50 cm centrifugal tubes (Corning) and 
centrifuged (Eppendorf) at 4,000 rpm for 30 min at 4oC. The supernatant from the 
two flasks were pooled, filtered using a 0.22 µm membrane syringe filter (Merck 
Millipore Ltd, Tullagreen, Ireland) and the cell-free supernatant collected into 50 
ml centrifuge tubes. The filtered supernatants were transferred into Amicon 
centrifugal filter unit Ultra- 15 (Merck Millipore Ltd.) with a 10 kDa cut-off and 
concentrated to around 2 ml by centrifugation at 4,000 rpm for 30 min at 4oC. The 
concentrated samples were transferred into ultra-clear centrifuge tubes (Beckman 
Coulter, CA, USA). Tubes were then centrifuged at 45,000 rpm for 3 h using a TLS 
55 rotor at 4oC in Optima TL Ultracentrifuge (Beckman Instruments, Palo Alto, CA). 
After ultracentrifugation, the supernatant was discarded and the pellet was 
resuspended in 200 µl sterile PBS. Aliquots were prepared and stored at -20oC. 
Small volumes of each sample were taken for quantification of protein 
concentration using a BCA assay as described in Section 2.4.1. 
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2.6 Confocal fluorescent microscopy techniques 
 
For confocal microscopy, IECs were processed using the following procedure: 
IECs were cultured on a glass cover slips for 24 h. Cells were grown to 50-60% 
confluence in a 5% CO2 incubator. If inhibitors were used, these were added 1 h 
prior to infection with bacteria. Cells were then washed with PBS three times and 
infected with bacteria for the duration required. Once incubation ended, media 
were gently removed from the wells. 500 µl of 3.7% (v/v) paraformaldehyde (PFA) 
(Sigma-Aldrich) was added and incubated for 10 min at RT to fix the cells. Fixed 
cells were washed with PBS and permeabilised with 0.2% v/v Triton X-100 (Sigma-
Aldrich) in PBS for 5 min. Once the cells and bacteria were fixed and 
permeabilised, the slide was now ready to be stained with any required stains to 
observe the specific structure or element (organelles) in the cell, as well as the 
extracellular or intracellular bacteria. Cells were incubated with stains and primary 
or secondary antibodies for the appropriate time at RT in the dark to protect the 
fluorescent dyes. After the final rinse with PBS, the edge of coverslips was dabbed 
with an absorbent paper to remove any remaining liquid. Coverslips were then 
mounted inverted on a drop of mounting medium containing 4’6-diamidino-2-
phenylindole (DAPI) (Vector Laboratories, Peterborough, UK) at final 
concentration of 1.5 µg/ml with fluoresave (Sigma-Aldrich) on a glass slide (Fisher 
Scientific). Slides were left to air-dry for a minimum of 20 min, after which nail 
varnish was used to seal the coverslips ring to prevent further drying of the cells. 
Slides of a specimen could be observed straight away or kept at 4oC for up to 1 
week. Specimens were imaged on an inverted confocal laser-scanning 
microscope (LSM 510, Zeiss, Jena, Germany) using a ×63 oil immersion objective 
at ambient temperature. Images were acquired and processed using Zeiss 
confocal software and Image J (NIH) software. For each experiment, the confocal 
microscope settings and conditions were kept identical between control and 
treated cells monolayers. Random images were captured. The acquired images 
were analysed for each experimental condition. Islands of Caco-2 or T84 cells 
consisted of approximately 20-50 cells were analysed for bacterial internalisation. 
For each experiment, the entire slide was examined and on average a minimum 
of three representative islands of cells were imaged by capturing single image or 
making Z-stacks of the entire island. However, this only allowed a presumptive 
microscopic quantification of the number of intracellular bacteria. 
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2.6.1 Plasma membrane stain 
 
For cell membrane staining, Wheat germ agglutinin (WGA) was used. WGA binds 
to glycoproteins of the cell membrane. However, the cells should not be 
permeabilised prior to staining and the incubation time should be limited to prevent 
WGA from staining internal structures. IECs were grown on glass cover slips for 
24 h. Following treatment with inhibitors and bacterial infection as described in 
Section 2.5, cells were washed two times with PBS and fixed with 3.7% (v/v) 
paraformaldehyde (PFA) per well for 10 min at RT. After removal of PFA, cells 
were washed three times with PBS. Cells were then stained with 250 µl of WGA 
conjugated with Alexa Fluor 553 (Sigma-Aldrich) at a dilution of 1:500 in PBS per 
well and incubated for 10 min at RT. Cells were permeabilised by adding 250 µl of 
0.2% (v/v) Triton X-100 per well and incubated for 5 min. Cells were washed again 
three times with PBS and excess fluid was removed by touching the coverslip 
edges onto tissue paper. Coverslips were then placed on top of a 3 µl drop of DAPI 
on a glass slide. Once dried, nail varnish was used to seal the coverslips. Slides 
were then ready to be viewed using confocal microscopy or stored at 4oC in the 
dark. 
 
 
2.6.2 Actin stain  
 
IECs were grown on glass coverslips for 24 h. Following treatment with inhibitors 
and bacterial infection as described in Section 2.5, cells were washed and fixed 
with 250 µl 3.7% (v/v) paraformaldehyde per well for 10 min at RT. Cells were then 
washed three times with PBS. Permeabilisation was performed using 250 µl per 
well of 0.2% (v/v) Triton X-100 for 5 min. Cells were washed three times with PBS, 
and then 250 µl of Rhodamine phalloidin (Sigma-Aldrich) diluted at 1: 4000 in PBS 
was added and incubated in the dark for a minimum of 45 min. Cells were washed 
again three times with PBS. Excess fluid was removed and coverslips were placed 
on top of a 3 µl drop of DAPI on a glass slide. Once dried, nail varnish was used 
to seal the coverslips. Slides were then ready to be viewed using confocal 
microscopy or stored at 4oC in the dark. 
 
 
91 
 
2.6.3 Late endosomal stain  
 
IECs were prepared as described in Section 2.5. For visualisation of the late 
endosome, protein marker lysosome associated membrane protein 1 stain (Lamp-
1 (H4A3): sc-20011) from Santa Cruz Bio technology Inc (Texas, USA) was used 
at a concentration of 1:100 according to the manufacturer's recommendations. The 
cells were infected with C. jejuni 11168H wild-type, cadF or flpA mutants for 2 h. 
After co-incubation with bacterial cells, the cells were washed three times with 
PBS, and then 250 µl of the lamp-1 conjugated with Alexa Fluor 647 (far red) was 
added to the cells and incubated for 1 h. Cells were washed again three times with 
PBS. Excess fluid was removed and coverslips were placed on top of a 3 µl drop 
of DAPI on a glass slide. Once dried, nail varnish was used to seal the coverslips. 
Slides were then ready to be viewed using confocal microscopy or stored at 4oC 
in the dark.  
 
 
 
2.6.4 Differential staining of adherent and intracellular bacteria  
 
Cells were prepared as described in Section 2.5. Briefly, after the 2 h bacterial 
infection, cells were washed in sterile PBS to remove non-adherent bacteria and 
fixed by incubating infected cells in 500 μl of 3.7% PFA for 1 h at RT. Cells were 
blocked by incubating in blocking solution for 1 h at RT. To detect adherent 
bacteria, cells were probed with rabbit anti-Campylobacter polyclonal antibody at 
a concentration of 1:1000 (Abcam, Cambridge, UK) diluted in blocking solution for 
1 h at RT or overnight at 4oC. Following incubation with primary antibody, the cells 
were washed three times with PBS and 0.1% (v/v) Tween 20 for 5 min for each 
wash. The cells were incubated with secondary antibody Alexa Fluor far red 
conjugated mouse anti-rabbit anti-Campylobacter(Abcam anti-mouse ab25245) at 
a concentration of 1:1000 for 30-45 min. These steps were performed prior to cell 
permeabilisation at RT in the dark. 30 µl per well of intracellular bacteria were not 
stained with primary or secondary antibody since once bacteria were internalised, 
cells were not permeabilised and remained green (GFP). Cells were further 
washed with PBS three times. Excess fluid was removed and coverslips were 
placed on top of a 3 µl drop of DAPI on a glass slide. Once dried, nail varnish was 
used to seal the coverslips. Slides were viewed using confocal microscopy or 
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stored in the fridge at 4oC in the dark. In each experiment, non-infected cells were 
used as internal controls of IECs auto-fluorescence. Adherent bacteria appear red 
as they have been stained red, while intracellular GFP C. jejuni appear green only. 
 
2.7 Statistical analysis 
 
Differences between mean values were tested for significance by performing 
unpaired two-tailed Student’s tests using the GraphPad Prism software version 7.0 
(GraphPad Software, California, USA).  
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CHAPTER THREE: COMPARISON OF THE EFFECTS OF MUTATION OF 
cadF or flpA IN THE 11168H AND 81-176 WILD-TYPE STRAINS 
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3.1 Introduction  
 
Both cadF and flpA are highly conserved genes in C. jejuni (Flanagan et al., 2009, 
Konkel et al., 1997). Gene regulation in bacteria usually occurs at the level of 
transcription, when RNA polymerase transcribes genes to mRNA. Promoter 
sequences are usually located upstream of a gene and are the region that RNA 
polymerase binds to during the initiation of transcription. Different promoter activity 
levels were observed during expression of the two fibronectin binding proteins 
CadF and FlpA (Scanlan et al., 2017). This data showed that promoter region 
activity of cadF was at a higher level compared to promoter region activity of flpA 
in both the 11168 and 81-176 wild-type strains. However, there was a small 
increase in promoter activity of flpA in the 81-176 strain in comparison to promoter 
activity of flpA in the 11168 strain. The difference was linked to the different status 
of DNA supercoiling in the respective strains. The genomic DNA in the 11168 strain 
is more negatively supercoiled compared to the more relaxed genomic DNA in the 
81-176 strain (Eoin Scanlan, PhD Thesis, UCD, 2014). 
In addition, a previous study performed at the LSHTM showed that both the 81-
176 cadF and flpA mutants had a similar significant reduction in bacterial 
interactions with intestinal epithelial cells (IECs). However, the 81-176 flpA mutant 
displayed a more pronounced reduction in bacterial invasion of IECs compared to 
the 81-176 cadF mutant (Neveda Naz, PhD Thesis, LSHTM, 2014). This 
suggested that FlpA plays a more important role in C. jejuni invasion than CadF, 
even though based on promoter activity levels, CadF may be expressed at higher 
levels than FlpA. 
In many C. jejuni research studies, the strains used varies for example from recent 
clinical isolates to laboratory wild-type strains, to mutants constructed in lab, from 
less motile to highly motile strains, from non-invasive to highly invasive strains. In 
addition, the use of different experimental conditions together with the use of 
different tissue culture cell lines adds further confusion to an already complicated 
research area, making interpretation and comparison of different data sets more 
difficult. Because of all these factors, many of the results reported are diverse.  
Due to the non-consensus over many of the mechanisms of C. jejuni interactions 
with human IECs described in the literature, further investigations are required to 
confirm whether the highly diverse data is strain-specific or species-specific. 
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Therefore, the aim of this chapter was to investigate and compare the role of the 
fibronectin binding proteins CadF and FlpA between two different C. jejuni wild-
type strains and respective cadF and flpA mutants. 
 
 
3.2 Results 
 
3.2.1 Bioinformatic analysis of CadF and FlpA in the NCTC 11168 and the 
81-176 strains 
 
The similarity in nucleotide and amino acid sequences between CadF and FlpA 
from different strains was investigated. Gene sequences were obtained from NCBI 
and pairwise sequence alignment analysis was performed using ClustalW 
(Thompson et al., 1994). In the C. jejuni NCTC 11168 genome sequence, CadF is 
annotated as Cj1478c (an outer membrane fibronectin-binding protein) and FlpA 
as Cj1279c (a putative fibronectin domain-containing lipoprotein). In the 81-176 
genome sequence, CadF is annotated as Cj81176_1471 (a fibronectin-binding 
protein) and FlpA is annotated as CJJ81176_1295 (a fibronectin type III domain 
protein) (Gundogdu et al., 2007).   
Sequence alignment analysis showed CadF in NCTC 11168 differs from CadF in 
81-176 at four amino acids at the N-terminus (Figure 3.1). In row 1 of Figure 3.1, 
one is a semi-conserved substitution where a serine is in the 81-176 strain whilst 
a glycine is in the NCTC 11168 strain. The other is a conserved substitution where 
an isoleucine is in the 81-176 strain and a phenylalanine is in the NCTC 11168 
strain. In row 4, one is a non-conserved substitution where the 81-176 strain has 
a proline compared to an alanine in the NCTC 11168 strain and a conserved 
substitution of an alanine compared to a threonine. 
Based on the sequence alignment analysis of CadF in the NCTC 11168 and 81-
176 strains, FlpA was speculated to be highly conserved. FlpA showed seven 
amino acid differences (Figure 3.2), thus making it more difficult to infer FlpA 
function only by sequence analysis. In row 1 of Figure 3.2, the 81-176 strain has a 
glycine compared to a serine in the NCTC 11168 strain; in row 2, the 81-176 strain 
has a serine compared to a proline in the NCTC 11168 strain. In row 4, the 81-176 
strain has a glutamic acid compared to a glycine in the NCTC 11168 strain and a 
proline compared to a serine. In row 5, the 81-176 strain has an asparagine 
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compared to a serine in the NCTC 11168 strain, a methionine compared to an 
isoleucine and a valine compared to an alanine. One of these amino acid 
differences is conserved, three are semi-conserved and three are non-conserved 
substitutions (Figure 3.2). However, none of the identified amino acid differences 
is in the conserved fibronectin binding motif. 
 
 
 
Figure 3.1. ClustalW output showing multiple sequence alignment of CadF 
from the NCTC 11168 and 81-176 wild-type strains. An “*” indicates a fully 
conserved amino acid; a “:” indicates conservation between amino acids with 
strongly similar properties; a “.” indicates conservation between amino acids with 
weakly similar properties. 
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Figure 3.2. ClustalW output showing multiple sequence alignment of FlpA 
from the NCTC 11168 and 81-176 wild-type strains. An “*” indicates a fully 
conserved amino acid; a “:” indicates conservation between amino acids with 
strongly similar properties; a “.” indicates conservation between amino acids with 
weakly similar properties. 
 
Further pairwise sequence alignments showed there was 98.7% identity and 
98.7% similarity for CadF (Figure 3.1) and 98.3% identity and 98.8 similarity for 
FlpA (Figure 3.2) between strains NCTC 11168 and 81-176. Even though more 
variation was observed in the FlpA protein sequence compared to the CadF protein 
sequence, the two proteins are suggested to have almost identical roles in both 
strains. CadF and FlpA showed binding ability to fibronectin in both the 11168H 
and 81-176 strains (see Section 3.2.10). 
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However, for the NCTC 11168 CadF and FlpA proteins sequences, there is only 
19.8% identity and 32.2% similarity between them (Figure 3.3). This suggested 
that although there maybe functional differences between the two proteins, some 
function might be conserved between different strains, as CadF and FlpA do both 
function as fibronectin binding proteins in both the 11168H and 81-176 strains. 
 
 
 
Figure 3.3. ClustalW output showing multiple sequence alignment of CadF 
and FlpA from the NCTC 11168. An “*” indicates a fully conserved amino acid; a 
“:” indicates conservation between amino acids with strongly similar properties; a 
“.” indicates conservation between amino acids with weakly similar properties. 
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3.2.1.1 Predicted 3-D models of CadF and FlpA 
 
To gain further insights into the structure, function and localisation relationship of 
CadF and FlpA, the amino acid sequences were submitted to the online tool Phyre 
(Kelley et al., 2015) and the highest score alignments were selected for 
comparison of 3-D structures. Predicting a 3-D model structure from an amino acid 
sequence provides three-dimensional information. A Ribbon diagram or 
Richardson diagram is the most common method used for representation of 
protein structures (Richardson, 1985). A ribbon diagram shows the organisation 
and path of the backbone proteins in a simple, basic molecular structure. 
Secondary protein structures such as an α-helix are depicted as coiled ribbons, 
whilst β-strands are depicted as an arrow with a pleat or thin line/tube. The CadF 
3-D model was based on template c5wt1B crystal structure of the periplasmic 
portion of outer membrane protein2 a (ompa) a member of protein-like OmpA from 
Capnocytophaga gingivalis. The FlpA 3-D model was based on template c1zlgA a 
solution structure of the extracellular matrix protein anosmin1. Both have 100% 
confidence against the templates but the sequence coverage was 46% for CadF 
and 95% for FlpA. FlpA has three fibronectin binding motifs, which are simillar to 
fibronectin found in ECM hence the higher sequence coverage (95%). Cartoon 
ribbon diagrams were generated from the Phyre2 web portal for protein modeling, 
prediction and analysis (Kelley et al., 2015). However, limitations with homology 
detection are; if there is no known structure/template for the sequence to be 
modelled on, the modelling will be impossible and very unreliable and also the 
method cannot predict point mutations (Kelley et al., 2015). 
Generally, proteins with a similar structure indicates proteins with a similar 
function, but it is not the case here with the generated 3-D structure models of 
CadF and FlpA. Although there is an apparent redundancy in C. jejuni 11168H 
between the CadF and FlpA homologues, the amino acid sequences of these two 
proteins with putatively similar functions are quite divergent (19.8% identity and 
32.2% similarity) (see Figure 3.3). These differences are reflected in the 3-D model 
structure. However, it is unclear whether this sequence diversity reflects 
differences between their functions. 
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Figure 3.4. Predicted 3-D models of CadF and FlpA. The 3-D structures of CadF 
(A) and FlpA (B). The models are coloured based on the rainbow colouring scheme 
showing N-terminus (Blue) and C-terminus (Red). Related proteins have similar 
length and similar colour in a particular region of related proteins. The structure 
models were generated by Pyre2 (http://www.phyre). 
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3.2.2 Construction of a 11168H cadF mutant 
 
To investigate the role of CadF in the 11168H wild-type strain, a 11168H cadF 
mutant was constructed via homologous recombination (Karlyshev and Wren, 
2005). cadF Forward and cadF Reverse primers were designed to amplify a cadF 
gene fragment from 11168H genomic DNA (gDNA). A PCR reaction was 
performed then analysed using agarose gel electrophoresis to confirm the 
amplification of the correct sized fragment as described in Section 2.3.4. Then a 
PCR clean up was performed to purify the PCR product prior to ligation into the 
pGEMT-easy vector. The ligated PI vector was transformed into XL-2 Blue MRF 
competent cells and plated onto LB agar plates containing ampicillin. After 
incubation, any resulting blue colonies were indicative of negative transformants, 
whilst colourless colonies were indicative of positive transformants. Boilates from 
these positive colonies were screened for the presence of cadF by PCR. A 
kanamycin cassette was then inserted into the cloned cadF gene fragment. The 
resulting construct was pGEMT-easy-cadF-11168H-KanR which was transformed 
into XL-2 Blue MRF competent cells. Plasmid DNA from E. coli containing a 
construct with the kanamycin cassette in the correct orientation was used to 
electroporate C. jejuni 11168H competent cells, which were plated onto a non-
selective CBA plate. The plate was incubated for 24 hours under microaerophilic 
conditions at 37oC. A bacterial suspension in PBS was made from the resulting 
growth on the CBA plate. Two hundred microliters of this suspension was spread 
onto a fresh CBA plate supplemented with kanamycin and incubated under the 
same conditions for further 3 – 4 days. 
gDNA was isolated from the putative 11168H cadF mutants and screened for 
insertion of the kanamycin cassette using gene specific primers (reverse and 
forward) using a standard PCR reaction. PCR products were analysed by gel 
electrophoresis. The amplified cadF mutant band was 2360 bps in size because 
of the successful insertion of the 1400 bp kanamycin cassette into the 960 bp cadF 
gene (Figure 3.5). The correct kanamycin cassette orientation was confirmed 
using kanamycin Forward out and cadF gene specific primers (data not shown). 
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Figure 3.5. PCR verification of the construction of a C. jejuni 11168H cadF 
mutant. Lane 1: Ladder; Lane 2: Positive control; Lane 3: Negative control; Lane 
4 – Lane 8: 11168H cadF mutants (clones 1-5). 
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3.2.3 Growth kinetics of the 11168H wild-type strain, cadF and flpA mutants 
 
As an initial phenotypic investigation to assess the effect of the mutation of cadF 
and flpA in the 11168H strain, growth rate experiments were performed. Both the 
11168H cadF and flpA mutants exhibited reduced growth rates compared to the 
wild-type strain during the early and mid log phases of growth. However, towards 
the late log phase, growth of the cadF and flpA mutants was similar to the level of 
wild-type strain. (Figure 3.6). 
 
 
 
 
Figure 3.6. Representative growth curves of C. jejuni 11168H wild-type strain, 
cadF and flpA mutants. Brucella broth was inoculated with C. jejuni 11168H wild-
type or mutant strains at an OD600 of 0.1 and incubated with constant shaking at 
75 rpm under microaerobic conditions at 37oC. At intervals of 2 h, 1 ml samples 
were removed and the OD600 recorded. Data shown are representative of three 
independent experiments. 
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3.2.4 Motility assay for 11168H wild-type strain, cadF and flpA mutants 
 
C. jejuni displays rapid and darting motility that enables the bacteria to colonise 
the intestine of humans, animals and avians (Wassenaar et al., 1991, Black et al., 
1988, Poly and Guerry, 2008). Mutation of cadF or flpA resulted in reduced motility 
in the 11168H strain (Figure 3.7). Initially at 24 h, both the wild-type strain and the 
cadF mutant exhibited similar motility, but the flpA mutant was less motile. At 48 
h, the cadF mutant exhibited a similar reduction in motility as the flpA mutant. 
However, at 72 h, the flpA mutant exhibited a greater reduction in motility 
compared to the cadF mutant.  
 
 
 
 
Figure 3.7. Motility assessment of 11168H wild-type strain, cadF and flpA 
mutants. Bacteria were grown for 24 h on blood agar plates. A suspension was 
prepared and adjusted to an OD600 of 1.0. 1.5 μl of this suspension was pipetted 
into the centre of soft agar plates and incubated at 37oC under microaerobic 
conditions for 72 h. The level of motility was assessed by measuring the diameter 
of the growth halo at 24 h, 48 h and 72 h. 
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3.2.5 Growth kinetics of the 81-176 wild-type strain, cadF and flpA mutants 
 
Both the 81-176 cadF and flpA mutants exhibited a similar growth rate compared 
to the wild-type strain. However, the flpA mutant exhibited a reduced growth rate 
during the late logarithmic / early stationary growth phases. 
 
 
 
 
Figure 3.8. Representative growth curves of C. jejuni 81-176 wild-type strain, 
cadF and flpA mutants. Brucella broth was inoculated with C. jejuni 81-176 wild-
type or mutant strains at an OD600 of 0.1 and incubated with constant shaking at 
75 rpm under microaerobic conditions at 37oC. At intervals of 2 h, 1 ml samples 
were removed and the OD600 recorded. Data shown are representative of three 
independent experiments. 
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3.2.6 Motility assay for 81-176 wild-type strain, cadF and flpA mutants  
 
Mutation of cadF or flpA in the 81-176 wild-type strain reduced motility significantly. 
In addition, the flpA mutant showed significantly reduced motility compared to the 
cadF mutant. 
 
 
 
Figure 3.9. Motility assessment of 81-176 wild-type strain, cadF and flpA 
mutants. Bacteria were grown for 24 h on blood agar plates. A suspension was 
prepared and adjusted to an OD600 of 1.0. 1.5 μl of this suspension was pipetted 
into the centre of soft agar plates and incubated at 37oC under microaerobic 
conditions for 72 h. The level of motility was assessed by measuring the diameter 
of the growth halo at 24 h, 48 h and 72 h. 
 
 
3.2.7 Gene expression analysis in the 11168H and 81-176 wild-type strains 
 
A recent study investigating the impact of DNA supercoiling on promoter region 
activity showed that in both the 11168H and 81-176 wild-type strains, the promoter 
region of cadF exhibited a higher activity than the promoter region of flpA. 
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However, the promoter region of flpA in 81-176 was slightly more active than the 
promoter region of flpA in 11168H (Eoin Scanlan, PhD Thesis, UCD, 2014). 
Gene expression in both the 11168H and 81-176 strains was analysed to 
investigate the extent of differences in cadF and flpA transcription in both strains. 
 
 
3.2.7.1 RT-PCR analysis of cadF and flpA expression in the 11168H and 81-
176 strains 
 
The correlation between promoter region activity and the resulting transcription of 
genes was investigated to see whether higher promoter region activity resulted in 
higher levels of transcription. Total RNA was isolated from the 11168H and 81-176 
wild-type strains and respective mutants. The mRNA was converted to cDNA using 
RT-PCR and then used as a template for amplification using standard PCR with 
either cadF or flpA primers. PCR products were analysed on an agarose gel. 
Resulting bands were further analysed using Image J software. Data analysis was 
performed by comparing the expressed density of the selected peaks (wild-type 
strain or mutants) relative to a standard peak (gyrA). The relative density was 
calculated by dividing the percentage value for each sample by the percentage 
value for the standard. The standard used was the gyrA primer band. In addition, 
the relative density for standard is 1 (expression of gyrA) (Table 3.1). 
 
Table 3.1 Relative density for each selected Image J peak.  
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Figure 3.10 is a representative photo of an agarose gel showing that bands 
amplified from cDNA were less intense and smaller in size compared to bands 
amplified from gDNA isolated from wild-type strains. 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.10. Comparison of cadF and flpA PCR products amplified from 
either genomic DNA or complementary DNA from the 11168H or 81-176 wild-
type strains. Representative agarose gel electrophoresis of PCR products. Lane 
1: Ladder; Lane 2: 11168H cDNA / cadF primers; Lane 3: 11168H cDNA / flpA 
primers; Lane 4: 11168H cDNA / gyrA primers; Lane 5: 81-176 cDNA / cadF 
primers; Lane 6: 81-176 cDNA / flpA primers; Lane 7: 81-176 cDNA / gyrA primers; 
Lane 8: 11168H gDNA / flpA primers; Lane 9: 11168H gDNA / cadF primers; Lane 
10: 81-176 gDNA / flpA primers; Lane 11: 81-176 gDNA / cadF primers. 
 
Both the 11168H and 81-176 wild-type strains were compared for expression of 
cadF and flpA (Figure 3.11). cadF was expressed at a higher level than flpA in both 
strains. In the 81-176 wild-type strain, cadF was expressed at a significantly higher 
level than in the 11168H wild-type strain (p < 0.01). Both 11168H and 81-176 wild-
type strains expressed flpA at a lower level than cadF and at almost the same level 
with no significance difference between the 11168H and 81-176 strains. This data  
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supports the promoter region activity data showing that the cadF promoter region 
exhibited higher activity compared to the flpA promoter region in both the 11168 
and 81-176 strains. 
 
              
 
Figure 3.11. Increased expression of cadF in both 11168H and 81-176 wild-
type strains. RNA from both wild-type strains was isolated and converted to cDNA 
by RT-PCR. cDNA was used as a PCR template using either cadF, flpA or gyrA 
primers. PCR products were analysed by agarose gel electrophoresis. Image J 
was used to quantify band intensities. cadF and flpA expression is presented 
relative to gyrA expression and is representative of at least triplicate experiments. 
** denotes p < 0.01. 
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3.2.8 RT-PCR analysis of cadF and flpA expression in the 11168H cadF and 
flpA mutants 
 
The expression of cadF was increased in the 11168H flpA mutant compared to the 
11168H wild-type strain, suggesting that cadF expression is increased in the 
absence of FlpA. 
              
 
Figure 3.12. RT-PCR analysis of cadF expression in the 11168H wild-type 
strain and flpA mutant. RNA from the 11168H wild-type strain and flpA mutant 
were isolated and converted to cDNA by RT-PCR. cDNA was used as PCR 
template using cadF or gyrA primers. PCR products were analysed by agarose gel 
electrophoresis. Image J was used to quantify band intensities. cadF expression 
is presented relative to gyrA expression and is representative of at least triplicate 
experiments. * denotes p < 0.05. 
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In contrast, no significant changes in the expression of flpA were observed in the 
cadF mutant compared to the 11168H wild-type strain.  
 
               
 
Figure 3.13. RT-PCR analysis of flpA expression in the 11168H wild-type 
strain and cadF mutant. RNA from wild-type strain and cadF mutant were 
isolated and converted to cDNA by RT-PCR. cDNA was used as PCR template 
using flpA or gyrA primers. PCR products were analysed by agarose gel 
electrophoresis. Image J was used to quantify band intensities. flpA expression is 
presented relative to gyrA expression and is representative of at least triplicate 
experiments.  
 
 
 
 
112 
 
3.2.9 RT-PCR analysis of cadF and flpA expression in the 81-176 cadF and 
flpA mutants 
 
No significant changes in the expression of cadF were observed in the 81-176 flpA 
mutant compared to the 81-176 wild-type strain.  
 
               
 
Figure 3.14. RT-PCR analysis of cadF expression in the 81-176 wild-type 
strain and flpA mutant. RNA from the 81-176 wild-type strain and flpA mutant 
were isolated and converted to cDNA by RT-PCR. cDNA was used as PCR 
template using cadF or gyrA primers. PCR products were analysed by agarose gel 
electrophoresis. Image J was used to quantify band intensities. cadF expression 
is presented relative to gyrA expression and is representative of at least triplicate 
experiments. 
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There was a non-significant increase in flpA expression observed in the 81-176 
cadF mutant compared to the 81-176 wild-type strain.  
              
 
Figure 3.15. RT-PCR analysis of flpA expression in the 81-176 wild-type 
strain and cadF mutant. RNA from the 81-176 wild-type strain and cadF mutant 
were isolated and converted to cDNA by RT-PCR. cDNA was used as PCR 
template using flpA or gyrA primers. PCR products were analysed by agarose gel 
electrophoresis. Image J was used to quantify band intensities. flpA expression is 
presented relative to gyrA expression and is representative of at least triplicate 
experiments.   
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3.2.10 Binding to fibronectin in vitro of the 11168H and 81-176 wild-type 
strains  
 
During colonisation, C. jejuni must interact with receptors on human IECs. 
Numerous C. jejuni proteins mediate this interaction with the multiple components 
of the IEC surface. Fibronectin binding plays an important role in the pathogenesis 
of many bacteria (Pankov and Yamada, 2002). 
Fibronectin and laminin are components of the extracellular matrix of epithelial 
cells. CadF and FlpA are probably the most studied C. jejuni adhesions and are 
highly conserved amongst C. jejuni strains. Experiments were performed to 
investigate any differences in the binding capabilities of CadF and FlpA in the 
11168H and 81-176 wild-type strains. 
To determine if the binding capability of the 11168H and 81-176 wild-type strains 
to fibronectin was the same, fibronectin binding assays were performed. The data 
showed that the 81-176 wild-type strain binds to immobilised fibronectin at a 
significantly reduced level compared to the 11168H wild-type strain at both 15 min 
and 60 min time points. However, at 30 min, there was no significant difference 
observed in the level of fibronectin binding between 11168H and 81-176 wild-type 
strain. 
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Figure 3.16 Fibronectin binding assays. Immobilised fibronectin in a 96 well 
plate was infected with inoculums of C. jejuni 11168H or 81-176 wild-type strains 
at OD600 of 0.1 (≈108 cfu/ml) for 15, 30 or 60 min. At the end of incubation period, 
wells were washed with PBS. Trypsin EDTA was used to detach adherent bacteria. 
Suspensions were serially diluted and plated on CBA plates. Data are 
representative of a minimum of triplicate biological replicates. **** denotes p < 
0.0001. 
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3.2.11 Binding to fibronectin in vitro of the 11168H wild-type strain, cadF 
and flpA mutants 
 
Mutation of either cadF or flpA in the 11168H strain resulted in reduced binding to 
immobilised fibronectin at all-time points (Figure 3.17). There was an increase in 
binding to fibronectin over time for both the 11168H wild-type strain and cadF 
mutant. For the 11168H cadF mutant, there was a steady increase in binding from 
15 min to 60 min as was the case for the wild-type strain. It interesting to note that 
the cadF mutant could recover to the level of binding similar to that of the wild-type 
strain after 60 min (Figure 3.17A). However, mutation of flpA resulted in 
significantly reduced binding to immobilised fibronectin compared to the wild-type 
strain. The flpA mutant was not able to recover to the level of binding similar to that 
of the wild-type strain after 60 min (Figure 3.17B). 
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Figure 3.17. Fibronectin binding assays. Immobilised fibronectin in a 96 well 
plate was infected with inoculums of C. jejuni 11168H wild-type strain, cadF or flpA 
mutants at OD600 of 0.1 (≈108 cfu/ml) for 15, 30 or 60 min. At the end of incubation 
period, wells were washed with PBS. Trypsin EDTA was used to detach adherent 
bacteria. Suspensions were serially diluted and plated on CBA plates. Data are 
representative of a minimum of triplicate biological replicates. * denotes p < 0.05; 
*** denotes p < 0.001; **** denotes p < 0.0001. 
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3.2.12 Binding to fibronectin in vitro of the 81-176 wild-type strain, cadF 
and flpA mutants 
 
 
Mutation of cadF or flpA in the 81-176 strain produced similar results as with the 
11168H strain, with reduced binding to immobilised fibronectin compared to the 
wild-type strain (Figure 3.18). Both the 81-176 cadF and flpA mutants showed 
reduced binding, at both 30 and 60 min. However at 15 min this was not significant. 
At 60 min both the 81-176 cadF and flpA mutants showed reduced binding (p < 
0.0001) compared to the wild-type strain. Also at this time point, the cadF mutant 
bound to fibronectin at a higher level compared to the flpA mutant. 
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Figure 3.18. Fibronection binding assays. Immobilised fibronectin in a 96 well 
plate was infected with inoculums of C. jejuni 81-176 wild-type strain, cadF or flpA 
mutants at OD600 of 0.1 (≈108 cfu/ml) for 15, 30 or 60 min. At the end of incubation 
period, wells were washed with PBS. Trypsin EDTA was used to detach adherent 
bacteria. Suspensions were serially diluted and plated on CBA plates. Data are 
representative of a minimum of triplicate biological replicates. ** denotes 
p<0.01;**** denotes p < 0.0001. 
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3.2.13 Binding to laminin in vitro of the 11168H wild-type strain, cadF and 
flpA mutants 
 
Laminin is a major component in the basal lamina, a layer of the extracellular 
matrix secreted by the epithelial cells. Data have shown that all strains of H. pylori 
bind to laminin at a higher affinity compared to C. jejuni. This comparison was 
made to investigate whether C. jejuni binds as efficiently to laminin as to 
fibronectin. 
Laminin binding assays showed that the 11168H cadF mutant exhibited no 
significant difference in binding capacity to laminin compared to the 11168H wild-
type strain (Figure 3.19). However, the 11168H flpA mutant exhibited a 
significantly reduced binding capacity (p < 0.05). 
 
              
 
Figure 3.19. Laminin binding assays. Immobilised laminin in a 96 well plate was 
infected with inoculums of C. jejuni 11168H wild-type strain, cadF or flpA mutants 
at OD600 of 0.1 (≈108 cfu/ml) for 15, 30 or 60 min. At the end of incubation period, 
wells were washed with PBS. Trypsin EDTA was used to detach adherent bacteria. 
Suspensions were serially diluted and plated on CBA plates. Data are 
representative of a minimum of triplicate biological replicates. * denotes p < 0.05. 
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3.2.14 Binding to laminin in vitro of the 81-176 wild-type strain, cadF and 
flpA mutants 
 
Laminin binding assays showed that the 81-176 cadF mutant exhibited no 
significant difference in binding capacity to laminin compared to the wild-type strain 
(Figure 3.20). However, the 81-176 flpA mutant exhibited a significantly reduced 
binding capacity (p < 0.05).  
 
  
 
Figure 3.20. Laminin binding assays. Immobilised laminin in a 96 well plate was 
infected with inoculums of C. jejuni 81-176 wild-type strain, cadF or flpA mutants 
at OD600 of 0.1 (≈108 cfu/ml) for 15, 30 or 60 min. At the end of incubation period, 
wells were washed with PBS. Trypsin EDTA was used to detach adherent bacteria. 
Suspensions were serially diluted and plated on CBA plates. Data are 
representative of a minimum of triplicate biological replicates. * denotes p < 0.05. 
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3.2.15 Galleria mellonella model of infection for C. jejuni 
 
Due to the lack of a convenient small animal model available to study C. jejuni 
pathogenesis, the use of insects as alternative models of infection has been 
developed. The human and insect immune systems, both humeral and cellular, 
share many similarities. Even though insects lack an acquired immune system 
which is mediated by B and T lymphocytes, they have a well-developed innate 
immune system that reacts rapidly to infectious agents (Harding et al., 2013, 
Senior et al., 2011). Insects have specialised phagocytic cells known as 
haemocytes that function to phagocytose pathogens and form aggregates that 
encapsulate and neutralise bacteria. These cells mimic mammalian phagocytic 
cells and produce bactericidal compounds such as superoxide (Harding et al., 
2013, Senior et al., 2011). Activation of haemocytes triggers a phenol oxidase (PO) 
which results in melanisation and production of anti-microbial compounds (Lavine 
and Strand, 2002). 
G. mellonella larvae have been widely used as a non-mammalian model for 
bacterial infection studies (Champion et al., 2009). Larvae can be infected at 37°C 
and possess haemocytes. To investigate the effect of mutation of cadF or flpA in 
the 11168H and 81-176 strains, experiments were performed using G. mellonella 
as a model of infection. 
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3.2.15.1 Melanisation in G. mellonella larvae infected with C. jejuni 
 
Previous studies have shown that G. mellonella larvae are susceptible to bacterial 
infections. Haemolymph produces antimicrobials effectors that have been shown 
to inhibit growth of L. monocytogenes in an inhibition zone assay (Mukherjee et 
al., 2010). 
The melanisation reaction occurred when G. mellonella haemolymph was added 
to a lawn of C. jejuni (Figure 3.21A). This process was also reflected in the 
changing colour of larvae following injection of a C. jejuni inoculum (107 
CFU/larvae) (Figure 3.21B). As early as 30 minutes post-infection, larvae colour 
turned to brown. In addition, these larvae later turned black and died within 48 
hours. However, some larvae that turned brown but were still responsive to touch 
would return to a cream colour after 48 hours (data not shown). Larvae were 
counted as dead when the cream coloured larvae turned brown or black and were 
unresponsive to touch. No mortality of larvae was observed when injected with 
PBS or unchallenged. 
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Figure 3.21. C. jejuni infection in G. mellonella larvae. A. G. mellonella 
melanisation process. Haemolymph from several larvae was collected and added 
onto a lawn of C. jejuni on a CBA plate then incubated at 37oC for 48 hours. Zones 
of black granulation were observed where the haemolymph had been added. B. 
Corresponding colour change of larvae from cream to brown or black following 
infection with C. jejuni. 10 µl of OD600 0.1 C. jejuni suspension in PBS was injected 
into a hind leg of each larvae (≈107 CFU/larvae). Larvae were incubated at 37oC 
for 48 hours. Survival was observed at 24 intervals. 
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3.2.15.2 G. mellonella model of infection with 11168H wild-type strain, cadF 
and flpA mutants 
 
G. mellonella larvae were infected with the 11168H wild-type strain, cadF or flpA 
mutants (10 larvae for each strain). At intervals of 24 hours, survival was recorded. 
The 11168H wild-type strain was the most cytotoxic with more than 70% larval 
mortality compared to the 11168H cadF and flpA mutants, which both produced 
larval mortality below 50% (Figure 3.22). The 11168H cadF mutant killed 
significantly less larvae than the 11168H flpA mutant (p < 0.01). These results 
indicate that the flpA mutant is more cytotoxic to G. mellonella larvae than the cadF 
mutant in the 11168H strain. No mortality was observed with uninfected larvae, 
which received no C. jejuni inoculum or in larvae infected with only a PBS 
inoculum. 
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Figure 3.22. G. mellonella model of infection. Larvae was inoculated with 10 µl 
each of 11168H wild-type strain, cadF or flpA mutants at OD600 0.1, equivalent to 
≈107 CFU of C. jejuni, via the hind leg using a 10-gauge syringe. Larvae were 
incubated at 37oC for the duration of the experiment. At intervals of 24 h, larvae 
were inspected for live or death counts. Inoculation with PBS was used as control. 
10 larvae were used for every sample and data were from a minimum of three 
experiments. ** denotes p < 0.01 and **** denotes p < 0.0001. 
 
 
 
3.2.15.3 G. mellonella model of infection with 81-176 wild-type strain, cadF 
and flpA mutants 
 
G. mellonella larvae were infected with the 81-176 wild-type strain, cadF or flpA 
mutants (10 larvae for each strain). At intervals of 24 hours, survival was recorded. 
Mutation of cadF or flpA in the 81-176 strain reduced cytotoxicity in G. mellonella 
larvae compare to wild-type strain (Figure 3.23). The 81-176 wild-type strain was 
the most cytotoxic with 70% larval mortality. Moreover, the 81-176 cadF mutant 
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killed significantly less larvae with more than 90% survival than the 81-176 flpA 
mutant with 50% survival. This result also indicated that the flpA mutant is more 
cytotoxic than the cadF mutant to G. mellonella larvae in the 81-176 strain. 
Nevertheless, in comparison to the 11168H strain, the difference was not as high 
as in the 81-176 strain. No mortality was observed with uninfected larvae, which 
received no C. jejuni inoculum or in larvae infected with only a PBS inoculum. 
 
 
 
 
Figure 3.23. G. mellonella model of infection. Larvae were inoculated with 10 
µl each of 81-176 wild-type strain, cadF or flpA mutants at OD600 0.1, equivalent to 
≈107 CFU of C. jejuni, via the hind leg using a 10-gauge syringe. Larvae were 
incubated at 37oC for the duration of the experiment. At intervals of 24 h, larvae 
were inspected for live or death counts. Inoculation with PBS was used as control. 
10 larvae were used for every sample and data were from a minimum of three 
experiments. * denotes p < 0.05 and ** denotes p < 0.01. 
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3.2.16 Interaction of 11168H wild-type strain, cadF and flpA mutants with 
T84 intestinal epithelial cells 
 
 
Bacterial infection of IECs allows the investigation of both C. jejuni adhesion and 
invasion. The 11168H cadF mutant exhibited a reduced ability to interact (both 
adhesion and invasion) with T84 IECs compared to the wild-type strain with 
numbers of interacting bacteria lower but not significantly so. The increase in 
interaction between 3 h and 24 h was greater for the 11168H cadF mutant than for 
the wild-type strain (Figure 3.24A). There was a significant difference between the 
ability of the 11168H flpA mutant to interact with T84 IECs in comparison to the 
wild-type strain. The 11168H flpA mutant exhibited a reduced ability to interact with 
T84 IECs compared to the wild-type strain at 3 h, however this was not significant. 
The 11168H flpA mutant displayed a significant reduction in interaction at 24 h. 
The increase in interaction between 3 h and 24 h was greater for the 11168H flpA 
mutant than for the wild-type strain (Figure 3.24B).  
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Figure 3.24. Interaction of C. jejuni 11168H wild-type strain, cadF and flpA 
mutants with T84 IECs. Confluent monolayers were infected with C. jejuni 
11168H wild-type strain, cadF or flpA mutants and incubated for 3 h or 24 h. Triton 
X-100 was added following washes with PBS to lyse the cells. Serial dilutions of 
lysates were plated on CBA. After 48 h, CFU were counted. Data are 
representative of a minimum of triplicate biological replicates. ** denotes p < 0.01. 
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3.2.17 Invasion of 11168H wild-type strain, cadF and flpA mutants with T84 
intestinal epithelial cells 
 
Both 11168H cadF and flpA mutants displayed a significant reduction in invasion 
of T84 cells compared to the wild-type strain at both 3 h and 24 h time points. 
However, the invasion numbers for both mutants were still able to increase 
between 3 h to 24 h (Figure 3.25 A and B). 
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Figure 3.25. Invasion of C. jejuni 11168H wild-type strain, cadF and flpA 
mutants with T84 IECs. Confluent monolayers were infected with C. jejuni 
11168H wild-type strain, cadF or flpA mutants and incubated for 3 h or 24 h. 
Following PBS washes, cells were further incubated with gentamicin (150 μg/ml) 
for 2 h to kill extracellular bacteria, then lysed with Triton X-100. Serial dilutions of 
lysates were plated on CBA. After 48 h, CFU were counted. Data are 
representative of a minimum of triplicate biological replicates. *** denotes p < 
0.001; **** denotes p < 0.0001. 
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3.2.18 Interaction of 11168H wild-type strain, cadF and flpA mutants with 
Caco-2 intestinal epithelial cells 
 
Caco-2 IECs was chosen to further investigate the interaction and invasion 
capability of 11168H cadF and flpA mutants. The 11168H cadF mutant exhibited 
a slightly reduced ability to interact with Caco-2 IECs compared to the wild-type 
strain with numbers of interacting bacteria lower but not significantly so. The 
increase in interaction between 3 h and 24 h was slightly greater for the 11168H 
cadF mutant than for the wild-type strain (Figure 3.26A). However, the 11168H 
flpA mutant exhibited a significant reduction in interaction with Caco-2 IECs at 3 h 
and 24 h compared to that of wild-type strain (Figure 3.26B). In addition, the 
interaction numbers for both mutants were still able to increase between 3 h to 24 
h. 
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Figure 3.26. Interaction of C. jejuni 11168H wild-type strain, cadF and flpA 
mutants with Caco-2 IECs. Confluent monolayers were infected with C. jejuni 
11168H wild-type strain, cadF or flpA mutants and incubated for 3 h or 24 h. Triton 
X-100 was added following washes with PBS to lyse the cells. Serial dilutions of 
lysates were plated on CBA. After 48 h, CFU were counted. Data are 
representative of a minimum of triplicate biological replicates. ** denotes p < 0.01. 
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3.2.19 Invasion of 11168H wild-type strain, cadF and flpA mutants with 
Caco-2 intestinal epithelial cells 
 
 Both the 11168H cadF and flpA mutants displayed a significant reduction in 
invasion of Caco-2 IECs compared to wild-type strain at both 3 h and 24 h time 
points. In addition, the invasion numbers were able to increase between 3 h to 24 
h (Figure 3.27A and B). The flpA mutant exhibited a reduced level of invasion of 
Caco-2 IECs compared to the cadF mutant.  
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Figure 3.27. Invasion of C. jejuni 11168H wild-type strain, cadF and flpA 
mutants with Caco-2 IECs. Confluent monolayers were infected with C. jejuni 
11168H wild-type strain, cadF or flpA mutants and incubated for 3 h or 24 h. 
Following the PBS washes, cells were further incubated with gentamicin (150 
μg/ml) for 2 h to kill extracellular bacteria, then lysed with Triton X-100. Serial 
dilutions of lysates were plated on CBA. After 48 h, CFU were counted. Data are 
representative of a minimum of triplicate biological replicates. ** denotes p < 0.01; 
*** denotes p < 0.001; ****denotes p < 0.0001. 
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3.2.20 Comparison of interaction with T84 intestinal epithelial cells of 
11168H & 81-176 cadF and flpA mutants 
 
A previous study performed at the LSHTM showed that both the 81-176 cadF and 
flpA mutants had a similar significant reduction in bacterial interactions with 
intestinal epithelial cells (Neveda Naz, PhD Thesis, LSHTM, 2014). In this study, 
both 11168H cadF and flpA mutants exhibited a reduction in interactions with T84 
cells compared to the wild-type strain at both 3 h and 24 h time points. However, 
the interaction numbers were able to increase between 3 h to 24 h. The increase 
of interaction at 24 h was greater for the 11168H cadF mutant than for the 11168H 
flpA mutant (Figure 3.28A). Both 81-176 cadF and flpA mutants also exhibited a 
reduction in interactions with T84 cells compared to the wild-type strain at both 3 
h and 24 h time points. Again, the interaction numbers were able to increase 
between 3 h to 24 h. However, interaction of the 81-176 wild-type strain was the 
highest, the 81-176 cadF mutant was intermediate, and the 81-176 flpA mutant the 
lowest (Figure 3.28B). 
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Figure 3.28. Interaction of C. jejuni 11168H & 81-176 wild type strains, cadF 
and flpA mutants with T84 IECs. Confluent monolayer cells were infected with 
C. jejuni 11168H or 81-176 wild type strains, cadF or flpA mutants and incubated 
for 3 h or 24 h. Triton X-100 was added following washes with PBS to lyse the 
cells. Serial dilutions of lysates were plated on CBA. After 48 h, CFU were counted. 
Data are representative of a minimum of triplicate biological replicates.  
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3.2.21 Comparison of invasion of T84 intestinal epithelial cells of 11168H & 
81-176 cadF and flpA mutants 
 
Both the 11168H cadF and flpA mutants displayed a significant reduction in 
invasion of T84 IECs compared to the wild-type strain at both 3 h and 24 h time 
points. However, the invasion numbers were able to increase between 3 h and 24 
h. Interestingly, the 11168H cadF mutant exhibited a lower level of invasion of T84 
IECs compared to the 11168H flpA mutant at both 3 h and 24 h (Figure 3.29A). 
Both the 81-176 cadF and flpA mutants also displayed a significant reduction in 
invasion of T84 IECs compared to the wild-type strain at both 3 h and 24 h time 
points. However, the invasion numbers decreased between 3 h and 24 h for the 
wild-type strain, whilst the flpA mutant showed similar numbers whilst only the 
cadF mutant showed increased numbers (Figure 3.29B). 
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Figure 3.29. Invasion of C. jejuni 11168H & 81-176 wild-type strains, cadF and 
flpA mutants with T84 IECs. Confluent monolayers were infected with C. jejuni 
11168H or 81-176 wild-type strains, cadF or flpA mutants and incubated for 3 h or 
24 h. Following the PBS washes, cells were further incubated with gentamicin (150 
μg/ml) for 2 h to kill extracellular bacteria, then lysed with Triton X-100. Serial 
dilutions of lysates were plated on CBA. After 48 h, CFU were counted. Data are 
representative of a minimum of triplicate biological replicates.  
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3.3 Discussion 
 
Genomic diversity is widespread in bacteria, particularly in Campylobacter 
species. There is extensive evidence in the literature to support not only genomic 
but also phenotypic variation in C. jejuni (Duong and Konkel, 2009, Esson et al., 
2016, Friis et al., 2010, Gundogdu et al., 2016, Hanel et al., 2009, Poly et al., 2005, 
Wassenaar et al., 1998). The most extensively studied C. jejuni 81-176 wild-type 
strain was isolated from an outbreak in humans (Korlath et al., 1985). The C. jejuni 
81-176 strain has been used in many studies investigating signal transduction 
events, adhesion and invasion, intracellular survival, in vitro growth kinetics, 
motility and host immune responses (Monteville and Konkel, 2002, Hu et al., 2008, 
Wine et al., 2008, Boehm et al., 2012, Watson and Galan, 2008, Nemelka et al., 
2009). As such, the majority of our understanding of molecular pathogenesis of C. 
jejuni is derived from the study of this strain and only a small amount from the 
study of a few other strains that may or may not cause infection in humans. Other 
C. jejuni strains that have been studied include F38011, 81116, 11168, M129, 
GB11, GB19, and TGH9011. Even though based on just one strain, a study of 
pathogenesis can be performed, however, for confirmation of pathogenic 
mechanisms, data from other studies using different strains is preferable especially 
with C. jejuni. 
However optimised an assay, still some strains of C. jejuni exhibit invasion at a 
low-level compared to others. This leads to the question whether all C. jejuni 
strains are invasive and may indicate that the invasion phenotype is difficult to 
maintain when passaging strains in a laboratory. In addition, it is open to debate 
whether different C. jejuni strains use different mechanisms to enter a cell. With all 
this information in mind, the work in this chapter explored the roles of the two highly 
conserved adhesion proteins CadF and FlpA in two C. jejuni 11168H and 81-176 
strains. 
Bioinformatics analysis was performed to determine any variation in the amino 
acids sequences. It was clear that CadF and FlpA are two different proteins 
because they have only 19.8% identity and 32.2% similarity between them. This 
suggests that even though both CadF and FlpA are fibronectin binding proteins, 
they may have different functions. In addition, this is probably why CadF and FlpA 
work in collaboration and are both required for maximal binding as reported 
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previously by Konkel et al. (Konkel et al., 2010). CadF as a fibronectin binding 
protein, showed identical function in the 11168 and 81-176 strains; and the same 
for FlpA as a fibronectin binding protein in both the 11168H and 81-176 strains. 
This is probably because between the two strains, the identity and similarity are 
98.8%. These suggests in terms of individual functions, that CadF and FlpA are 
highly conserved in the 11168 and 81-176 strains. 
Data presented in this chapter indicates that differences exist between strains 
which can be observed in phenotypic assays as well as in other experiments. In 
conclusion, the roles of CadF and FlpA are similar in both the 11168H and 81-176 
strains but with different functional efficiency. 
Flagellum-driven motility is a key requirement for C. jejuni interactions with host 
cells (Poly and Guerry, 2008). Motility is essential for colonisation and non-motile 
strains exhibit reduced adhesion and invasion to IECs (Wassenaar et al., 1991). 
Other studies also showed that non-motile strains exhibited reduced invasion in 
vitro (Russell and Blake, 1994, Yao et al., 1994) and invasion in mice (Yanagawa 
et al., 1994). However, efficient invasion depends on more than motility alone as 
many fully motile mutants exhibit reduced invasion capabilities. It has been 
demonstrated that increased bacterial adherence is not sufficient for increased of 
invasion (Hu and Kopecko, 1999). 
Nevertheless, checking the motility of a mutant was suggested as the spontaneous 
loss of motility can affect invasion capabilities (Gaynor et al., 2004). In addition, it 
was reported that mutation and genomic variation could cause different 
morphology in C. jejuni (Esson et al., 2016). 
The phenotypic characterisation of the two C. jejuni 11168H and 81-176 strains in 
this study identified similarities and differences. The 11168H wild-type strain was 
more motile than the 11168H cadF and flpA mutants. Moreover, this result was in 
agreement with earlier work that showed 81-176 cadF and flpA mutants also 
exhibited reduced motility compared to the wild-type strain. However, the 81-176 
strain exhibited higher motility at all-time points compared to that of the 11168H 
strain. Interestingly, in both the 11168H and 81-176 strains, the cadF mutants 
exhibited similar levels of motility, as was also the case for the flpA mutants. These 
suggests that regardless of strain, mutation of cadF and flpA results in reduced 
motility in C. jejuni. 
Bacterial physiology changes successively through growth stages. Typically, cells 
must stabilise when first introduced into fresh medium. Bacteria then spend some 
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time in lag phase to adjust to the new environment. Bacteria then grow at a 
maximal rate after entering the log phase until limiting nutrients cause growth to 
slow and bacteria then enter the stationery phase. The growth curve data showed 
that in both the 11168H and 81-176 strains, mutation of cadF and flpA reduced 
growth in BB. In the 11168H strain, growth peaked at an O.D 600 of 1 at 24 h, 
whereas the 81-176 strain peaked at an O.D 600 of 0.9 at 22 h. In general, the 
growth rate experiments showed that cadF and flpA mutants exhibited reduced 
growth in comparison to the respective wild-type strains. 
In DNA topology, changes are correlated to growth stage. In log phase, DNA is 
negatively supercoiled, whereas in lag and stationery phases the DNA is in a more 
relaxed state (Dorman, 2013). DNA in the 81-176 strain is also in a more relaxed 
state compared to the more supercoiled DNA in the 11168H strain and this results 
in the 11168 strain been more motile than the 81-176 strain (Shortt et al., 2016). 
However, in this study the 81-176 strain was more motile than the 11168H strain, 
which may be due to the LSHTM 81-176 strain used in this study been more 
supercoiled than the UCD 81-176 strain.  
Motility and intact flagella have been shown to impact colonisation of C. jejuni to 
IECs in vivo and in vitro (Grant et al., 1993, Wassenaar et al., 1993). However, 
flagella were required for reaching a cell monolayer but not for adhesion (Grant et 
al., 1993). Hence, there have been studies where centrifugation was included as 
a step during adhesion and invasion assays to discount motility as a potential 
factor influencing invasion (Wassenaar et al., 1991, Konkel et al., 2004). However, 
it is still unclear as to how adhesion proteins such as CadF and FlpA can affect 
motility and this will require further investigation. 
To investigate the differences in levels of cadF and flpA expression, RT-PCR 
analysis was performed on the 11168H and 81-176 wild-type strains and the 
respective mutants. RT-PCR is a semi quantitative method used to measure the 
relative intensity of cadF and flpA expression using gyrA as reference gene. gyrA 
is a housekeeping gene which encodes DNA gyrase that is expressed 
constitutively in C. jejuni (Joslin and Hendrixson, 2009). 
Data from a recent study showed correlation between DNA supercoiling and 
motility. The more relaxed the supercoiling of DNA, the less motile the strain, as 
seen with the 81-176 strain. Whereas in the 11168 strain, the more negatively 
supercoiled DNA results in a more motile strain (Shortt et al., 2016). Another study 
also reported that the promoter region for cadF showed higher activities compared 
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to the promoter region for flpA in both the 11168 and 81-176 strains. However, the 
level of flpA promoter region activity was expressed slightly higher in the 81-176 
strain compared to in the 11168 strain (Eoin Scanlan, PhD Thesis, UCD, 2014). 
Results from this study showed that the level of expression of cadF is higher than 
that of flpA in both the 11168H and 81-176 wild-type strains. In addition, the 81-
176 wild-type strain expressed higher levels of cadF than the 11168H wild-type 
strain. Interestingly, no significant differences between the levels of flpA expressed 
in the 11168H or 81-176 strains was observed. In the 11168H strain, mutation of 
flpA increased the level expression of cadF to more than that of the wild-type strain, 
suggesting some form of compensation for the loss of FlpA. However, expression 
of flpA was at the same level in either the 11168H wild-type strain or the 11168H 
cadF mutant. In the 81-176 strain however, both wild-type strain and cadF mutant 
expressed flpA at the same level, whilst the flpA mutant expressed cadF at a higher 
level than the wild-type strain but not significantly so. This may indicate different 
compensation mechanisms for the loss of CadF or FlpA in different C. jejuni 
strains, but further work would be required to confirm this. 
Fibronectin is a major component of the extracellular matrix (ECM). Fibronectin is 
a 220 KDa monomer glycoprotein present at regions of cell-to-cell contact in IECs 
and composed of three types of repeating units (type I, II and III) (Konkel et al., 
2010). Fibronectin acts as an adhesion molecule that anchors cells to ECM 
components. Many cellular interactions including tissue repair, blood clotting, cell 
migration and adhesion are facilitated by fibronectin. Cells rely on the surface 
protein fibronectin to interact with the cells surroundings, but many pathogens can 
also bind to this molecule and hijack the host cell signalling pathways (Henderson 
et al., 2011). The binding of bacteria to fibronectin will trigger cellular signal 
pathways and result in subsequent formation of focal adhesion complexes that 
rearrange the cytoskeleton of the cells, resulting in bacterial uptake by the host 
cells. C. jejuni ability to bind to fibronectin increases the probability of bringing other 
virulence factors closer to host cells and promotes bacterial internalisation (Konkel 
et al., 1992c). 
Numerous C. jejuni proteins mediate the interaction between the multiple 
components of the IECs including fibronectin. In addition, numerous studies 
demonstrated the manipulation of host cell behaviour by pathogens binding to a 
component of the ECM such as fibronectin (van Putten et al., 1998). The two most 
characterised C. jejuni adhesins are CadF (Konkel et al., 2005) and FlpA 
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(Flanagan et al., 2009, Konkel et al., 2010). As CadF and FlpA are fibronectin 
binding proteins, the ability of CadF and FlpA to bind to fibronectin was determined 
using a fibronectin binding assay.  
The 11168H wild-type strain bound at higher levels to fibronectin at all time points 
in comparison to the 81-176 wild-type strain. However, binding capacity to 
fibronectin was significantly reduced in the 11168H and 81-176 following mutation 
of cadF or flpA. This is in agreement with previous studies that showed reduced 
binding was observed in both F38011 cadF and flpA mutants (Konkel et al., 2010). 
In both the 11168H and 81-176 strains, mutation of flpA appeared to result in a 
more significant reduction in the numbers of bacteria binding to fibronectin 
compared to mutation of cadF. This is surprising as the level of cadF promoter 
region activity was higher than that of the level of the flpA promoter region activity 
in both the 11168H and 81-176 strains, which would suggest that mutation of cadF 
should have a more significant effect on binding to fibronectin. However, in the 81-
176 strain, at 15 min and 30 min no significant differences between the cadF and 
flpA mutants binding capacity compared to the wild-type strain was observed but 
at 60 mins it was clear that the cadF mutant bound more than the flpA mutant. The 
data suggests that in both the 11168H and 81-176 strains, FlpA plays a more 
important role in binding to fibronectin than CadF. In addition, there were no 
significant differences in the binding of the 11168H and 81-176 flpA mutants to 
fibronectin whilst there was a slight increase in the 11168H cadF mutant binding 
capacity compared to that of the 81-176 cadF mutant. 
The theme that can be identified from the fibronectin binding study was that CadF 
and FlpA have similar roles and similar importance when in the same strain. 
However, the extent of the binding efficiency of both cadF and flpA mutants differs 
between strains. These findings support the data from various studies that showed 
maximal binding to host cells requires both CadF and FlpA (Konkel et al., 1997, 
Konkel et al., 2010, Flanagan et al., 2009, Krause-Gruszczynska et al., 2007b, 
Monteville et al., 2003). In general, it is established that C. jejuni strains adhere to 
IECs but to a different degree and efficiency depending on the strain (Ahmed et 
al., 2002) and results in this study also are in agreement with those data showing 
the consistency of the CadF and FlpA role during interactions with IECs. 
Non-mammalian models of infection have garnered much popularity and one that 
is simple, practical and widely used in research to study bacterial infection is the 
larvae of G. mellonella (wax moth) and this model can also can be used as a model 
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for antibiotic efficacy (Vogel et al., 2011). G. mellonella has an immune response 
similar to humans. The larvae possess innate immune cells called haemocytes 
that function like macrophages and neutrophils in humans. The haemocytes also 
produce melanin that result in melanisation. G. mellonella larvae have been used 
as a model of infection due to several advantages over big and small animal 
models. Studies have used G. mellonella with C. jejuni (Champion et al., 2009), 
with Legionella pneumophila (Harding et al., 2013), with Listeria spp (Mukherjee 
et al., 2010), with Pseudomonas aeruginosa (Jander et al., 2000) and with 
Francicisella tularensis (Aperis et al., 2007). 
Some of the advantages of using the larvae are; they are small and easy to handle, 
inexpensive, no specific food required and survive at 37oC (Champion et al., 2009, 
Champion et al., 2008, Chang and Miller, 2006, Mukherjee et al., 2010). Study of 
C. jejuni rrpA and rrpB mutants (Gundogdu et al., 2015, Gundogdu et al., 2011) 
and C. jejuni OMVs isolated from different mutants showed reduced cytoxicity 
(Elmi et al., 2012, Elmi et al., 2016). These data confirm that G. mellonella is 
susceptible to C. jejuni infection. 
Infection with C. jejuni caused the melanisation process to occur in G. mellonella 
larvae as exhibited in this study. Hemocytes generate melanin and deposit it in 
tissues surrounding the pathogen during infection. As a result, the infected larvae 
change colour from the normal uninfected cream colour to brown or black. The 
mechanisms and role of melanin in host defence are still unclear, however this 
result demonstrated and supported evidence that was in the literature about insect 
immunity against pathogens (Nappi and Christensen, 2005, Nappi and Vass, 
2001). 
A comparison of the results from the larval cytotoxicity study demonstrated that in 
both the 11168H and 81-176 wild-type strains mutation of cadF and flpA reduced 
cytotoxicity compare to the respective wild-type strain. In addition, in both the 
11168H and 81-176 strains, the cadF mutant exhibited significantly reduced 
cytotoxicity compared to the flpA mutant. However, the cytotoxicity of the 11168H 
cadF mutant was much less than the 81-176 cadF mutant. This is in keeping with 
the level of cadF promoter region activity been higher than that of the level of the 
flpA promoter region activity in both the 11168H and 81-176 strains, suggesting 
that CadF may play a more significant role in larval cytotoxicity than FlpA in the 
11168H and 81-176 strains. Alternatively it could be assumed that CadF and FlpA 
exhibited similar roles and importance in causing cytotoxicity although with 
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different efficiency due to different levels of expression. These data also 
contributed to the growing evidence that C. jejuni wild-type strain and mutants are 
cytotoxic to G. mellonella. Moreover, it supported data that G. mellonella showed 
a correlation between pathogen virulence in insect and in mammalian models. 
For successful attachment and colonisation, the process required is adhesion to 
and then invasion into the host cells. With all the numerous published data, the 
fact is that the invasion process of C. jejuni involves a myriad of bacterial and host 
factors and work in co-operation to mediate optimal adherence to host cells. Many 
studies showed adherence-defective mutants exhibit only reduced rather than 
severely abolished interactions with eukaryotic cells wherein the mutants reach 
adherence levels of about 20% to 50% of the wild-type strain (Backert and 
Hofreuter, 2013). 
The ability of C. jejuni to invade human IECs is crucial for the establishment of an 
infection. C. jejuni entrance to IECs is widely reported and some studies have 
shown C. jejuni inside of IECs during mouse infections (Stahl et al., 2014). CadF 
was characterised as a fibronectin binding protein in 1997 (Konkel et al., 1999a). 
Following that, many studies have reported the involvement of CadF in C. jejuni 
adhesion to and invasion of host cells. A cadF mutant exhibited reduced binding 
to host cells in vitro, such as to INT 407 cells (Moser et al., 1997). Reduced in vivo 
colonisation of broilers was also observed with a F38011 cadF mutant (Ziprin et 
al., 1999). A previous study demonstrated that FlpA plays a role in C. jejuni 
colonisation of chicks and a flpA mutant has reduced colonisation in chickens 
(Flanagan et al., 2009). 
IECs cell cultures provide a useful alternative method to study C. jejuni interactions 
in vitro (Friis et al., 2005). Both T84 and Caco-2 are cells from human colon 
adenocarcinoma and colonic carcinoma respectively. These IECs are 
characterised as polarised cells that display distinct apical and baso-lateral 
compartments. An earlier study by Kohler et al. provided evidence that polarised 
IECs are suitable for research into bacterial pathogenesis in general and in specific 
cell adherence and invasion (Kohler et al., 2002). Even though IECs are an 
established model for intestinal epithelial transport mechanisms, variation in 
experiments still exists. This is due to cell culturing condition factors such age, 
batch, density, passage frequency and numbers that have impact on cell line 
behaviour in the long term (Hidalgo et al., 1989). In these experiments to further 
explore the roles of CadF and FlpA in the two different 11168H and 81-176 strains, 
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both T84 and Caco-2 IECs were used. Results from a previous study suggested 
that FlpA plays a more important role in invasion of Caco-2 cells in the 81-176 
strain (Neveda Naz, PhD Thesis, LSHTM, 2014). 
Therefore, investigations were performed to confirm whether FlpA had the same 
more significant role in invasion in a different C. jejuni strain. However, in this 
study, this was not the case. There are a few things to consider here. Firstly, in 
assays using T84 cells, both the 11168H cadF and flpA mutants showed a 
reduction in interaction with and invasion compared to that of the 11168H wild-type 
strain. Interaction of the 11168H cadF mutant was reduced compared to that of 
the 11168H wild-type strain, but this was not significant. In contrast, interaction of 
the 11168H flpA mutant was significantly reduced compared to that of the 11168H 
wild-type strain. However, both the 11168H cadF and flpA mutants exhibited highly 
significant reduction in invasion of T84 cells compared to that of wild-type strain. 
Secondly, in assays using Caco-2 cells, only the 11168H flpA mutant 
demonstrated a significant reduction in interactions with Caco-2 cells compared to 
that of 11168H wild-type strain. Further, both the 11168H cadF and flpA mutants 
showed a significant reduction in invasion of Caco-2 cells compared to that of 
11168H wild-type strain. However, the 11168H flpA mutant ability to invade Caco-
2 cells appeared to be more reduced compared to that of the 11168H cadF mutant.  
Having established the above, looking at the cadF and flpA mutants in general, 
both initially displayed a reduction in ability to interact with and invade both T84 
and Caco-2 cell types compared to the wild-type strain. However, after 24 h 
infection, both the cadF and flpA mutants were able to increase interactions and 
invasion to a higher level than after 3 h infection, but not to the level of wild-type 
strain irrespective of the IECs used. Hence, in the 11168H strain, both CadF and 
FlpA were required for successful invasion of IECs with similar capability level and 
importance. Even though FlpA has three repeats of the same type 111 domain as 
Fn (Konkel et al., 1999c), that does not seem to make FlpA bind more strongly to 
Fn compared to CadF. In general, it is established that C. jejuni adhere to IECs 
but to a different degree and efficiency depending on different strains (Ahmed et 
al., 2002). In addition, it was also suggested that CadF and FlpA work in co-
operation to enable entry into host cells. A previous study reported C. jejuni 
induces IECs membrane ruffling, a phenomenom that was dependent on the CadF 
and FlpA Fn-binding proteins (Eucker and Konkel, 2012, Backert et al., 2013). This 
suggests that inactivation of cadF and flpA is sufficient to disrupt the activation of 
host signaling pathways. 
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The pathogenesis of C. jejuni has been studied in multiple IECs. To further 
investigate the roles of CadF and FlpA and to highlight the involvement of C. jejuni 
strain variation, T84 IECs were infected with C. jejuni 11168H and 81-176 wild-
type strains and respective cadF and flpA mutants. It was observed that both cadF 
and flpA mutants behaved similarly during adhesion to and invasion of T84 and 
Caco-2 cells. Reduced interaction of both the 11168H and 81-176 cadF and flpA 
mutants to T84 and Caco-2 cells was observed. However, in both the 11168H and 
81-176 strains, the flpA mutant exhibited a statistically significant reduction in 
binding to both T84 and Caco-2 cells. In contrast with these observation, the 
numbers of the cadF mutant internalised into T84 cells was slightly reduced 
compared to the flpA mutant.  
A study showed that C. jejuni invasiveness varies between C. jejuni strains (Biswas 
et al., 2000, Harvey et al., 1999). C. jejuni invasion into IECs depends on the 
concentration of bacteria used to infect IECs (Biswas et al., 2004, Biswas et al., 
2000). One study has reported that it is best to use a reduced multiplicity of 
infection (MOI) as this can result in maximum C. jejuni invasion (Friis et al., 2005). 
Furthermore, many subtle variations such as the use of different cell types such 
as HEP-2, INT 407 or HeLa from non-polarised cells and MDCK (monkey), have 
been shown to have implications on reaching a concensus on the ability of C. jejuni 
to invade IECs (De Melo et al., 1989, Fauchere et al., 1986, Oelschlaeger et al., 
1993). One study has suggested that cell lines originated from human intestinal 
epithelium are best and most suitable in investigating C. jejuni invasion 
mechanisms (Konkel et al., 1992a). It can be assumed that cell type can potentially 
influence the experiment outcomes as suggested by Friis et al. (Friis et al., 2005).   
The next chapter will explore further the roles of CadF and FlpA in C. jejuni 
interactions with host cells. 
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CHAPTER FOUR: FURTHER INVESTIGATION OF ROLES OF CADF AND 
FLPA DURING C. jejuni INTERACTIONS WITH HUMAN INTESTINAL CELLS 
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4.1 Introduction 
 
C. jejuni interaction with IECs is a multifactorial process, involving colonisation, 
followed by adherence to then invasion into IECs (O Croinin and Backert, 2012). 
The current view is that C. jejuni expresses proteins such as CadF and FlpA to 
interact with IEC receptors, particularly via fibronectin, which is attached to IECs 
by α5β1 integrins (Konkel et al., 2010). It has been hypothesised that the binding 
of CadF and FlpA to fibronectin triggers C. jejuni uptake via a IEC driven process 
involving actin remodelling, focal adhesion kinase and Src family kinases 
(Monteville et al., 2003). In vitro studies have suggested that fibronectin on the 
baso-lateral surface of IECs is sufficient for C. jejuni-integrin bridging.  
Several IECs types have been used to study the role of CadF and FlpA in various 
C. jejuni wild-type strains (Monteville et al., 2003, Krause-Gruszczynska et al., 
2011, Boehm et al., 2011). However, most previous studies have used a C. jejuni 
F38011 wild-type strain with INT 407 cells (Konkel et al., 2010). Although, these 
studies have elucidated the role of CadF and FlpA in the C. jejuni F38011 strain, 
gaps in our understanding of the roles of CadF and FlpA remain, particularly in the 
widely studied C. jejuni 11168H and 81-176 wild-type strains. There are also 
conflicting reports on the role of both proteins in C. jejuni capacity to interact with 
different IECs. Furthermore, mutation of either cadF or flpA partially diminishes the 
ability of C. jejuni F38011 strain to bind to fibronectin in vitro and/or interact with 
INT- 407 cells (Konkel et al., 1997, Monteville et al., 2003, Konkel et al., 2010).   
Different enteric pathogens have been shown to interact with and invade IECs by 
secreting proteins to facilitate interactions with and invasion of IECs (Singamsetty 
et al., 2008). Studies from different groups (Elmi et al., 2012, Lindmark et al., 2009) 
have described localisation of both fibronectin binding proteins CadF and FlpA in 
OMVs isolated from C. jejuni 11168H and 81-176 wild-type strains. Hence, the aim 
of this chapter is to investigate further the roles of CadF and FlpA in both live C. 
jejuni 11168H and 81-176 wild-type strains as well as associated with OMVs during 
interactions with host IECs.   
 
151 
 
 
 
 
 
4.2 Results 
 
4.2.1 TEER measurement in T84 and Caco-2 intestinal epithelial cells 
 
T84 and Caco-2 IECs are human intestinal cell lines that are able to form polarised 
monolayers (Everest et al., 1992, Monteville and Konkel, 2002). Polarised cells 
display distinct apical and baso-lateral compartments, form a brush border with 
microvilli and maintain tight junctions. These junctions function as a paracellular 
barrier for passage of solutes across Caco-2 monolayers (Hidalgo et al., 1989). A 
tight junction is a dynamic cell to cell adhesion which forms a continuous barrier 
around IECs (Yap et al., 1998). Barrier integrity is vital for the physiological 
activities of the tissue. Development of the membrane integrity of monolayers was 
assessed before further assays involving translocation of bacteria into IECs were 
performed. TEER measures tight junction permeability and monolayer integrity 
based on the resistance that intact monolayers provide. When the monolayers are 
compromised, the TEER value is reduced. 
To determine the role of CadF and FlpA in the ability of C. jejuni to breach the 
polarised IECs, the TEER value of confluent uninfected Caco-2 and T84 polarised 
monolayers was determined. Both cell types exhibited a different average range 
of TEER values. Caco-2 monolayers consistently had higher TEER values than 
T84 monolayers from day 1 to 15 post-seeding. At day 1 until day 6 post-seeding, 
T84 monolayers showed TEER values similar to the control value, however after 
day 6 post-seeding, T84 monolayers showed increasing TEER values until a peak 
at day 15 then reducing until day 21. Control values were from Transwell® inserts 
without IECs which produced constant TEER values at around 100 ohm (Ω) 
(Figure 4.1). 
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Figure 4.1. TEER values of uninfected T84 and Caco-2 IEC monolayers. T84 
and Caco-2 IECs were grown on Transwell® inserts in a 12-well plate. The 
media was changed every 48 h. The TEER measurements were recorded using 
EVOM prior to change of media. Blanks were the TEER values recorded from 
Transwell® inserts without IECs. Data are representative of triplicate independent 
experiments.  
 
 
4.2.2 No effect on TEER of T84 intestinal epithelial cells following infection 
with the 11168H cadF or flpA mutants 
 
Assays were performed to investigate whether infection with 11168H wild-type 
strain, cadF or flpA mutants affected the TEER of T84 IECs differently. There was 
no significant difference in TEER values in T84 IECs 24 h post-infection with the 
11168H wild-type strain, cadF or flpA mutants compared to the non-infected T84 
IECs (control). The 11168H wild-type strain exhibited slightly reduced TEER 
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values in T84 monolayers compared to both cadF and flpA mutants, however no 
significant differences were observed. In addition, the 11168H cadF mutant 
exhibited a slightly higher TEER value compared to the 11168H flpA mutant 
although this was not significant (Figure 4.2). 
 
               
 
Figure 4.2. Infection with 11168H wild-type strain, cadF or flpA mutants has 
no effect on TEER values of T84 IEC monolayers. T84 IECs were seeded and 
allowed to polarise on Transwell® inserts in a 12- well plate. Monolayers were then 
infected (MOI 100:1) with the 11168H wild-type strain, cadF or flpA mutants. TEER 
measurements were recorded after 24 h infection. Data are representative of 
triplicate independent experiments.  
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4.2.3 Translocation of C. jejuni 11168H wild-type strain, cadF and flpA 
mutants across T84 intestinal epithelial cells 
 
The ability of the 11168H wild-type strain, cadF and flpA mutants to translocate 
across a T84 IEC monolayer was investigated. There was no significant difference 
in the ability to translocate T84 IECs observed between the 11168H wild-type 
strain and either the 11168H cadF or flpA mutants. All three strains were able to 
translocate across the membrane barrier equally efficiently base on the similar 
level of relative fluorescence unit (RFU) (Figure 4.3 and Figure 4.4). 
 
 
 
Figure 4.3. 11168H cadF mutant translocates across a T84 IEC monolayer at 
the same rate as 11168H wild-type strain. T84 IECs were seeded and allowed 
to polarise on Transwell® inserts in a 12-well plate. T84 monolayers were infected 
(MOI 100:1) with the 11168H wild-type strain expressing GFP or the 11168H cadF 
mutant expressing GFP. At 2 h and 4 h time points, media from the baso-lateral 
compartment was collected into a 96-well opaque plate and the relative 
fluorescence units from the GFP expressing bacteria recorded. Data are 
representative of triplicate independent experiments. 
 
 
 
2 4
0
2 0
4 0
6 0
8 0
T im e  (H o u r)
R
F
U
1 1 1 6 8 H  W T
1 1 1 6 8 H c adF  m u ta n t
155 
 
 
 
 
Figure 4.4. 11168H flpA mutant translocates across a T84 IEC monolayer at 
the same rate as 11168H wild-type strain. T84 IECs were seeded and allowed 
to polarise on Transwell® filter inserts in a 12-well plate. T84 monolayers were 
infected (MOI 100:1) with the 11168H wild-type strain expressing GFP or the 
11168H flpA mutant expressing GFP. At 2 h and 4 h time points, media from the 
baso-lateral compartment was collected into a 96-well opaque plate and the 
relative fluorescence units from the GFP expressing bacteria recorded. Data are 
representative of triplicate independent experiments. 
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4.2.4 Induction of IL-8 from T84 intestinal epithelial cells following infection 
with 11168H wild-type strain, cadF and flpA mutants 
 
ELISA was performed to investigate the ability of C. jejuni 11168H wild-type strain, 
cadF and flpA mutants to induce IL-8 in IECs. 
Results from the ELISA showed that no significant difference was observed in the 
ability of the 11168H wild-type strain, cadF or flpA mutants to induce IL-8 from T84 
IECs. All strains induced IL-8 at a similar level after 24 h infection. 
 
               
 
Figure 4.5. IL-8 induction from T84 IECs following infection with 11168H wild-
type strain, cadF or flpA mutants. T84 IECs were infected (MOI 100:1) with 
11168H wild-type strain, cadF or flpA mutants. Supernatants were collected after 
24 h infection and the levels of IL-8 induced from T84 IECs quantified using a 
human IL-8 ELISA. Data are representative of triplicate independent experiments. 
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4.2.5 Induction of IL-8 from T84 intestinal epithelial cells following infection 
with 81-176 wild-type strain, cadF or flpA mutants 
 
A reduction in IL-8 induced from infected T84 IECs was observed with the 81-178 
cadF or flpA mutant in comparison to the 81-176 wild-type strain. Infection with the 
81-176 cadF mutant resulted in a small reduction in induction of IL-8 from T84 
IECs compared to wild-type strain, however this was not significant. In contrast, 
infection with the 81-176 flpA mutant resulted in a significant reduction in IL-8 
induction compared to that of the wild-type strain (Figure 4.6). The 81-176 wild-
type strain induced IL-8 to a similar level as the 11168H wild-type strain. 
 
                
 
Figure 4.6. IL-8 induction from T84 IECs following infection with 81-176 wild-
type strain, cadF or flpA mutants. T84 IECs were infected (MOI 100:1) with 81-
176 wild-type strain, cadF or flpA mutants. Supernatants were collected after 24 h 
infection and the levels of IL-8 induced from T84 IECs quantified using a human 
IL-8 ELISA. Data are representative of triplicate independent experiments. * 
denotes p < 0.05.  
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4.2.6 Rac1 activation in Caco-2 intestinal epithelial cells following infection 
with 11168H wild-type strain, cadF or flpA mutants 
 
Rac1 is a member of the Rho family of small GTPases and acts as a switch to 
activate signalling events that modulate cytoskeleton reorganisation resulting in 
bacterial uptake. Rac1 regulates the cycle between active GTP-bound to inactive 
GDP- bound status. In the GTP-bound active state, the GTPases transmits a signal 
and activates a series of intracellular events (Caron and Hall, 1998). It has been 
reported that C. jejuni internalisation into INT 407 IECs involved time-dependent 
activation of Rac1 and Cdc42 (Boehm et al., 2012, Krause-Gruszczynska et al., 
2007a, Eucker and Konkel, 2012). 
To investigate if the mutation of cadF or flpA has an impact on the activation of 
Rac1, a G-LISA assay was performed. Results showed that there was a significant 
difference observed in the activation of Rac1 between the 11168H wild-type strain 
and the cadF or flpA mutants (Figure 4.7). The activity of Rac1 following infection 
with the 11168H wild-type strain was set as 100%. Mutation of cadF or flpA 
induced Rac1 activation to a similar level at 66% or 65% respectively of the Rac1 
activity following wild-type strain infection.   
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Figure 4.7. Activation of Rac1 in serum starved Caco-2 IECs following 
infection with 11168H wild-type strain, cadF or flpA mutants. Caco-2 
monolayers were infected (MOI 100:1) with the 11168H wild-type strain, cadF or 
flpA mutants. After 20 minutes incubation, cells were lysed and the total protein 
concentration was determined. Whole cell lysates were processed and analysed 
for activated Rac1 by G-LISA™. Total active Rac1 was indicated in relative optical 
density. Data are representative of triplicate independent experiments. * denotes 
p < 0.05. 
 
 
4.2.7 Determination of protein concentration of OMVs isolated from 11168H 
or 81-176 wild-type strains and the respective cadF or flpA mutants 
 
 
OMVs are an important bacterial virulence factor, playing a major role in bacterial 
pathogenesis (Kuehn and Kesty, 2005, Kulp and Kuehn, 2010). A study by Elmi et 
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al. here at the LSHTM, identified both CadF and FlpA associated with C. jejuni 
11168H OMVs. Bacteria use OMVs to deliver virulence factors into host cells (Ellis 
and Kuehn, 2010). It was hypothesised that C. jejuni may use OMVs to deliver 
bacterial virulence factors to host cells which then promote bacterial interactions 
with and invasion of IECs, as well as the modulation of the host response (Elmi et 
al., 2012). 
Following OMV isolation from the 11168H or 81-176 wild-type strains and the 
respective cadF or flpA mutants, the protein concentration of these isolated OMVs 
was quantified using a BCA assay. The OMV protein concentration was 
determined using a standard curve of a known absorbance from varying 
concentrations of BSA (Figure 4.8A). Approximately 200 µg OMVs by protein 
content were isolated from 100 ml of culture supernatant. There was no significant 
difference (p > 0.05) between the protein concentrations of OMV isolated from the 
11168H or 81-176 wild-type strains and the respective cadF or flpA mutants 
(Figure 4.8B). 
. 
A             
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Figure 4.8. Protein concentration of OMVs isolated from the 11168H or 81-
176 wild-type strains and the respective cadF or flpA mutants. A. Standard 
curve for a BCA assay. Samples of known concentrations of BSA were added in 
triplicates to a 96-microtiter plate and incubated at room temperature. The line 
derived is from a linear regression analysis of the data. B. 50 ml of Brucella broth 
was inoculated with the 11168H or 81-176 wild-type strains, cadF or flpA mutants 
at an OD600 of 0.1 and grown for 16 h. OMVs were isolated then protein 
concentrations determined using a BCA assay. Data are representative of triplicate 
independent experiments. 
 
 
 
4.2.8 Pre-treatment of fibronectin binding assay with OMVs isolated from 
11168H wild-type strain, cadF or flpA mutants 
 
It has been shown that pre-treatment of T84 IECs with OMVs enhanced 11168H 
wild-type strain invasion (Elmi et al., 2016). When immobilised fibronectin was pre-
treated with 10 µg of OMVs isolated from the 11168H wild-type strain, the 11168H 
wild-type strain exhibited reduced binding to fibronectin. This is probably due to 
binding site competition by OMVs that block the live bacteria from binding to 
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fibronectin. When immobilised fibronectin was pre-treated with 10 µg of OMVs 
isolated from either the cadF or flpA mutants, no significant difference in reduction 
of binding of the 11168H wild-type strain was observed. 
                                                    
                          
Figure 4.9. Pre-treatment of immobilised fibronectin with OMVs prior to 
incubation with C. jejuni. Immobilised fibronectin was pre-treated with OMVs 
(10 µg) isolated from either the 11168H wild-type strain, cadF or flpA mutants for 
1 h at 37oC before co-incubation with the 11168H wild-type strain. At the end of 
the incubation period, wells were washed with PBS. Trypsin EDTA was used to 
detach adherent bacteria. Suspensions were serially diluted and plated on CBA 
plates. Data are representative of triplicate independent experiments. **** 
denotes p < 0.0001. 
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4.2.9 Cytotoxicity assay (LDH) with OMVs isolated from 11168H wild-type 
strain, cadF or flpA mutants 
 
OMV cytotoxicity towards Caco-2 IECs was investigated by quantifying the release 
of cytosolic lactate dehydrogenase (LDH) as a measure of cellular damage. OMVs 
isolated from the 11168H cadF mutant showed no significant difference in 
cytotoxicity compared to OMVs isolated from the wild-type strain. However, OMVs 
isolated from the 11168H flpA mutant showed a significant increase (p < 0.001) in 
cytotoxicity compared to OMVs isolated from the 11168H wild-type strain. Total 
lysis of Caco-2 IECs following treatment with 1% (v/v) Triton X-100 represented 
100% cytotoxicity. Cells treated with PBS represented the negative control. 
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Figure 4.10. Cytotoxic effects of OMVs on Caco-2 IECs. OMVs (100 µg) 
isolated from 11168H wild-type strain, cadF or flpA mutants were co-
incubated with Caco-2 IECs for 24 h. Supernatants were collected and analyse 
for the released of lactate dehydrogenase (LDH.) Positive control was Caco-2 
cells lysed with 1% (v/v) Triton X-100. Negative control was Caco-2 cells co-
incubated with PBS. Data are representative of triplicate independent 
experiments. *** denotes p < 0.01; ns denotes no significant difference. 
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4.2.10 Cytotoxicity assay (LDH) with OMVs isolated from 81-176 wild-type 
strain, cadF or flpA mutants 
 
OMVs isolated from the 81-176 cadF or flpA mutants showed significantly 
increased cytotoxicity towards Caco-2 IECs compared to OMVs isolated from the 
81-176 wild-type strain. There was a small increase in LDH released by OMVs 
from the 81-176 cadF mutant compared to OMVs from the 81-176 flpA mutant. 
                                   
                  
 
Figure 4.11. Cytotoxic effects of OMVs on Caco-2 IECs. OMVs (100 µg) 
isolated from 81-176 wild-type strain, cadF or flpA mutants were co-
incubated with Caco-2 IECs for 24 h. Supernatants were collected and subjected 
to LDH assay. Positive control was Caco-2 cells lyse with 1% (v/v) Triton X-100. 
Negative control was Caco-2 cells co-incubated with PBS. Data are representative 
of triplicate independent experiments. * denotes p < 0.5; ** denotes p < 0.01; ns 
denotes no significant difference. 
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4.2.11 Cytotoxicity of OMVs isolated from 11168H wild-type strain, cadF 
and flpA mutants in the Galleria mellonella model of infection 
 
Further investigations were performed to see whether the mutation of cadF or flpA 
had any effect on the cytotoxic potential of C. jejuni OMVs in the G. mellonella 
larvae model of infection. This invertebrate model has been widely used to 
investigate pathogenesis of various pathogens including C. jejuni (Champion et 
al., 2010). G. mellonella larvae were injected with OMVs (5 µg) isolated from the 
11168H wild-type strain, cadF or flpA mutants. After 24 h infection, larvae were 
inspected for mortality. Results showed that mutation of cadF or flpA in the 11168H 
strain significantly reduced the cytotoxicity of OMVs to G. mellonella compared to 
OMVs isolated from the 11168H wild-type strain. OMVs isolated from the 11168H 
flpA mutant were slightly less cytotoxic than OMVs isolated from the 11168H cadF 
mutant (Figure 4.12). No further mortality was observed at 48 h and 72 h post-
infection (data not shown). 
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Figure 4.12. Cytotoxicity of OMVs isolated from 11168H wild-type strain, 
cadF or flpA mutants in G. mellonella model of infection. Larvae was 
inoculated with 5 µg of OMVs isolated from the 11168H wild-type strain, cadF or 
flpA mutants, injected into the hind leg using a 10-gauge syringe. Larvae were 
incubated at 37oC for the duration of the experiment. At 24 h, larvae were inspected 
for live and deed counts. Inoculation with PBS was used as control. 10 larvae were 
used for every sample. Data are representative of triplicate independent 
experiments. * denotes p < 0.05; ** denotes p < 0.01. 
 
 
 
4.2.12 Cytotoxicity of OMVs isolated from 81-176 wild-type strain, cadF and 
flpA mutants in the Galleria mellonella model of infection 
 
OMVs isolated from the 81-176 flpA mutant showed significantly less cytotoxicity 
compared to OMVs isolated from the 81-176 cadF mutant or the 81-176 wild-type 
strain. This was demonstrated by highest survival of larvae infected with OMVs 
isolated from the flpA mutant. OMVs isolated from the cadF mutant caused a slight 
increase in G. mellonella larvae mortality compared to wild-type strain OMVs, 
however this was not significant (Figure 4.13). 
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Figure 4.13. Cytotoxicity of OMVs isolated from 81-176 wild-type strain, cadF 
or flpA mutants in G. mellonella model of infection. Larvae was inoculated with 
5 µg of OMVs isolated from the 81-176 wild-type strain, cadF or flpA mutants, 
injected into the hind leg using a 10-gauge syringe. Larvae were incubated at 37oC 
for the duration of the experiment. At 24 h, larvae were inspected for live and dead 
counts. Inoculation with PBS was used as control. 10 larvae were used for every 
sample. Data are representative of triplicate independent experiments. *** denotes 
p < 0.001; ns denotes no significant difference. 
 
4.2.13 Induction of IL-8 from T84 intestinal epithelial cells following co-
incubation with OMVs isolated from 11168H wild-type strain, cadF or flpA 
mutants 
 
Both OMVs isolated from 11168H cadF or flpA mutants induced slightly lower 
levels of IL-8 in comparison to OMVs isolated from wild-type strain, however this 
was not significant. As previously observed with IL-8 induced from T84 cells 
infected with live 11168H wild-type strain, cadF or flpA mutants, similar results 
were observed with OMVs isolated from the respective strains. Interestingly, the 
level of IL-8 induced by live C. jejuni (≈108 cfu/ml) was more than double the IL-8 
level induced by the respective OMV samples (100 g) at 800 pg/ml and 300 pg/ml 
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respectively (compare Figure 4.5 with Figure 4.14). These results suggest that C. 
jejuni 11168H OMVs induce IL-8 from T84 IECs via a CadF / FlpA independent 
mechanism. 
 
 
                
 
Figure 4.14. Induction of IL-8 from T84 IECs following co-incubation with 
OMVs isolated from 11168H wild-type strain, cadF or flpA mutants. T84 IECs 
were co-incubated with 100 µg OMVs isolated from 11168H wild type strain, cadF 
or flpA mutants for 24 h. Supernatants were collected and the levels of IL-8 
quantified using a human IL-8 ELISA. Data are representative of triplicate 
independent experiments. 
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4.2.14 Induction of IL-8 from T84 intestinal epithelial cells following co-
incubation with OMVs isolated from 81-176 wild-type strain, cadF and flpA 
mutants 
 
OMVs isolated from 81-176 cadF or flpA mutants induced significantly lower levels 
of IL-8 compared to OMVs isolated from the wild-type strain. However, the 
difference level induced by cadF and flpA mutants was not significant. It was also 
observed that IL-8 induction following co-incubation with OMVs was around half 
that induced following infection with live C. jejuni strains (compare Figure 4.6 with 
Figure 4.15). 
 
             
 
Figure 4.15. Induction of IL-8 from T84 IECs following co-incubation with 
OMVs isolated from the 81-176 wild-type strain, cadF or flpA mutants. T84 
IECs were co-incubated with 100 µg OMVs isolated from 81-176 wild type strain, 
cadF or flpA mutants. Supernatants were collected and the levels of IL-8 quantified 
using a human IL-8 ELISA. Data are representative of triplicate independent 
experiments. **** denotes p < 0.0001; ns denotes no significant difference.  
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4.2.15 Methyl-beta-cyclodextrin inhibition of 11168H wild-type strain, cadF 
or flpA mutants invasion of T84 intestinal epithelial cells 
 
The epithelial cell plasma membrane contains microdomains termed lipid rafts 
composed of cholesterol. Fusion of bacteria within the microdomain enables an 
invasion pathway via caveolin-mediated endocytosis. This is because the lipid rafts 
invaginate into a caveolae with bacteria inside it. Methyl-beta-cyclodextrin (MβCD) 
depletes the cholesterol in the lipid rafts, thus inhibiting this particular pathway 
(Simons and Toomre, 2000). Disruption of lipid rafts by pre-treating T84 IECs with 
MβCD reduced the invasion of the 11168H wild-type strain and also both the cadF 
and flpA mutants (Figure 4.16). The wild-type strain exhibited a similar level of 
invasion of T84 IECs after the cells were treated with MβCD as the cadF or flpA 
mutants. 
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Figure 4.16. Methyl-beta-cyclodextrin (MβCD) inhibition of bacterial invasion. 
T84 IECs were pre-treated with 5 μM MβCD for 1 h prior to infection. C. jejuni 
11168H wild-type strain, cadF or flpA mutants were co-incubated with T84 IECs 
that were pre-treated with MβCD or a control with no inhibitor treatment, for 3 h. 
After incubation, T84 IECs were lysed with 0.2% (v/v) Triton X-100 and interacting 
bacteria enumerated. Comparison was made between treated and non-treated 
T84 IECs. Data are representative of triplicate independent experiments. *** 
denotes p < 0.001 and **** denotes p < 0.0001.  
 
 
 
 
4.2.16 Cytochalasin D inhibition of 11168H wild-type strain, cadF or flpA 
mutants invasion of T84 intestinal epithelial cells 
 
Pathogens use the host cell cytoskeleton to mediate or trigger bacterial 
internalisation. The host cell cytoskeleton consists of microfilaments that are 
smaller than microtubules. Many studies have shown that disruption of 
microfilaments by cytochalasin D (Cyto D) inhibites the entry of many pathogens 
including Listeria monocytogenes (Cossart, 1995), EPEC E. coli (Sanger et al., 
1996) and Shigella flexneri (Mounier et al., 1997). Inhibition of microfilament 
polymerisation by pre-treating T84 IECs with Cyto D reduced the invasion of the 
11168H wild-type strain and also both the cadF and flpA mutants (Figure 4.17). In 
addition, the cadF and flpA mutants showed a further reduction in invasion 
compared to the wild-type strain in pre-treated cells. Depolymerisation of 
microfilaments affected the invasion of the 11168H flpA mutant more significantly 
than the 11168H cadF mutant. 
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Figure 4.17. Cytochalasin D inhibition of bacterial invasion. T84 IECs were 
pre-treated with 3 μM cytochalasin D (Cyto D) for 1 h prior to infection. C. jejuni 
11168H wild-type strain, cadF or flpA mutants were co-incubated with T84 IECs 
that were pre-treated with Cyto D or with a control with no inhibitor treatment, for 
3 h. After incubation, T84 IECs were lysed with 0.2% (v/v) Triton X-100 and 
interacting bacteria enumerated. Comparison was made between treated and non-
treated T84 IECs. Data are representative of triplicate independent experiments. 
*** denotes p < 0.001 and **** denotes p < 0.0001   
 
 
 
 
1
1
1
6
8
H
 W
T
 
1
1
1
6
8
H
 W
T
 +
 C
y
to
 D
1
1
1
6
8
H
 c
a
d
F
 
1
1
1
6
8
H
 c
a
d
F
 +
 C
y
to
 D
1
1
1
6
8
H
 f
lp
A
 
1
1
1
6
8
H
 f
lp
A
 +
 C
y
to
 D
1 0 0
1 0 1
1 0 2
1 0 3
1 0 4
C
F
U
/m
l * * * *
* * * *
* * *
174 
 
4.2.17 Colchicine inhibition of 11168H wild-type strain, cadF or flpA 
mutants invasion of T84 intestinal epithelial cells 
 
In order to establish the involvement of MTs in the invasion mechanisms of C. 
jejuni, colchicine, an inhibitor that causes MT depolymerisation, was used in the 
invasion assay. Tubulin is pivotal for microtubules, and depolymerisation of 
microtubulin impacts on the cytoskeleton (Wei et al., 2013). Inhibition of MT 
polymerisation by pre-treating T84 IECs with colchicine reduced the invasion of 
the 11168H wild-type strain and cadF mutant. The wild-type strain exhibited a 
similar level of invasion of T84 IECs after the cells were pre-treated with colchicine 
as the cadF mutant. However, no significant reduction in invasion of the 11168H 
flpA mutant was observed with cells pre-treated with colchicine compared to non-
treated cells. Interestingly with T84 IECs pre-treated with colchicine, the 11168H 
flpA mutant exhibited a significantly higher level of invasion compared to the 
11168H wild-type strain. 
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Figure 4.18. Colchicine inhibition of bacterial invasion. T84 IECs were pre-
treated with 10 μM colchicine for 1 h prior to infection. C. jejuni 11168H wild-type 
strain, cadF or flpA mutants were co-incubated with T84 IECs that were pre-treated 
with colchicine or a control with no inhibitor treatment, for 3 h. After incubation, T84 
IECs were lysed with 0.2% (v/v) Triton X-100 and interacting bacteria enumerated. 
Data are representative of triplicate independent experiments. Comparison was 
made between treated and non-treated T84 IECs. *** denotes p < 0.001. 
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4.2.18 Wortmannin inhibition of 11168H wild-type strain, cadF and flpA 
mutants invasion of T84 intestinal epithelial cells 
 
PI3-K is a signal transducer enzyme involved in many basic cell functions, 
including cell proliferation, differentiation, motility growth and intracellular 
trafficking. Wortmannin inhibits the activity of PI3-K (Biswas et al., 2000), was not 
required for invasion of T84 IECs by the 11168H cadF mutant. Inhibition of PI3-K 
activation by pre-treating T84 IECs with wortmannin reduced the invasion of the 
11168H wild-type strain and flpA mutant. However, no significant reduction in 
invasion of the 11168H cadF mutant was observed with cells pre-treated with 
wortmannin compared to non-treated cells. The wild-type strain exhibited a similar 
level of invasion of T84 IECs after the cells were pre-treated with wortmannin as 
the cadF mutant, whilst the flpA mutant showed a further reduction in invasion 
compared to the wild-type strain. 
 
 
 
177 
 
                 
 
 
Figure 4.19. Wortmannin inhibition of bacterial invasion. T84 IECs were pre-
treated with 1 μM wortmannin for 1 h prior to infection. C. jejuni 11168H wild-type 
strain, cadF or flpA mutants were co-incubated with T84 IECs that were pre-treated 
with wortmannin or a control with no inhibitor treatment, for 3 h. After incubation, 
T84 IECs were lysed with 0.2% (v/v) Triton X-100 and interacting bacteria 
enumerated. Data are representative of triplicate independent experiments. 
Comparison was made between treated and non-treated T84 IECs. *** denotes p 
< 0.001 and ****denote p < 0.0001.  
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4.2.19 Comparison of the inhibition of 11168H wild-type strain, cadF or flpA 
mutant invasion of T84 intestinal epithelial cells 
 
The inhibitors used in this study all affected the ability of C. jejuni to invade T84 
IECs. Figure 4.20 shows the effect of each inhibitor on the invasion of T84 IECs 
by C. jejuni 11168H wild-type strain, cadF or flpA mutants. Invasion by the 11168H 
wild-type strain was reduced by all inhibitors. However, whilst the reduction in 
invasion caused by pre-treatment with MβCD, Cyto D and colchicine was at a 
similar same level, pre-treatment with wortmannin appeared to have less of an 
impact on wild-type invasion of T84 IECs. Invasion by the 11168H cadF mutant 
was also reduced by pre-treatment with MβCD, Cyto D and colchicine. However 
pre-treatment with wortmannin had no impact on invasion by the cadF mutant. 
Invasion by the 11168H flpA mutant was reduced by pre-treatment with MβCD, 
Cyto D and wortmannin. However pre-treatment with colchicine increased the level 
of invasion by the flpA mutant.  
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Figure 4.20. Comparison of the effect of eukaryotic inhibitors on the invasion 
of T84 IECs by 11168H wild-type strain, cadF or flpA mutants. T84 IECs that 
were pre-treated with an inhibitor or a control with no inhibitor treatment were 
infected (MOI 100:1) with C. jejuni 11168H wild-type strain, cadF or flpA mutants 
for 3 h. After incubation, T84 IECs were lysed with 0.2% (v/v) Triton X-100 and 
interacting bacteria enumerated. Data are representative of triplicate independent 
experiments. Comparison was made between treated and non-treated T84 IECs. 
*** denotes p < 0.001 and ****denote p < 0.0001. ns denotes no significant 
difference. 
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4.2.20 Summary of effects of inhibitors on 11168H and 81-176 wild-type strains, cadF and flpA mutants invasion into T84 intestinal 
epithelial cells. 
 
Many studies that have investigated the pathways that C. jejuni utilises to invade intestinal epithelial cells have used pharmacological inhibitors 
that block the function or specific components in the invasion pathways that C. jejuni are hypothesised to use. 
 Table 4.1. Effect of eukaryotic inhibitors on the invasion of T84 IECs by 11168H or 81-176 wild-type strains and 11168H cadF or flpA 
mutants. 
 
Inhibitors Actions Mechanisms 11168H wild-
type strain 
11168H cadF 
mutant 
11168H flpA 
mutant 
81-176 wild-type  
Cytochalasin 
D 
Depolymerises 
actin 
Depolymerises actin units that 
assemble into microfilaments and 
inhibits membrane fusion with 
bacteria 
 
√ 
     (inhibited) 
 
√ 
 
√ 
 
× 
(not inhibited) 
Methyl-beta 
cyclodextrin 
Depletes 
cholesterol 
Depletes cholesterol in the 
microdomain of the plasma 
membrane that form the lipid rafts 
 
√ 
 
√ 
 
√ 
 
√ 
Colchicine Depolymerises 
tubulin 
Depolymerises tubulin units that 
assemble into microtubules 
 
√ 
 
√ 
 
× 
 
√ 
Wortmannin Inhibits PI3K 
for protein 
synthesis 
Binds directly and irreversibly to 
the catalytic protein (110kDa) of 
PI3K 
 
√ 
 
× 
 
√ 
 
√ 
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4.3 Discussion 
 
The human IEC lines and methodologies used to study the pathogenesis 
mechanisms of enteric bacteria in vitro attempt to mimic the cells found in the 
intestine and the intestinal environment in vivo. Much of what is known about 
C. jejuni adhesion to and invasion of human IECs in vitro has been generated 
using non-polarised cell lines, such as Hep-2, HeLa, INT 407, Caco-2 or T84 
cells (Wine et al., 2008, Monteville et al., 2003, Monteville and Konkel, 2002, 
Fauchere et al., 1986). While these studies have provided important insights 
into aspects of C. jejuni infection of non-polarised IECs, all are inherently limited 
by the significant differences that exist between cell lines as well as the 
difference between in vitro cell culture conditions (De Melo et al., 1989, 
Fauchere et al., 1986, Konkel and Joens, 1989). Non-polarised IECs lack key 
morphological phenotypes and do not completely reflect the IECs in vivo. 
Previous studies have reported that human IECs grown on permeable 
Transwell® filters can form a highly polarised IEC monolayer with a 
characteristic apical plasma membrane domain and baso-lateral surface. These 
cells more closely resemble and serve as a better model to investigate 
pathogen infections or toxin exposure (Kohler et al., 2007, Hurley and 
McCormick, 2003, Berkes et al., 2003).  
The mechanisms of C. jejuni adhesion to and invasion of IECs have been 
studied in some detail using polarised T84 (human colonic carcinoma) and 
Caco-2 (small intestine epithelial cell) cell lines (Grant et al., 1993, Pignata et 
al., 1994, Nataro et al., 1996). As polarised monolayers, these IECs cells exhibit 
normal microvilli and brush borders, and more closely resemble IECs in vivo 
(Finlay and Falkow, 1990, Everest et al., 1992). The integrity of the polarised 
IECs is sustained through cell-cell sealing mediated by tight junctions, adherens 
junctions and desmosomes, which act as barriers to prevent invasion of C. jejuni 
(Boehm et al., 2012).The tight junction is the most lumenal cell-cell junction and 
completely surrounds IECs. The tight junction is also composed of scaffolding 
proteins, including zonula occludens (ZO)-1, junctional adhesion molecule 
(JAM)-1, claudin, and occludin.  
The integrity of polarised IECs monolayers in vitro before and after infection 
with C. jejuni can be determined by measuring TEER. TEER measurement is a 
sensitive indicator for barrier integrity of electrical resistance between the apical 
182 
 
and baso-lateral compartments. The IECs Transwell® filter insert model has 
been used to investigate the impact of C. jejuni infection on IEC barrier integrity 
(Boehm et al., 2012, Bras and Ketley, 1999, MacCallum et al., 2005b). 
In this chapter, around 14 days after seeding in 12-well inserts (0.3 µm pore 
size), the T84 and Caco-2 IECs reached peak levels of TEER. This supports 
the data from previous studies (Bras and Ketley, 1999, Konkel et al., 1992c, 
Grant et al., 1993, Mills et al., 2012). TEER levels reflect retention of barrier 
function. However, other studies have shown that only 7 days were required for 
Caco-2 IECs to form a polarised monolayer (Hu et al., 2008, Harvey et al., 
1999). Weekly feeding (change of fresh culture medium) has been shown to 
maintain the peak TEER for a month, while a lack of feeding will lower the TEER 
quickly after 14 days (Hurley et al., 2016). In this study, Caco-2 and T84 IECs 
showed a peak TEER of 500 Ω cm2 and 400 Ω cm2 respectively. A previous 
study also reported that the TEER value for T84 IECs averages 400 Ω cm2 
whilst non-infected Caco-2 IECs showed a peak TEER of between 300-500 Ω 
cm2 (Konkel et al., 1992c). Having established the polarised state of the IECs, 
the monolayers were infected 14 days after seeding. Any IECs which showed 
a TEER value less than or equal 100 Ω cm2 were excluded in this study because 
the blank Transwell® insert (baseline TEER) without cells produced TEER 
values around 100 Ω cm2. In contrast, some studies have reported the opposite 
(Hurley et al., 2016). The variable TEER value results were probably due to 
different methods and lab settings employed. Despite these limitations, 
polarised human IEC models are a useful model for investigation of enteric 
pathogen interactions with host cells. These IECs cultured on Transwell® filters 
offer numerous advantages compared to laboratory animal studies.  
The TEER assay was used to determine the impact of bacterial infection on 
IECs monolayers, while C. jejuni translocation from apical to baso-lateral 
compartment was studied to provide evidence of disruption of IECs monolayer 
integrity. Generally, the degree of pathogen invasion correlates with the 
reduced integrity of the host cell plasma membrane, because loss of membrane 
integrity results in increased permeability hence more bacterial translocation 
across the membrane barrier.   
A decrease of TEER in IECs may be because of increased paracellular 
permeability, local cell lysis within the monolayer or a change of ion flux across 
the monolayer (Madi et al., 2010). S. Typhimurium translocates across 
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polarised human IECs with the complete loss of TEER after 6 h (Finlay and 
Falkow, 1990). The same effect was observed with Vibrio parahaemolyticus 
(Lynch et al., 2005) and E. coli (Puthenedam et al., 2007). Bacteria such as P. 
fluorescens were found to decrease the TEER of Caco-2/TC7 monolayers, 
which was associated with increased paracellular permeability and the 
rearrangement of F-actin microfilaments in the cytoskeleton (Madi et al., 2010).  
However, the results from this study showed that translocation of the C. jejuni 
11168H wild-type strain, cadF and flpA mutants were not associated with a 
reduction in TEER of T84 cells. These results suggest that barrier integrity was 
not disrupted following infection with either the 11168H wild-type strain, cadF 
or flpA mutants. This is consistent with previous studies that have showed C. 
jejuni wild-type strains M129, 81116 and 81-176 were able to translocate across 
Caco-2 monolayers without a reduction of TEER after between 6 h to 72 h post 
infection (Konkel et al., 1992c, Grant et al., 1993, Louwen et al., 2012). In 
addition, it was also reported that an increase of inoculum (1000 fold) still had 
no impact on TEER even after 6 h infection. However in another study, infection 
with clinical isolates C. jejuni over 24 h reduced TEER in Caco-2 cells (Bras and 
Ketley, 1999).  
C. jejuni has been reported to translocate via M cells, transcellularly across cells 
and paracellularly between cells (Bras and Ketley, 1999, Walker et al., 1988, 
Everest et al., 1999, Konkel and Cieplak, 1992, Harvey et al., 1999). C. jejuni 
M129, F38011 and 81116 strains translocate across Caco-2 IECs in a time-
dependent manner. However, translocation reached a peak 4 h post-infection 
(Konkel et al., 1992c). In this study, the ability of the 11168H wild-type strain, 
cadF and flpA mutants to translocate across T84 cells was assessed. Instead 
of counting the CFUs, a 11168 wild-type strain, cadF and flpA mutants 
expressing GFP were used. After a period of incubation, the baso-lateral media 
was collected and fluorescence intensity quantified. The cadF GFP and flpA 
GFP mutants were both observed to translocate across T84 IECs as efficiently 
as the 11168H GFP wild-type strain, based on the fluorescence intensity. This 
suggests that CadF and FlpA are not involved in the transmigration of C. jejuni 
across IECs.  
The mechanisms by which C. jejuni transmigrate across IECs are poorly 
defined. Previous studies reported that C. jejuni can translocate across 
polarised cell monolayers via the paracellular route without reduction of TEER 
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(Konkel and Cieplak, 1992, Everest et al., 1992, Harvey et al., 1999, Bras and 
Ketley, 1999). In contrast, other studies observed the opposite that C. jejuni 
infection caused a reduction in TEER (Pogacar et al., 2010, Wine et al., 2008, 
Chen et al., 2006).   
In previous studies, the loss of TEER in Caco-2 IECs after 24 h infection was 
observed using a high MOI of 105:1 (MacCallum et al., 2005b) and similarly in 
T84 IECs (Chen et al., 2006). Both events were associated with reorganisation 
of TJ proteins such as occludin. OMVs isolated from the 11168H wild-type strain 
were able to cleave E-cadherin and occludin in T84 IECs (Elmi et al., 2016). 
Another suggested entry mechanism that has been described is a paracellular 
pathway called subvasion. C. jejuni invade non-polarised Chang epithelial cells 
from the baso-lateral surface (van Alphen et al., 2008). Without evidence of a 
decrease in monolayer integrity, it is still inconclusive to confirm whether the 
translocation occurred transcellularly or paracellularly. C. jejuni probably 
employ both or either pathways at the same time or at different times depending 
on strain and IECs. One study has suggested that C. jejuni enters the host cell 
by HtrA mediated-cleaving E-cadherin, without a reduce in TEER (Boehm et al., 
2012). Alternatively epithelial cells of human origin could reseal after 
penetration as has been observed in guinea pig epithelial cells (Takeuchi, 
1967). 
Numerous studies have reported that breaches in IEC barrier integrity following 
paracellular invasion results in penetration of luminal antigens and microbes, 
stimulating pro-inflammatory responses (Larson et al., 2008). Mutation of cadF 
and flpA in the 81-176 strain reduced the level of IL-8 released by T84 IECs, in 
contrast no significant reduction in IL-8 induction was observed by the 11168H 
cadF and flpA mutants. Previous studies have shown that C. jejuni interactions 
with IECs induces innate immune responses, such as production of IL-6 (Friis 
et al., 2009), IL-8 (MacCallum et al., 2006) and TNFα (Al-Salloom et al., 2003). 
The MacCallum et al. study also reported that C. jejuni infection induces more 
IL-8 from T84 IECs than from Caco-2 IECs (MacCallum et al., 2006). However, 
in another study, the 81-176 wild-type strain was observed to induce IL-8 more 
than the 11168H wild-type strain in Caco-2 and Hep-2 cells (Zilbauer et al., 
2005). Several studies also have reported a link between C. jejuni 11168H 
virulence factors and the induction of the innate immune response (Black et al., 
1988, Russell et al., 1989). There are several C. jejuni virulence factors that 
play a role in the activation of host cell innate immune responses, nevertheless 
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the bigger picture is still unclear (Hickey, et al. 2000). Production of IL-8 from 
host cells is an important immune response against infection and may also 
result in inflammatory diarrhoea during C. jejuni infection (Watson and Galan, 
2005, Hu and Hickey, 2005). IL-8 induced by Shigella and Salmonella involved 
signalling via Nuclear factor kappaB (NF-ĸB) (Hobbie et al., 1997, Philpott et 
al., 2000). The same impact was also observed in HeLa cells infected with C. 
jejuni NCTC 11168 (Mellits et al., 2002). Infection of C. jejuni 81-176 wild-type 
strain in NF-ĸB deficient mice results in the mice chronically colonised and 
developing gastritis compared to wild-type mice (Fox et al., 2004). Furthermore, 
another study reported that C. jejuni induction of IL-8 from IECs was both 
independent and dependent on CDT (Hickey et al., 2000). 
The cellular mechanisms that allow C. jejuni adhesion to and invasion into IECs 
are not well understood (O Croinin and Backert, 2012, Cossart and Sansonetti, 
2004). The debate regarding the zipper and/or trigger mechanisms of bacterial 
invasion is still ongoing (O Croinin and Backert, 2012) C. jejuni interacts with 
IECs in a very specific manner preferably via Rac1 and Cdc42. Many aspects 
of actin dynamics are regulated by activation of Rac1 (Albertson et al., 2008) 
such as lamellipodia formation and protrusion of actin networks. Rho and Rac 
regulate the polymerisation of actin to produce stress fibres and lamellipodia 
respectively (Nobes and Hall, 1995a). C. jejuni 81-176, 84-25 and F38011 wild-
type strains were all shown to induce Rac1 in INT 407 cells (Krause-
Gruszczynska et al., 2007a). The activation of Rac1 was attributed to the 
recruitment of lipid rafts (Boehm et al., 2011).  
Based on these observations, the ability of cadF and flpA mutants to activate 
Rac1 in IECs was investigated. Both cadF and flpA mutants exhibit a similar 
significant reduction in the ability to induce Rac1 activation in serum-starved 
T84 IECs compared to wild-type strain. This suggests that both CadF and FlpA 
are involved in Rac1 activation, demonstrating a further role of these fibronectin 
binding protein in C. jejuni pathogenesis. Activation of Rac1 leads to actin 
cytoskeleton reorganisation, such as membrane ruffling and formation of 
lamellipodia (Nobes and Hall, 1995a). These have been shown to play a role in 
the zipper or trigger entry pathway mechanism (Cossart and Sansonetti, 2004). 
However, it also suggests that other C. jeuni virulence factors must be involved, 
since cadF and flpA mutants were still able to activate Rac1 in T84 IECs. 
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Consistent with this hypothesis, a recent study of Rac1 in fibroblast cells 
provides further evidence. Boehm et al. proposed that the pathway of 
fibronectinintegrin beta 1FAK involved Rac1 activation. This study used 
fibroblast cells which knockout fibronectin and integrin beta 1. This study used 
C. jejuni wild-type strains 81–176, 84–25 and F38011 with the respective 
isogenic cadF, flaAB and flhA mutants, and the IECs used were INT 407 cells. 
The results showed that fibronectin, integrins and FAK were involved during 
efficient uptake of C. jejuni. In this study, the role of the second fibronectin 
binding protein FlpA (Flanagan et al., 2009) as well as CadF was investigated. 
Rac1 is a member of the Rho superfamily of small GTPases (Tran Van Nhieu 
et al., 1999, Hall, 1990, Cossart and Sansonetti, 2004), which also includes 
Cdc42 and RhoA (Caron and Hall, 1998, Nobes and Hall, 1995a). GTPases act 
as a molecular switch in the active state to transmit signals in many cellular 
pathways. The collective events in turn will control many cellular functions 
including cytoskeleton rearrangements in host cells such as membrane ruffles 
(lamellipodia) and microprojections (filopodia) (Nobes et al., 1995). Rac1 
activation in host cells results in formation of membrane ruffling (Nobes et al., 
1995, Nobes and Hall, 1995b). Rac1 was shown to be a central regulator in C. 
jejuni 81-176 internalisation into host cells (Krause-Gruszczynska et al., 2007a). 
In other pathogens such as S. Enterica and S. flexneri, invasion into host cells 
was observed to be heavily associated with membrane ruffles (Hardt et al., 
1998, Cossart and Sansonetti, 2004, Tran Van Nhieu et al., 1999). In this study, 
in the Rac1 activation assay, both cadF and flpA mutants were able to induce 
Rac1 activation but at a reduced level compared to wild-type strain, suggesting 
that in C. jejuni 11168H, both CadF and FlpA work synergistically to facilitate C. 
jejuni entry into host intestinal epithelial cells. This finding also supports the 
previous data that showed bacterial fibronectin-binding proteins acted together 
and with secreted proteins to promote maximal C. jejuni invasion of host cells 
by stimulating membrane ruffling (Eucker and Konkel, 2012). A F38011 cadF 
mutant has also been shown to play a role in Rac1 and Cdc42 activation in INT 
407 cells. It was also suggested that CadF might not function independently 
and that other bacterial factors were involved (Krause-Gruszczynska et al., 
2007a). However, even when only one of the fibronectin binding proteins is 
present as in the case with either of the cadF or flpA mutants, both these 
mutants were still able to induce Rac1 activation. This suggested that both 
CadF and FlpA act in tandem to activate Rac1 for efficient C. jejuni invasion.  
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C. jejuni produces OMVs that contain many proteins (Lindmark et al., 2009, 
Elmi et al., 2012, Jang et al., 2014). C. jejuni 11168H OMVs have been reported 
to contain 151 proteins (Elmi et al., 2012). C. jejuni virulence proteins identified 
in OMVs include all three components of CDT (CdtA, CdtB and CdtC), the HtrA 
and Cj0511 proteases, 16 N-linked glycoproteins, major antigenic protein Peb3 
and both fibronectin binding proteins CadF and FlpA (Elmi et al., 2012).  
C. jejuni OMVs have been shown to be cytotoxic to human IECs (Lindmark et 
al., 2009, Elmi et al., 2012). Mutation of cadF or flpA in both the 11168H and 
81-176 strains resulted in the OMVs isolated from either mutant exhibiting 
reduced cytotoxicity in the G. mellonella larvae model of infection. In Chapter 3, 
it was shown that infection with either the cadF or flpA mutant increased the 
survival of G. mellonella larvae compared to infection with a wild-type strain. 
OMVs were less cytotoxic compared to live bacteria when injected into G. 
mellonella larvae. This indicates that CadF and FlpA play a role in pathogenesis 
in the G. mellonella larvae model of infection. These results support previous 
data that showed OMVs isolated from either a htrA mutant or a Cj1365c mutant 
exhibited reduced cytotoxicity in G. mellonella larvae (Elmi et al., 2016). In 
contrast, OMVs isolated from a cdtA mutant showed cytotoxicity levels similar 
to OMVs isolated from the 11168H wild-type strain (Elmi et al., 2012). In this 
study, the cytotoxicity of OMVs from C. jejuni wild-type strains and from 
respective cadF or flpA mutants to Caco-2 cells was investigated. OMVs 
isolated from either the cadF or flpA mutants showed reduced cytotoxicity 
against Caco-2 IECs. 
C. jejuni OMVs have also been reported to induced immune responses much 
like live bacteria that results in production of IL-8 from intestinal epithelial cells 
(Elmi et al., 2012) In this study OMVs isolated from the 11168H wild-type strain, 
cadF or flpA mutants were able to induce production of IL-8 from T84 IECs 
similar to live bacteria. In addition, there was also no significant difference 
between IL-8 production by the cadF and flpA mutants compared to the wild-
type strain, both with live bacterial cells or OMVs. However the level of IL-8 
production was much lower after co-incubation with OMVs (300 pg/ml) 
compared to infection with live bacterial cells (800 pg/ml). However OMVs 
isolated from the 81-176 cadF or flpA mutants showed a significant reduction in 
IL-8 production by T84 IECs compared to OMVs isolated from the wild-type 
strain. The level of IL-8 induced by the 81-176 wild-type strain OMVs was lower 
by 50% than the level induced by live wild-type bacterial cells at 400 pg/ml and 
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800 pg/ml respectively. Also the level of IL-8 induced by the 81-176 cadF or 
flpA mutant OMVs was reduced compared to the respective live bacterial cells 
at 200 pg/ml to 600 pg/ml respectively. These conflicting results could be 
explained by differences in protein expression between the C. jejuni 11168H 
and 81-176 strains, including size of OMV release and production (Lindmark et 
al., 2009, Elmi et al., 2012). A study reported that OMV protein contents from 
Pseudomonas aeruginosa are strain dependent (Bauman and Kuehn, 2006). In 
the same study, it was also shown that different composition in OMVs protein 
cause variations in OMVs morphology.  
Bacterial invasion into IECs allow pathogens to establish a niche inside the host 
cells. Certain pathogens utilise more than one invasion pathway to not only 
maximise the chance to successfully invade IECs, but also to survive the 
defence by varieties of immune weaponry mounted by the IECs (Cossart and 
Sansonetti, 2004). C. jejuni invasion into IECs is considered as one of the 
hallmarks for C. jejuni-caused tissue damage, however the molecular 
mechanism of C. jejuni invasion is widely unclear. Pharmacological inhibitor 
studies can identify cellular pathways used by pathogens to enter host cells 
(Backert and Hofreuter, 2013). In this study, specific pharmacological inhibitors 
were used to investigate whether C. jejuni invasion into IECs involved caveolae-
mediated endocytosis, microfilaments, microtubules and/or the PI3 Kinase host 
signalling pathways. 
The plasma membrane of IECs contains a special region termed lipid rafts. Lipid 
microdomains are enriched with cholesterol and sphingolipids. Functions of lipid 
rafts include polarised secretion, membrane transport and the generation of cell 
polarity. Lipid rafts are also enriched in many signal transduction molecules and 
play a role in sensing the extracellular environment. Caveolae are a subset of 
lipid rafts with a caveolin filament component which is a cholesterol binding 
protein (Rothberg et al., 1992). Many pathogens including bacteria, viruses and 
parasites have been reported to target the lipid rafts function to their advantage. 
E.coli has been shown to enter mast cells through lipid rafts (Shin et al., 2000) 
as has Mycobacterium bovis uptake by mouse macrophages (Gatfield and 
Pieters, 2000). Plasmodium falciparum surrounding membrane was reported to 
be enveloped in a caveolae-like structure (Olliaro and Castelli, 1997). In the 
case of viruses, measles and influenza virus assembly were both observed at 
this domain. In addition, components of mature virion were also found 
associated with the lipid rafts (Manie et al., 2000, Scheiffele et al., 1999). Other 
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studies showed that entry of virus particles was inhibited by caveolae -
disrupting drugs (Parton and Lindsay, 1999, Norkin, 1999). Many studies have 
shown that caveolae-mediated endocytosis plays a role in C. jejuni 
internalisation into IECs. Drugs that inhibit lipid rafts also inhibit C. jejuni 
invasion of Caco-2, T84 and INT 407 cells (Wooldridge et al., 1996, Watson 
and Galan, 2008, Krause-Gruszczynska et al., 2007b, Hu et al., 2006). However 
a study by Konkel et al. demonstrated that C. jejuni invasion was not dependent 
on caveolae (Konkel et al., 2013).  
Treatment of IECs with MβCD reduces the cholesterol content in lipid raft 
fractions and resulted in a significant reduction of C. jejuni invasion of T84 IECs 
by the 11168H wild-type strain, cadF mutant and flpA mutant to similar levels. 
This suggests that C. jejuni invasive ability is in part dependent on intact lipid 
rafts in the plasma membrane of IECs, but that neither CadF nor FlpA are 
involved in this invasion pathway. These findings are in agreement with a study 
reported by Watson & Galan that showed with T84 cells treated with MβCD, C. 
jejuni invasion was blocked in a dose-dependent manner (Watson and Galan, 
2008). Moreover, upon depletion and sequestration of plasma membrane 
cholesterol, the invasion ability of the C. jejuni 81-176 wild-type strain was 
reduced (Watson and Galan, 2008). 
Lipid rafts are thought to be involved in cell signalling pathways. C. jejuni OMVs 
induced a reduced level of IL-8 from lipid raft depleted T84 cells (Elmi et al., 
2012). Since lipid rafts are highly ordered structures enriched in sphingolipids 
and glycosylphosphatidylinositol-anchored proteins (GPI-Aps), the reduced 
levels of IL-8 from IECs treated with cadF and flpA mutants OMVs may be 
correlated with the reduced ability of cadF and flpA mutants to interact with 
fibronectin. Similar results were reported for other enteropathogens in which 
depleted lipid rafts from IECs accounted for a reduced entry or internalisation 
into host cell (Kohler et al., 2002, de Souza Santos and Orth, 2014, Steele-
Mortimer, 2008). It was also reported that treatment of IECs with cholesterol-
sequestering agent flippin III reduced the levels of Salmonella interacting with 
IECs (Lim et al., 2010). 
MF depolymerisation by cyto D has been used to study the involvement of MFs 
in C. jejuni invasion into IECs (De Melo et al., 1989, Konkel and Joens, 1989). 
The rapidly growing ends of actin filaments were inhibited and shortened by 
cyto D. This has been used to establish that most intracellular bacterial 
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pathogens including S. Typhimurium use pathways that involved MF elements 
to enter host epithelial cells (Finlay and Falkow, 1988, Elsinghorst et al., 1989). 
However, diverse results have been reported. C. jejuni internalisation was 
markedly reduced in Hep-2 cells that were treated with cytochalasin B, another 
inhibitor that depolymerises actin and inhibits endocytosis (De Melo et al., 
1989). In contrast, one study showed increased invasion (Bouwman et al., 
2013), while another observed reduced invasion into IECs that were pre-treated 
with cyto D (Monteville et al., 2003). Yet another study showed no inhibition of 
invasion as observed with the 81-176 strain in Caco-2 cells (Russell and Blake, 
1994). The results in this study are in agreement to that of Monteville et al. who 
used the F38011 and 81-176 strains with INT 407 cells. Depolymerisation of 
MFs significantly reduced the invasion of the 11168H wild-type strain, the cadF 
mutant as well as the flpA mutant. Moreover, the cadF and flpA mutants were 
both further reduced in invasion into T84 IECs compared to that of the 11168H 
wild-type strain. However, the reduction of invasion between the cadF and the 
flpA mutants was not significant. This indicates that C. jejuni invasion into T84 
IECs is dependent on MFs and that both CadF and FlpA play a role in this 
invasion pathway. In contrast, a previous study here at the LSHTM had shown 
that the 81-176 wild-type strain increased invasion into Caco-2 IECs pre-treated 
with cyto D (Neveda Naz, PhD Thesis, LSHTM, 2014) in agreement with the 
Bouwman et al. study. This also supported the evidence that C. jejuni 81-176 
invasion into INT 407 and T84 IECs was increased and did not required MFs 
when the cells were pre-treated with cytochalasin D (Oelschlaeger et al., 1993). 
These contrasting results are probably due to a combination of both strain- and 
cell line-dependent effects (Oelschlaeger et al., 1993). 
Colchicine is a tubulin inhibitor that blocks polymerisation of MTs (Dalbeth et 
al., 2014). The use of colchicine as an inhibitor showed reduced invasion of C. 
jejuni, Citrobacter freunddi and enterohemorrhagic E. coli (EHEC) (Biswas et 
al., 2003, Hu and Kopecko, 1999, Oelschlaeger et al., 1993) in Caco-2 IECs, 
however not in T84 IECs (Wine et al., 2008). A previous study, using the 81-
176 wild-type strain also showed a reduction in invasion of Caco-2 IECs 
(Neveda Naz, PhD Thesis, LSHTM, 2014). In this study, invasion of T84 IECs 
by both the 11168H wild-type strain and cadF mutant was reduced significantly 
when T84 IECs were pre-treated with colchicine compared to the non-treated 
cells. However, the flpA mutant showed no significant reduction in invasion 
when T84 IECs were pre-treated with colchicine compared to the non-treated 
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cells. In addition, the flpA mutant invasion was increased compared to the wild-
type invasion in T84 IECs pre-treated with colchicine. This may be due to the 
higher levels of cadF expressed in the 11168H flpA mutant compared to the 
wild-type strain (see Chapter 3). These results indicate that C. jejuni invasion 
into T84 IECs is dependent on MTs and that FlpA plays a role in this invasion 
pathway.  
However, the data published regarding the involvement of MTs and MFs during 
C. jejuni invasion again varies. Specifically, this falls into four groups. The first 
group of studies report that C. jejuni required MTs and MFs. In this group, C. 
jejuni 81-176, F38011 and M129 strains were observed to reduce invasion in 
cells treated with cyto D (depolymerise MFs), mycalolide B (depolymerise F-
actin) and nocodazole (MT inhibitor) (Konkel and Joens, 1989, Biswas et al., 
2000, Bacon et al., 2000, Oelschlaeger et al., 1993, Hu and Kopecko, 1999, 
Monteville and Konkel, 2002, Monteville et al., 2003). In the second group, C. 
jejuni invasion requires MTs only. In this study, 81-176 wild-type strain entry 
into INT 407 cells was inhibited as much as 90% when the cells were treated 
with many MT depolymerising inhibitors that included colchicine, demecolcine, 
vincristine or vinblastine as well as nocodazole (Oelschlaeger et al., 1993, Hu 
and Kopecko, 1999). In addition, invasion was increased in the presence of 
inhibitors of MFs by around 200%. In the third group, C. jejuni invasion requires 
MFs only. A study reported that in the 81-176 and F38011 strains that CadF 
plays an important role in invasion of host cells. Since CadF mediates binding 
to fibronectin, which is found at the basal side of epithelial cells, it was 
suggested that MFs are required for internalisation (Monteville and Konkel, 
2002, De Melo et al., 1989, Konkel and Joens, 1989). Whilst in the fourth group, 
C. jejuni internalisation into Caco-2 cells required neither MTs nor MFs (Russell 
and Blake, 1994). However in this study, the 11168H wild-type strain and cadF 
mutant fall into group one as for both invasion of T84 IECs was significantly 
reduced when MTs or MFs were inhibited by colchicine or cyto D respectively. 
In contrast, the flpA mutant falls into group three as inhibition of MTs resulted 
in no significant reduction of invasion into T84 IECs. In this study, a slight 
modification was made to the protocol used with the inhibitor removed after 1 h 
incubation prior to infection, whilst in other studies the inhibitor was left for the 
entire duration of infection. What clear from those studies are the strains and 
cells used as well as methods employed in each study was different, hence the 
results. 
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Protein kinases are key regulator for many cell functions thus have many 
membrane receptors. Interaction between receptors and ligands result in 
activation or phosphorylation of certain set of proteins in host cells. 
Phosphoinositol kinase (PI3-K) activity can be inhibited by wortmannin. A study 
reported that C. jejuni 81-176 invasion was reduced in wortmannin treated 
Caco-2 IECs (Hu et al., 2006). Other kinases inhibitors such as stauroporine for 
general kinase and genistein for tyrosine kinase were also shown to inhibit 
invasion of the 81-176 strain (Kopecko et al., 2001) and also the 81116 strain 
(Biswas et al., 2004, Wooldridge et al., 1996). Treatment with wortmannin was 
shown to reduce invasion of C. jejuni and inhibit the activation of GTPase in INT 
407 cells (Krause-Gruszczynska et al., 2011). Activation will trigger Rac1 and 
be followed by cascading events, cytoskeleton reorganisations and membrane 
ruffling (Cossart and Sansonetti, 2004, Cossart, 2004, Hawkins et al., 1995). 
Euker et al. reported that wortmannin inhibited the invasion of C. jejuni F38011 
into INT 407 cells in a dose-dependent manner (Eucker and Konkel, 2012). In 
this study, the 11168H wild-type strain and flpA mutant showed a reduction in 
invasion of T84 IECs pre-treated with wortmannin compared to cells not treated 
with wortmannin. However, the 11168H cadF mutant showed no significant 
reduction in invasion between treated and non-treated cells. Previous data 
showed that the 81-176 wild-type strain exhibited reduced invasion of Caco-2 
IECs pre-treated with wortmannin. This indicates that C. jejuni invasion into T84 
IECs is dependent on the involvement of protein kinase activity, specifically in 
this case PI3K activation and that CadF plays a role in this invasion pathway. 
Other evidence of the involvement of protein kinases was reported with the 
mitogen-activated protein kinase (MAPK) which regulates nuclear transcription 
events that result in bacterial uptake via rearrangement of cytoskeleton in host 
cells (Biswas et al., 2004, MacCallum et al., 2005a). Inhibitors for p38MAPK 
were shown to reduce 81-176 invasion into INT 407 cells (Hu et al., 2006, Hu 
and Kopecko, 1999) . 
Studies have clearly demonstrated that the cellular events during C. jejuni 
interactions (adhesion and invasion) with IECs are multifactorial processes (Hu 
and Kopecko, 1999, Ketley, 1997, Wassenaar and Blaser, 1999). Therefore, 
looking at the individual C. jejuni strain findings in this study in some ways 
explain and support the above statements, as well as the variation of data 
previously published. The invasion pathways used by the 11168H wild-type 
strain, cadF or flpA mutants can be partially deduced from the inhibitors assays. 
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With the 11168H wild-type strain, all inhibitors used significantly reduced 
invasion of T84 IECs. All inhibitors reduced invasion of the 11168H wild-type 
strain to a similar level except wortmannin that resulted in a slightly higher level 
of invasion. Reduction in invasion was similar to that of cadF and flpA mutants 
in T84 IECs treated with MβCD. In T84 IECs treated with colchicine and 
wortmannin, the wild-type strain also exhibited similar levels of invasion to the 
cadF mutant. Therefore, the results indicate that 11168H wild-type strain 
invasion into T84 IECs is dependent of MFs, MTs, intact lipid rafts as well as 
PI3 kinases. However the C. jejuni invasion pathways mediated by CadF and 
FlpA appear to be different. Invasion of the 11168H cadF mutant is reduced by 
cyto D and colchicine, but not by wortmannin. This suggests that CadF-
mediated invasion involves PI3 activation. Invasion of 11168H flpA mutant is 
reduced by cyto D and wortmannin, but not by colchicine. This suggests that 
FlpA-mediated invasion involves a MT-dependent pathway. CadF and FlpA are 
different fibronectin-binding proteins and share less than 20% identity and 
around 32% similarity. This supports the hypothesis that CadF and FlpA play a 
role in different invasion pathways utilised by C. jejuni to enter IECs. Thus, it 
also may explain and reflect the involvement of many pathways with different 
mechanisms that C. jejuni in general exhibit regarding interactions with host 
IECs. However, further investigations using different strains will be required to 
see the true picture of pathogenesis in C. jejuni. 
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CHAPTER FIVE: VISUALISATION OF INTERACTIONS OF GFP 
EXPRESSING C. jejuni STRAINS WITH HUMAN INTESTINAL EPITHLIAL 
CELLS 
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5.1 Introduction 
 
In order to escape the host immune defence, bacteria often invade host cells 
as a means of survival. C. jejuni interactions with human intestinal epithelial 
cells have been investigated in vitro using polarised Caco-2 and T84 cell lines. 
The stable expression of GFP in 11168H strains will provide an important tool 
for studying C. jejuni interactions with different cell types in vitro. In addition, 
studies involving animal models of infection will benefit from a C. jejuni strain 
stably expressing GFP to follow intracellular bacteria in vivo for the further 
investigation of C. jejuni mechanisms of pathogenesis. 
The GFP plasmid (pCJC4) was provided by Dr Dennis Linton (University of 
Manchester). Plasmid pCJC4 contains a chloramphenicol resistance cassette 
(cat) with upstream and downstream restriction sites, flanked by regions of the 
C. jejuni NCTC 11168H pseudogene Cj0223. The porA promoter region, a 
strong promoter from C. jejuni NCTC 11168 is located upstream of a green 
fluorescent reporter gene (gfp), inserted upstream of the cat gene. C. jejuni cells 
that conjugated with pCJC4 were observed internalised following bacterial 
invasion of HeLa cells by fluorescent microscopy (Jervis et al., 2015). 
Competent cells of C. jejuni 11168H wild-type strain, cadF and flpA mutants 
were prepared and 1 ug of purified GFP plasmid DNA was used to transform 
the wild-type strain, cadF and flpA mutants as described in Section 2.3.15. 
pCJC4 was successfully transformed into the 11168H wild-type strain, cadF 
and flpA mutants, resulting in stable expression of GFP in all strains based on 
confocal fluorescent microscopy images. These strains were used to visualise 
C. jejuni interactions with human intestinal epithelial cells. 
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5.2 Results 
 
5.2.1 Growth kinetics of 11168H wild-type strain, cadF and flpA mutants 
expressing GFP 
 
Growth assays were performed to assess the impact of expressing GFP. The 
growth kinetics of the 11168H wild-type strain, cadF and flpA mutants 
expressing GFP exhibited a similar pattern compared to the respective non-
GFP expressing strains. Initially the 11168H wild-type strain growth was slightly 
reduced compared to the cadF and flpA mutants, however after 15 h, the wild-
type strain growth was highest followed by cadF mutant with the flpA mutant 
lowest (compare Figure 5.1 with Figure 3.6). This indicated that GFP expression 
does not impact significantly on the growth of these C. jejuni strains.  
 
 
 
Figure 5.1. Representative growth curves of C. jejuni 11168H wild-type 
strain, cadF and flpA mutants expressing GFP. Brucella broth was 
inoculated with C. jejuni 11168H wild-type strain, cadF or flpA mutants at an 
OD600 of 0.1 and incubated with constant shaking at 75 rpm under microaerobic 
conditions at 37oC. At intervals of 2 h, 1 ml samples were removed and the 
OD600 recorded. Data shown are representative of three independent 
experiments. 
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5.2.2 Motility assays for 11168H wild-type strain, cadF and flpA mutants 
expressing GFP  
 
Motility assays were performed to assess the impact of expressing GFP. Both 
the 11168H cadF and flpA mutants showed reduced motility compared to wild-
type strain and the same phenotypes were observed in the respective non-GFP 
expressing strains. In addition, cadF and flpA mutants expressing GFP showed 
similar motility to the cadF and flpA non-GFP expressing mutants. However, in 
comparison to the non-GFP expressing wild-type strain, the 11168H wild-type 
strain expressing GFP exhibited increased motility (compare Figure 5.2 with 
Figure 3.7). 
 
 
A 
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Figure 5.2. Motility assessment of 11168H wild-type strain, cadF and flpA 
mutants expressing GFP. Bacteria were grown for 24 h on blood agar plates. 
A suspension was prepared and adjusted to an OD600 of 1.0. 1.5 μl of this 
suspension was pipetted into the centre of soft agar plates and incubated at 
37oC under microaerobic conditions for 72 h. The level of motility was assessed 
by measuring the diameter of the growth halo at 24 h, 48 h and 72 h. A. 
Differences of motility observed in 11168H wild-type, cadF mutant and flpA 
mutant expressing GFP. B. Representative images showing motility assay 
plates of 11168H wild-type, cadF mutant or flpA mutant expressing GFP at 24, 
48 and 72 h. *** denotes p< 0.001 and **** denotes p<0.0001. Data is 
representative of three independent experiments. 
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5.2.3 Interactions with and invasion of Caco-2 IECs by the 11168H wild-
type strain, cadF and flpA mutants expressing GFP 
 
In comparison to the non-GFP expressing strains (see Chapter 3), the strains 
expressing GFP exhibited similar patterns of interaction and invasion with 
Caco-2 cells. 
As with the non-GFP expressing strains, both the 11168H cadF and flpA 
mutants expressing GFP exhibited a reduction in interactions with Caco-2 cells 
compared to the wild-type strain at both 3 h and 24 h time points. However, the 
interaction numbers increased between 3 h to 24 h (compare Figure 5.3 A with 
Figure 3.26 A and Figure 3.26 B).   
No significant reduction in invasion was observed at 3 h time points for both the 
11168H cadF and flpA mutants expressing GFP. However, both the 11168H 
cadF and flpA mutants expressing GFP displayed a significant reduction in 
invasion of Caco-2 IECs compared to wild-type strain at 24 h time points. In 
addition, there was no significant increased from 3 h to 24 h on both the 11168H 
cadF and flpA mutants expressing GFP invasion, compared to the non-GFP 
expressing strains (compare Figure 5.3 B with Figure 3. 27A and Figure 3.7 B). 
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Figure 5.3. Interactions and invasion of C. jejuni 11168H wild-type strain, 
cadF and flpA mutants expressing GFP with T84 IECs. Confluent 
monolayers were infected (MOI 100:1) with C. jejuni 11168H wild-type strain, 
cadF or flpA mutants expressing GFP and incubated for 3 h or 24 h. A. For 
interaction assays, Triton X-100 was added following washes with PBS to lyse 
the cells; B. For invasion assays, cells were further incubated with gentamicin 
(150 μg/ml) for 2 h to kill extracellular bacteria, then lysed with Triton X-100. 
Serial dilution of lysates were plated on CBA plates. After 48 h, CFU were 
counted. Data are representative of a minimum of triplicate biological replicates. 
* denotes p < 0.05; ** denotes p < 0.01. 
 
 
5.2.4 C. jejuni 11168 wild-type strain expressing GFP invades Caco-2 
IECs 
 
In the pathogenesis of many intestinal infections, it appears that adherence to 
surface mucosa is a pre-requisite for bacterial invasion into host cells. 
Therefore, initial experiments were performed to investigate the visualisation of 
C. jejuni interactions with Caco-2 IECs using the 11168H wild-type strain 
expressing GFP. At 30 min post-infection, bacteria were observed 
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extracellularly surrounding the Caco-2 cells (Figure 5.4). At 60 min post-
infection, bacteria were observed at the periphery of cells (Figure 5.5). At both 
2 h and 24 h post-infection, many bacteria were observed intracellularly 
adjacent to the nucleus (Figure 5.6 and Figure 5.7). 
 
 
 
 
 
Figure 5.4. Representative confocal micrograph of Caco-2 cells infected 
with GFP expressing 11168H wild-type strain showing the position of 
bacteria 30 minutes post-infection. Caco-2 cells infected (MOI 100:1) with 
GFP expressing 11168H wild-type strain were prepared and stained using DAPI 
(Blue) for nucleus and WGA (Red) for plasma membrane. Combined confocal 
fluorescence images of Caco-2 cells infected with GFP expressing 11168H 
wild-type strain (Green) for 30 min, showing extracellular bacteria close to the 
Caco-2 cells. The majority of bacteria was observed outside of the cells.  
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Figure 5.5. Representative confocal micrograph of Caco-2 cells infected 
with GFP expressing 11168H wild-type strain showing the position of 
bacteria 60 minutes post-infection. Caco-2 cells infected (MOI 100:1) with 
GFP expressing 11168H wild-type strain were prepared and stained using DAPI 
(Blue) for nucleus and WGA (Red) for plasma membrane. Combined confocal 
fluorescence images of Caco-2 cells infected with GFP expressing 11168H 
wild-type strain (Green) for 60 min, showing majority of bacteria at the periphery 
of the cells and internalised within plasma membrane of cells. 
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Figure 5.6. Representative confocal micrograph of Caco-2 cells infected 
with GFP expressing 11168H wild-type strain showing the position of 
bacteria 2 h post-infection. Caco-2 cells infected (MOI 100:1) with GFP 
expressing 11168H wild-type strain were prepared and stained using DAPI 
(Blue) for nucleus and WGA (Red) for plasma membrane. Combined confocal 
fluorescence images of Caco-2 cells infected with GFP expressing 11168H 
wild-type strain (Green) for 2 h, showing majority of bacteria were internalised. 
Most bacteria were observed inside the cytoplasm of the cells and some aligned 
just inside the plasma membrane of cells. Some bacterial were membrane-
associated with the cytoskeleton appeared yellow. 
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Figure 5.7. Representative confocal micrograph of Caco-2 cells infected 
with GFP expressing 11168H wild-type strain showing the position of 
bacteria 24 h post-infection. Caco-2 cells infected (MOI 100:1) with GFP 
expressing 11168H wild-type strain were prepared and stained using DAPI 
(Blue) for nucleus and WGA (Red) for plasma membrane. Combined confocal 
fluorescence images of Caco-2 cells infected with GFP expressing 11168H 
wild-type strain (Green) for 24 h, showing bacteria close to the nucleus. Some 
bacteria that were membrane-associated with the cytoskeleton appeared 
yellow.  
 
 
 
 
 
 
205 
 
5.2.5 C. jejuni 11168H wild-type strain expressing GFP invades T84 IECs 
 
Further experiments were performed to investigate the visualisation of C. jejuni 
interactions with T84 IECs using the 11168H wild-type strain expressing GFP. 
Confocal microscopy of T84 cells confirm the association of C. jejuni 11168H 
with T84 IECs. Bacteria were readily observed internalised in T84 IECs 24 h 
post-infection in various stages simultaneously (Figure 5.8 A and B). At the 
initial stage, some bacteria were seen adhering to the outside of the cell at the 
plasma membrane, whilst others were already internalised inside the cells 
(Panel A). In the same micrograph, the ruffling of the membrane surrounding 
the T84 cell was also observed. Entering the cell results in C. jejuni being 
enveloped in the plasma membrane (Red) as observed in Panel B. Thus some 
internalised C. jejuni were seen as yellow in colour as these bacteria were 
associated with the host cell plasma membrane. However, bacteria were also 
observed without any association with the plasma membrane (Green). 
 
A 
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Figure 5.8. Cellular association of C. jejuni in T84 IECs. Representative 
confocal micrograph of T84 cells infected with GFP expressing 11168H 
wild-type strain showing the position of bacteria 24 h post-infection. T84 
cells infected (MOI 100:1) with GFP expressing 11168H wild-type strain for 24 
h. Cells were prepared and stained using DAPI (Blue) for nucleus and WGA 
(Red) for plasma membrane. Panel A shows C. jejuni adhered at the plasma 
membrane outside cells and internalised inside the plasma membrane inside 
cells. Panel B shows a Z stack-combined confocal fluorescence images of T84 
cells infected with GFP expressing 11168H wild-type strain (Green), showing 
bacteria about to enter the cell has no plasma membrane around it, whilst 
another bacteria almost inside the cell, was enclosed with the plasma 
membrane (Red) around it. Another bacteria already inside the cell can be 
observed close to the cell nucleus. Bacterial which were membrane-associated 
with the cytoskeleton appeared yellow.  
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5.2.6 Control untreated and uninfected Caco-2 IECs   
 
Comparison was made in untreated and uninfected Caco-2 cells to visualise 
and establish C. jejuni invasion prior performing further experiments. Caco-2 
cells were grown on cover slips as described in Section 2.19. As a control, cells 
untreated with inhibitors and uninfected with C. jejuni were stained either with 
WGA to show the plasma membrane or with rhodamine-phalloidin to highlight 
the actin cytoskeleton (Figure 5.9). Caco-2 cells were stained showing the 
plasma membrane (Red) in uninfected Caco-2 cells (Panel A) and infected with 
C. jejuni (Green) (Panel B). Caco-2 cells were stained showing actin filaments 
(Red) in uninfected Caco-2 cells (Panel C) and infected with C. jejuni (Green) 
(Panel D). 
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Figure 5. 9. Uninfected and infected Caco-2 IECs. A and C are uninfected 
IECs whilst B and D are IECs infected (MOI 100:1) with C. jejuni 11168H wild-
type strain expressing GFP (Green). IECs were grown on coverslips and co-
incubated with or without bacteria for 2 h. Following incubation cells were fixed, 
washed and stained using DAPI (Blue) for nucleus, WGA (Red) for plasma 
membrane (in A and B) or rhodamine-phalloidin (Red) for actin filaments (in C 
and D). Panel A. Uninfected Caco-2 cell stained with WGA (Red) showing the 
presence of plasma membrane; Panel B. Infected Caco-2 cell stained with 
WGA (Red) showing the presence of plasma membrane and C. jejuni (Green); 
Panel C. Uninfected Caco-2 cell stained with rhodamine-phalloidin (Red) 
showing the presence of actin filaments; Panel D. Infected Caco-2 cells stained 
with rhodamine-phalloidin (Red) showing the presence of actin filaments and C. 
jejuni (Green). 
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5.2.7 Reorganisation of actin cytoskeleton showing membrane ruffling in 
Caco-2 IECs 
 
C. jejuni infection results in reorganisation of the actin cytoskeleton in both 
Caco-2 and T84 IECS. The S. flexneri IpaABCD secreted proteins have been 
reported to play an important role in the bacterial entry process (Menard et al., 
1993) by inducing actin polymerisation and formation of filopodia and 
lamellipodia upon entry into epithelial cells . These structures were triggered by 
the S. flexneri IpaC protein and were dependent on Cdc42 and Rac GTPases 
(Tran Van Nhieu et al., 1999). Cytoskeleton assembly in cells is a result of 
activated small GTPases (Russell and Blake, 1994). 
A study by Hall et al. showed that small GTPases such as Rho, Rac and Cdc42 
control the assembly and organisation of the actin cytoskeleton in epithelial cells 
(Nobes and Hall, 1995b). Among the effects observed following Rho, Rac or 
Cdc42 activation in these cells were the formation of stress fibres and 
lamellipodia (Ridley and Hall, 1992, Ridley et al., 1992). In line with these 
observations, experiments were performed to visualise the effects of infection 
with the 11168H wild-type strain expressing GFP on Caco-2 cells. 
Following bacterial infection of Caco-2 cells, membrane ruffling was observed. 
The different formations observed were protrusion finger-like filopodia (Figure 
5.10 A), lamellipodia (Figure 5.11 A) and stress fibres (Figure 5.12 A). Filopodia 
appear like microspikes of actin protrusions and very motile. Filopodia grow by 
extension up to 25 µm in length. Filopodia and lamellipodia are highly motile 
with ‘wave’ movement because the structures are able to detach, reattach and 
fold back upon themselves. Filopodia were closely associated to lamellipodia 
and the highly motile dynamic structures were observed to be co-ordinated 
forming one after another and to produce membrane ruffles (Nobes et al., 1995, 
Nobes and Hall, 1995a). 
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5.2.7.1 Filopodia formation in Caco-2 cells 
 
Data has been published that activation of Rac1 results in induction of 
membrane ruffles in epithelial cells. Filopodia and lamellipodia are examples of 
membrane ruffles (Caron and Hall, 1998, Ridley and Hall, 1992). To determine 
whether changes in the actin cytoskeleton were mediated by C. jejuni infection 
as a result of the activation Rac GTPases, experiments were performed 
whereby Caco-2 cells were infected with 11168H and confocal microscopy 
images were analysed. 
Following infection with the 11168H wild-type strain, formations such as 
filopodia and lamellipodia were observed in Caco-2 cells (Figure 5.10). A 
structure of filopodia that resemble micro spikes and also protrusions of actin 
filaments were observed (see panel B and C). In panel D, similar structures 
were also observed in association with C. jejuni (Green). These observations 
are similar to the structures observed in a previous study (panel A) (Nobes and 
Hall, 1995b). 
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Figure 5.10. Representative confocal micrographs of Caco-2 cells infected 
with GFP expressing 11168H wild-type strain showing the formation of 
filopodia. Caco-2 cells infected with GFP expressing 11168H wild-type strain 
(MOI 100:1) were prepared and stained using (DAPI) (Blue) for nucleus and 
rhodamine phalloidin (Red) for actin filament. Panel A. Image showing 
formation of filopodia in Swiss 3T3 fibroblast cells (Nobes and Hall, 1995a). 
Panel B and C. Structures of filopodia observed in Caco-2 cells infected with C. 
jejuni 11168H wild-type strain. Panel D. Representative confocal fluorescence 
images of Caco-2 cells infected with 11168H wild-type strain showing actin 
filaments as protrusion like formations (filopodia) (Red) and some internalised 
C. jejuni (Green). 
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5.2.7.2 Lamellipodia formation in Caco-2 cells 
 
Studies have reported that lamellipodia and membrane ruffles were produced 
at the cell periphery as a result of Rac activation that regulates polymerisation 
of actin (Nobes and Hall, 1995b, Caron and Hall, 1998, Ridley et al., 1992). 
Following infection with the 11168H wild-type strain, formation of lamellipodia 
were observed in Caco-2 cells (Figure 5.11). In panel B, formation of 
lamellipodia was observed as a membrane protrusion induced by actin 
polymerisation at the cell periphery following infection with C. jejuni 11168H. In 
panel C, the similar structure was observed along with some internalised C. 
jejuni (Green). This is in agreement with observation (panel A) from a previous 
study (Ridley et al., 1992). 
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Figure 5.11. Representative confocal micrograph of Caco-2 cells infected 
with GFP expressing 11168H wild-type strain showing the formation of 
lamellipodia. Caco-2 cells infected with GFP expressing 11168H wild-type 
strain (MOI 100:1) were prepared and stained using (DAPI) (Blue) for nucleus 
and rhodamine phalloidin (Red) for actin filament. Panel A. Image showing 
lamellipodia in Swiss 3T3 fibroblast cells (Hall, 1999). Panel B. Representative 
confocal fluorescence images of Caco-2 cells infected with GFP expressing 
11168H wild-type strain, showing membrane ruffles as ribbon-like formation 
(lamellipodia) (Red). Panel C. Both Figure A and B are infected Caco-2 cells 
showing membrane ruffles and lamellipodia with some internalised C. jejuni 
(Green).  
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5.2.7.3 Stress fibre formation in Caco-2 cells 
 
Infection with C. jejuni activated Rac1 member of small GTPases, results in 
cytoskeleton rearrangements including stress fibres (Nobes and Hall, 1995a) 
During infection with the 11168H wild-type strain (Green), formation of stress 
fibres (Red) were observed in Caco-2 cells (Figure 5.12). In panel B, stress 
fibres were observed and panel C, some internalised C. jejuni (Green) were 
also seen in close contact with the stress fibres. This observation was similar to 
the one reported (panel A) where Swiss 3T3 fibroblast cells were injected with 
recombinant Rac protein (V12rac) for GTPases activation (Hall and Nobes, 
2000).  
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Figure 5.12. Representative confocal micrograph of Caco-2 cells infected 
with GFP expressing 11168H wild-type strain showing the formation of 
stress fibres. Caco-2 cells infected with GFP expressing 11168H wild-type 
strain (MOI 100:1) were prepared and stained using (DAPI) (Blue) for nucleus 
and rhodamine phalloidin (Red) for actin filament. Panel A. Image showing 
stress fibres in Swiss 3T3 fibroblast cells (Nobes and Hall, 1995a). Panel B. 
Representative confocal micrograph of Caco-2 cells infected with 11168H wild-
type strain showing the actin stress fibres within the cells. Panel C. Combined 
confocal fluorescence images showing stress fibres as a result of interaction 
with C. jejuni (Green) and some internalised C. jejuni. 
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5.2.8 Intracellular C. jejuni 11168H wild-type strain expressing GFP 
associated with actin cytoskeleton 
 
After internalisation into the host cell, C. jejuni appears closely associated with 
the actin cytoskeleton structure. Therefore experiments were performed to 
visualise the association of C. jejuni 11168H with the actin cytoskeletal following 
the invasion of IECs. The position of C. jejuni and actin cytoskeleton 
accumulation were observed 1 h post-infection (Figure 5.13). The results 
showed C. jejuni clearly associated with the actin cytoskeleton. Highly 
fluorescent intracellular C. jejuni expressing GFP were readily visualised within 
the actin cytoskeleton network inside the cells. 
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Figure 5. 13. Representative confocal micrograph of Caco-2 cells infected 
with GFP expressing 11168H wild-type strain showing internalised 
bacteria at the proximity of actin cytoskeleton. Caco-2 cells infected with 
GFP expressing 11168H wild-type strain (MOI 100:1) were prepared and 
stained using DAPI (Blue) for nucleus and rhodamine pallodine (Red) for actin 
filaments. Panel A, B and C show position of C. jejuni clearly associated with 
actin accumulation. Panel D shows an enlarged image and transversal optical 
sections to the side of panels for the location of the bacteria relative to the cells 
basis. 
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5.2.9 Intracellular C. jejuni 11168H wild-type strain expressing GFP is not 
associated with actin cytoskeleton 
 
In a previous study, infection of HeLa cells with C. jejuni showed various stages 
of penetration. Some of the internalised bacteria appeared to be co-localised 
with vacuoles, some partially lysed, some associated with actin structures and 
some retain the size and S shaped (Fauchere et al., 1986). 
From confocal microscopy images following bacterial invasion of Caco-2 cells, 
internalised C. jejuni can be observed inside the cytoplasm (Figure 5.14). The 
GFP expressing 11168H wild-type strain (Green) was observed internalised in 
Caco-2 cells but also with no apparent association with the actin cytoskeleton 
(Red). Some bacteria also appeared singly showing the characteristic spiral 
shape (arrow). This result is also consistent with a previous study showing C. 
jejuni internalised in INT 407 cells with no apparent association with actin (Hu 
and Kopecko, 1999). 
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Figure 5.14. Internalised GFP expressing 11168H wild-type strain showed 
non-association with actin cytoskeleton in Caco-2 IECs. Representative 
confocal micrograph of Caco-2 cells infected with GFP expressing 11168H wild-
type strain (MOI 100:1) (Green) for 1 h. Caco-2 cells infected with GFP 
expressing 11168H wild-type strain were prepared and stained using DAPI 
(Blue) for nucleus and rhodamine phalloidin for actin filaments (Red). GFP 
expressing 11168H wild-type strain bacteria (arrow) were observed in cell 
cytoplasm, showing no apparent specific association with the actin 
cytoskeleton. 
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5.2.10 Co-localisation of intracellular 11168H wild-type strain expressing 
GFP with a vacuole in Caco-2 IECs 
 
Based on previous observations, C. jejuni has been shown to invade IECs then 
reside either free within the cytoplasm, associated with actin or in close 
proximity to the nucleus (Fauchere et al., 1986). In this study, C. jejuni was 
observed to reside within a membrane vacuole and form tight co-localisation, 
which resulted in yellow fusion structures (Figure 5.15). This suggests that GFP 
expressing 11168H wild-type strain resides within a membrane-bound vacuole 
in Caco-2 cells.  
 
 
 
 
 
225 
 
C 
               
 
Figure 5.15. Representative confocal micrograph of Caco-2 cells infected 
with 11168H wild-type strain expressing GFP showing specific co-
localisation with plasma membrane. Caco-2 cells infected with GFP 
expressing 11168H wild-type strain (MOI 100:1) were prepared and stained 
using DAPI (Blue) for nucleus and WGA (Red) for plasma membrane. Panel A. 
Combined confocal fluorescence images of Caco-2 cells infected with GFP 
expressing 11168H wild-type strain for 1 h, showing bacteria internalised and 
co-localised with plasma membrane. Yellow fusion colour represented tight co-
localisation of C. jejuni 11168H wild-type strain (Green) with plasma membrane 
(Red) and could be seen to various degrees with bacteria throughout the cells 
(arrowhead). Panel B. Z-stack showing relative position of bacteria with plasma 
membrane in the cells. Panel C. One confocal image plane showing two 
bacteria residing in vacoules that are co-localised tightly with plasma membrane 
which appeared as a yellow fusion colour. 
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5.2 11 Internalisation of C. jejuni 11168H wild-type strain expressing GFP 
into Caco-2 IECs 
 
It has been shown that that the initiation of invasion by C. jejuni involves 
cytoskeleton rearrangements (Konkel et al., 2013). Studies have reported that 
C. jejuni was observed interacting with finger-like protrusions of the host cell 
membrane during invasion (Biswas et al., 2003, Biswas et al., 2004). Membrane 
ruffles were shown engulfing C. jejuni F3801 wild-type strain into INT 407 cells 
(Eucker and Konkel, 2012). Confocal microscopy images were analysed after 
Caco-2 cells were infected with the 11168H wild-type strain expressing GFP 
(Figure 5.16). C. jejuni (Green) was observed engulfed by membrane ruffles 
formations (Red) during actin cytoskeleton rearrangements. 
 
 
 
Figure 5.16. Membrane ruffles engulfing C. jejuni during invasion into 
Caco-2 IECs. Representative confocal micrograph of Caco-2 cells infected with 
GFP expressing 11168H wild-type strain showing internalisation of bacteria into 
the cell via membrane ruffles. Caco-2 cells infected with GFP expressing 
11168H wild-type strain (MOI 100:1) for 1h. Cells were prepared and stained 
using DAPI (Blue) for nucleus and WGA (Red) for plasma membrane. Scale in 
µm showing the depth and position of bacterial. 
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5.2.12 Intracellular 11168H wild-type strain expressing GFP co-localises 
with late endosomal compartments 
 
Following the observation that intracellular 11168H wild-type strain resides 
within the Caco-2 cell cytoplasm and also co-localised with actin, further 
investigations were performed to see whether the CCV co-localises with the late 
endocytic lysosome–associated membrane protein 1 (Lamp-1). As judged by 
confocal microscopy, the majority of intracellular bacteria were not co-localised 
with the late endosomal marker Lamp-1. However, a small number of bacteria 
were shown to co-localise with late endosomal compartments. 
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Figure 5.17. Representative confocal micrograph of Caco-2 IECs infected 
with GFP expressing 11168H wild-type strain for 1 h. Caco-2 IECs infected 
with GFP expressing 11168H wild-type strain (MOI 100:1) (Green) were 
prepared and stained using DAPI (Blue) for nucleus and late endosome with 
(Lamp-1 (H4A3): sc-20011) (Red). Panel A. Combined confocal fluorescence 
images of Caco-2 cells infected with GFP expressing 11168H wild-type strain 
for 1 h, showing bacteria co-localised with lamp-1. A slight tinge of yellow fusion 
colour represents co-localisation of C. jejuni 11168H wild-type strain with late 
endosomal vacoule (arrowhead). Panel B. One confocal image plane showing 
two bacteria residing in a vacoule that has co-localised with lamp-1 which 
appears as a yellow fusion colour. Panel C. Z-stack showing relative position of 
bacteria with actin cytoskeleton in the cells.  
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5.2.13 Extracellular and intracellular C. jejuni wild-type strain expressing 
GFP in Caco-2 IECs 
 
Dual staining of extracellular bacteria was used to differentiate between 
extracellular and intracellular bacteria. C. jejuni 11168H wild-type strain 
expressing GFP was used to visualise intracellular bacteria. Caco-2 IECs were 
seeded and grown overnight on glass coverslips in 24 well plate. Cells were 
infected with GFP expressing 11168H at MOI of 100:1 for 2 h. Cells were then 
fixed with 2% (v/v) paraformaldehyde. Polyclonal rabbit anti-campylobacter 
antibody was added for 30 mins and then cells were washed three times with 
PBS. After that, anti-rabbit antibody rhodamine conjugated was added for 30 
min, and the cells were finally washed again with PBS. Since the cells were not 
permeabilised, only extracellular bacteria were labelled red with the anti-
campylobacter antibody, while intracellular bacteria were free of antibody and 
remain GFP green. Hence, intracellular 11168H GFP was observed expressing 
green fluorescence.  
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Figure 5.18. Representative confocal micrograph of Caco-2 cells infected 
with GFP expressing 11168H wild-type strain for 1 h. Caco-2 cells infected 
with GFP expressing 11168H wild-type strain (MOI 100:1) were prepared and 
stained using DAPI (Blue) for nucleus and anti-campy (Red). Panels A and B 
show combined confocal fluorescence images of Caco-2 cells infected with 
GFP expressing 11168H wild-type strain for 1 h, showing extracellular bacteria 
(Red) and intracellular bacteria (Green). Panel C. Some intracellular C. jejuni 
11168H wild-type strain expressing GFP (Green) was observed outside and 
released from Caco-2 cells, which appeared to be lysed. 
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5.2.14 Disruption of actin cytoskeleton by eukaryotic inhibitor 
Cytochalasin D in Caco-2 IECs 
 
C. jejuni invasion into host cells involves interaction with IEC signalling 
pathways as shown in Chapter 4. A common feature of signalling pathways is 
the regulation of actin cytoskeleton polymerisation and re-organisation that 
results in C. jejuni internalisation into into host cells. To visualise the effects of 
the eukaryotic inhibitors on actin cytoskeletal architecture, IECs treated with 
inhibitors were investigated using confocal microscopy. 
Caco-2 IECs were treated with the eukaryotic inhibitors as described in Section 
2.2.9. In cells treated with cyto D, actin filaments (Red) were greatly 
disorganised compared to the non-treated cells (Figure 5.19) 
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Figure 5.19. Disruption of actin cytoskeleton in Caco-2 IECs. Islands of 
polarised Caco-2 cells were treated with 3 µM cyto D. Cells were incubated with 
the inhibitor for 1 h. Following washes with PBS, cells were then fixed with 
paraformaldehyde and stained with rhodamine phalloidin (Red) for actin and 
DAPI (Blue) for nucleus. Panel A shows untreated Caco-2 cells and panel B 
shows Caco-2 cells treated with cyto D. 
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5.2.15 Disruption of actin cytoskeleton by eukaryotic inhibitor methyl-
beta cyclodextrin in Caco-2 IECs 
 
Caco-2 cells treated with MβCD showed significantly damaged actin 
cytoskeleton compared to the non-treated cells (Figure 5.20). 
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Figure 5.20. Disruption of actin cytoskeleton in Caco-2 IECs. Islands of 
polarised Caco-2 IECs were treated with 5 µM MβCD. Cells were incubated 
with the inhibitor for 1 h. Following washes with PBS, cells were then fixed with 
paraformaldehyde and stained with rhodamine phalloidin (Red) for actin and 
DAPI (Blue) for nucleus. Panel A shows untreated Caco-2 cells and panel B 
shows Caco-2 cells treated with MβCD. 
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5.2.16 Infection of cytochalasin D pre-treated Caco-2 IECs with 11168H 
wild-type strain expressing GFP 
 
An investigation was performed to attempt to correlate the reduction in invasion 
caused by the eukaryotic inhibitors as seen with the CFU method in the previous 
chapter with the effect of the same inhibitor on the cells. Treated and untreated 
IECs infected with C. jejuni strains were compared. 
Experiments were performed to determine the role of actin microfilaments in C. 
jejuni 1116H invasion with Caco-2 cell. No difference in the invasion ability was 
observed from confocal fluorescence microscopy images between the 
untreated (Panel A) and treated (Panel B) Caco-2 cells infected with 11168H 
wild-type expressing GFP (Figure 5.21).  
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Figure 5.21. Representative confocal micrograph of Caco-2 cells infected 
with GFP expressing 11168H wild-type strain. Caco-2 cells were A. 
untreated and B. pre-treated with 3 µM cyto D for 1 h and infected with GFP 
expressing 11168H wild-type strain (MOI 100:1) for 1 h. Cells were fixed and 
stained using (DAPI) (Blue) for nucleus and rhodamine phalloidin (Red) for actin 
filaments.  
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5.2.17 Infection of cytochalasin D pre-treated Caco-2 IECs with the 
11168H cadF mutant expressing GFP 
 
Following construction of GFP expressing 11168H cadF and flpA mutants, 
invasion assays was performed and analysed using confocal microscopy as 
described in Section 2.4 and Section 2.6. Further experiments were performed 
to determine the role of actin microfilaments in C. jejuni 1116H cadF mutant 
invasion with Caco-2 cell. As observed from confocal microscopy image, a 
small number of 11168H cadF mutants were observed inside the cells which 
were not treated with cyto D (panel A). Whilst one C. jejuni was observed 
associated with actin filament (arrow) and some other C. jejuni appeared to be 
in closed contact with the membrane ruffles at the outside of Caco-2 cells 
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Figure 5.22. Representative confocal micrograph of Caco-2 cells infected 
with 11168H cadF mutant expressing GFP. Caco-2 cells were A. untreated 
and B. pre-treated with 3 µM cyto D for 1 h and infected with GFP expressing 
11168H cadF mutant (MOI 100:1) for 1 h. Cells were prepared and stained 
using DAPI (Blue) for nucleus and rhodamine phalloidin (Red) for actin 
filaments.  
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5.2.18 Infection of cytochalasin D pre-treated Caco-2 IECs with the 
11168H flpA mutant expressing GFP 
 
As with the C. jejuni 11168H cadF mutant, experiments were also performed to 
determine the role of actin microfilaments in C. jejuni 1116H flpA mutant 
invasion of Caco-2 cell. Both in Caco-2 cells untreated with cyto D (panel A) 
and treated with cyto D (panel B) the C. jejuni 1116H flpA mutant was not 
observed able to invade Caco-2. However, the infection with C. jejuni 11168H 
flpA mutant appeared to induce membrane ruffles around the infected Caco-2 
cells. Note heavy ruffling surrounding untreated Caco-2 cells (panel A). 
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Figure 5. 23. Representative confocal micrograph of Caco-2 cells infected 
with 11168H flpA mutant expressing GFP. Caco-2 cells were A. untreated 
and B. pre-treated with 3 µM cyto D for 1 h and infected with GFP expressing 
11168H flpA mutant (MOI 100:1) for 1 h. Cells were fixed and stained using 
DAPI (Blue) for nucleus and rhodamine phalloidin (Red) for actin filaments. No 
invasion was observed by C. jejuni flpA mutant into both untreated and treated 
(panel A and panel B respectively). However, the infection caused formation of 
membrane ruffles around the infected cells. 
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5.3 Discussion 
 
Successful application of the use of the recombinant green fluorescent protein 
(GFP) from the jellyfish A. victoria to monitor bacterial interactions with 
eukaryotic cells was first demonstrated in 1994 (Chalfie et al., 1994). The use 
of recombinant GFP protein to image bacterial interactions with eukaryotic cells 
has many advantages including the none requirement for any extrinsic factors 
except blue or UV light. Monitoring of GFP fluorescence is also compatible with 
various detection technologies, such as simple UV light visualisation, 
fluorescence microscopy and fluorescence plate readers for in vitro and in vivo 
imaging (Errampalli et al., 1999, Tombolini et al., 1999). In addition, the use of 
recombinant GFP has been shown to have no toxic effects on cells (Chalfie et 
al., 1994). Recombinant GFP has been widely used to track and visualise 
bacterial cells localisation within eukaryotic cells and tissue. The attempts to 
visualise GFP expressing bacteria interacting with eukaryotic cells has 
promoted the advancement of our understanding of pathogenesis and 
intracellular survival mechanisms.  
The use of GFP to investigate C. jejuni interactions with IECs is not widely used 
due to problems with bacterial expression of GFP in the intracellular 
environment. In this chapter, the availability of the new C. jejuni GFP construct 
with a highly fluorescent recombinant GFP protein under the control of the 
strong C. jejuni porA promoter that has recently been reported was exploited 
(Jervis et al., 2015). C. jejuni 11168H wild-type strain, cadF and flpA mutants 
expressing a bright fluorescence GFP protein were constructed and used to 
investigate the localisation of these C. jejuni strains during interactions with and 
invasion of both Caco-2 and T84 cells in vitro. These experiments have 
confirmed the invasion pathways of the C. jejuni 11168H wild-type strain 
expressing fluorescence GFP in both Caco-2 and T84 cells. This is the first 
study, which used a C. jejuni 11168H wild-type strain expressing a GFP to 
characterise the interactions, invasion and intracellular survival of 11168H in 
IECs. Since IECs are non-phagocytic in nature, C. jejuni must actively induce 
entry into IECs. Traditionally C. jejuni 11168H interactions with IECs have been 
visualised either using immunofluorescence, where antibodies bound to 
fluorescent dyes are used to target C. jejuni (Hu and Kopecko, 1999) or by 
live/dead staining (Watson and Galan, 2008). 
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Expression of GFP was confirmed not to impact significantly growth or motility 
(Clark et al., 2009, Kadioglu et al., 2001). For all the experiments conducted, 
GFP-expressing C. jejuni strains maintained the ability to constitutively express 
GFP. Initially, comparisons were made between the growth kinetics of the wild-
type GFP-expressing strain and GFP-expressing mutants. In all instances, the 
growth curves were virtually identical to the respective non-GFP expressing 
strains and no significant differences in growth rate were observed. These 
observations suggested that recombinant GFP expression in these C. jejuni 
11168H strains did not significantly affect bacterial growth rate and are in 
agreement with previous studies (Chalfie et al. 1994; Skillman et al. 1998). 
However, there was a slight change in motility, where the C. jejuni 11168H wild-
type strain expressing GFP exhibited increased motility compared to non-GFP 
expressing wild-type strain, but still within the range of other C. jejuni wild-type 
strains and similar to the level of the highly invasive 81-176 wild-type strain (see 
Section 3.2.5). As growth rate and motility are known modulators of C. jejuni 
physiology and virulence potential, it was important to eliminate attenuation of 
these virulence traits as a possible effect of recombinant GFP expression. 
A study by Clark et al. showed that expression of GFP has no impact on S. 
Typhimirium invasiveness during optimal growth (Clark et al., 2009). Previously, 
it was also reported that the ability of Streptococcus pneumoniae D39 to invade 
and grow within the infected host was not impacted by carriage of a GFP 
plasmid (Kadioglu et al., 2001). The S. pneumoniae pGFP1 and wild-type strain 
showed no difference in growth in lung tissue or blood over 48 h of infection. In 
an earlier study, it was reported that GFP expression did not compromise 
bacterial activities of S. Typhimirium, Yersinia pseudotuberculosis or 
Mycobacterium marium either in vitro or in vivo (Valdivia et al., 1996).   
C. jejuni interactions with and invasion into IECs are the initial steps of the 
pathway taken during C. jejuni infection (van Spreeuwel et al., 1985). The 
confocal microscopy analysis of the 11168H wild-type strain expressing GFP 
confirmed that C. jejuni is readily internalised into T84 and Caco-2 IECs in a 
time-dependent manner. The results agreed with previous reports which 
demonstrated immediate interactions of C. jejuni with IECs (Hu and Kopecko, 
1999). In another study, Hu et al. also reported that C. jejuni 81-176 was seen 
at the periphery of INT 407 cells 30 min post-infection (Hu et al., 2008). In this 
study, bacterial interactions were observed very early on 30 min after infection 
of IECs, as bacteria were observed surrounding cells at the plasma membrane 
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outside the cell. At 2 hours post-infection, bacteria were already observed 
internalised inside cells with the cell monolayer and nuclei appearing to be intact 
despite the presence of intracellular bacteria. 
C. jejuni enters IECs cells via largely uncharacterised mechanisms (Backert et 
al., 2013). Various studies using specific inhibitors such as MβCD and cyto D 
have revealed C. jejuni to enter IECs by a microtubule-dependent (actin-
filament-independent) and/or actin-filament-dependent (microtubule-
independent) mechanism (De Melo et al. 1989; Konkel and Joens 1989; 
Oelschlaeger et al. 1993; Russell and Blake 1994; Hu and Kopecko 1999; 
Biswas et al. 2003; Monteville et al. 2003). Interestingly, C. jejuni requirements 
for MTs and/or MFs to enter IECs is in contrast to the invasion pathways of 
other enteric pathogens such as the highly invasive Salmonella or Shigella 
species (Galan, 2001, Sansonetti, 2001). C. jejuni 81-176 has been reported to 
enter IECs cells via a mechanism involving MTs but not MFs, while other studies 
have reported C. coli VC167 and other strains of C. jejuni that enter cells via a 
mechanism involving MFs but not MTs. The implications of C. jejuni wild-type 
strains differing in IEC invasion pathways supports the hypothesis that different 
C. jejuni strains have different host cytoskeletal requirements for invasion, 
depending on both the bacterial strain and IEC line. 
Various steps precede the invasion of C. jejuni into IECs leading to membrane 
and cytoskeletal rearrangements. These include binding to IECs, delivery of 
bacterial virulence factors into the IECs and re-programming of intracellular 
IECs signalling cascades. These processes commonly involve the activation of 
small Rho family GTPases such as RhoA, Cdc42 and Rac1, which act as 
guanine nucleotide-regulated switches and induce various responses during 
the bacterial infection processes. The three GTPases are linked in actions and 
to each other, because activation of Cdc42 results in formation of filopodia that 
leads to Rac activation which in turn induces formation of lamellipodia (Nobes 
and Hall, 1995b, Nobes et al., 1995). Rac subsequently activates Rho and the 
resulting focal complexes formation. As suggested by Hall et al., Rho, Rac and 
Cdc42 work in co-ordination to cause the spatial and temporal actin 
cytoskeleton reorganisation that leads to cell movement and bacterial 
internalisation (Hall, 1990). However, while the internalisation of C. jejuni strains 
such 81-176 and F38011 has typically been observed to induce rearrangement 
of the host actin-cytoskeletal structure, the invasion characteristics of a GFP 
expressing C. jejuni 11168H wild-type has not been investigated yet. 
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The actin cytoskeleton maintains cell shape and plays a pivotal role in cell 
motility, phagocytosis and cytokinesis. Small GTPases such as Rho, Rac and 
Cdc42 have been shown to produce stress fibres, lamellipodia and filopodia 
respectively by regulating the polymerisation of actin in host cells (Mackay et 
al., 1995, Nobes and Hall, 1995b). Swiss 3T3 cells were serum starved and 
microinjected with proteins such as V12rac (Rac 1 isotype) and V14rho (RhoA 
isotypes) as well as V12cdc42. From between 50-100 cells microinjected, more 
than 90% exhibited the various forms of membrane ruffles such as stress fibres, 
lamellipodia and filopodia. In addition, the cells also exhibited the formation of 
focal adhesions and other adhesion complexes. 
Activation of Rac1 is an important event for many invasive pathogens (van 
Triest et al., 2001, Hardt et al., 1998). Lafont et al. reported that GFP-tagged S. 
flexneri upon entering HeLa cells induced membrane ruffles which had lipid raft 
components (Lafont and van der Goot, 2005). Activated Rac1 induced intensive 
ruffling of the membrane, as has been observed frequently (Ridley et al., 1992, 
Obermeier et al., 1998). When serum starved confluent Swiss 3T3 fibroblasts 
were injected with Cdc42, filopodia were observed 5 min post-injection. In 
addition to activated Rac1, the cells were then observed to form lamellipodia 
and spreading rapidly between projection of spikes to form a web that looked 
like a ‘veil’ (Nobes and Hall, 1995b). Rho and Rac were shown to control actin 
polymerisation that leads to formation of stress fibres and membrane ruffle 
lamellipodia (Ridley and Hall, 1992). 
C. jejuni 81-176 wild-type strain induces profound membrane ruffling in INT 407 
cells but not in fibronectin, integrin or FAK knockout cells (Boehm et al., 2011). 
In this study, formation of membrane ruffles was also observed in the Caco-2 
serum starved cells infected with 11168H expressing GFP. In addition, infection 
with the wild-type strain, cadF or flpA mutants not expressing GFP were shown 
to induce activation of Rac1 (see Section 4.2.6). Observations from this study 
were consistent with reports from previous studies which suggested that the C. 
jejuni 81-176 wild-type strain was able to induce membrane ruffling in Caco-2 
cells as the result of Rac-1 activation as seen in the formation of lamellipodia 
(Biswas et al., 2003, Biswas et al., 2004, Hu and Kopecko, 1999). This indicates 
that C. jejuni 11168H wild-type strain activates Cdc42, as well as Rho, as 
suggested by the observed filopodia and stress fibres respectively.  
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Having established that the C. jejuni 11168H wild-type GFP strain could invade 
T84 and Caco-2 efficiently, experiments were performed to investigate the 
intracellular fate of C. jejuni. Intracellular pathogens have adapted a variety of 
survival mechanisms to be able to replicate and survive within host cells. L. 
monocytogenes (Goebel and Kuhn, 2000), S. flexneri (Cossart, 2004, Ogawa 
and Sasakawa, 2006), and Trypanosoma cruzi (Brener, 1973) were able to 
replicate in the cytosol after breaking free from lysosome. Others such as M. 
tuberculosis (Deretic et al., 2006) or S. Typhimurium (Knodler and Steele-
Mortimer, 2003) reside and survive in compartments that deviate from being 
fused into lysosomes. In this study, fluorescence confocal micrographs showed 
that the 11168H wild-type expressing GFP was efficiently internalised within 
T84 monolayers. Once internalised within T84 cells, C. jejuni either co-localised 
with actin filaments or remained free from any actin filament association. Not all 
internalised C. jejuni bacteria (stained Green) appeared yellow in colour which 
would suggest association with actin filaments (stained Red). Some bacteria 
were observed as only a green stain that suggests no association with actin 
filaments. 
This data supports the study published by Galan’s group who previously 
reported that following internalisation, the C. jejuni 81-176 wild-type strain 
resides in a CCV (Watson and Galan, 2008). In addition, other studies have 
reported that upon infection with IECs, C. jejuni co-localises in vacuole or 
membrane bound compartment (Russell and Blake, 1994, Humphrey et al., 
1986, Kiehlbauch et al., 1985, Hickey et al., 2005). In one study, C. jejuni 81-
176 wild-type strain was observed and even appeared to be motile and able to 
replicate in a vacuole within human monocytes (Hickey et al., 2005).  
Following internalisation into IECs, the CCV was not shown to follow the 
pathway that usually deliver these vacuole compartments to the conventional 
cellular lysosomes. This was confirmed when endocytic dextran tracer was not 
found within the CCV (Watson and Galan, 2008). However, in macrophages, C. 
jejuni found in the CCV cannot avoid the endocytic pathway and is lysed by 
lysosomes (Watson and Galan, 2008). These data indicate that CCVs were 
separated from following the endocytic pathway and fusion with lysosomes in 
cytoplasm. In the endocytic pathway, early and late endosomal markers such 
as Rab5 and Rab7 respectively could be stained with immunofluorescence 
antibodies. Once again the CCVs were not accessible to those markers. The 
mechanisms used by C. jejuni to deviate from the classical endocytic pathway 
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and block fusion with lysosomes remain unknown. Other enteric pathogens 
utilise virulence effectors that target the regulatory machinery that controls 
endomembrane transport and fusion, to block and disrupt the function of the 
Rab proteins (Knodler and Steele-Mortimer, 2003, Meresse et al., 1999). 
In order to investigate which endosomal marker the matured CCVs acquired to 
prevent fusion with lysosomes, an antibody for the late endosomal marker 
Lamp-1 was used to stain the CCVs. Not many bacteria were observed co-
localised with Lamp-1 even though the majority of the intracellular bacteria 
resided within vacoules as judged by yellow colour fusion in the cells. One study 
reported that co-localisation with Lamp-1 is transient even though most 81-176 
wild-type CCVs were all stained with Lamp-1 2 h post-infection (Watson and 
Galan, 2008). It was also shown that the CCV was not co-localised with 
cathepsin B, a lysosomal protein marker. Hence, the data now indicates that C. 
jejuni 81-176 (Watson and Galan, 2008) and 11168H (this study) would reside 
intracellularly within a vacuole and progress towards the Golgi to allow survival 
in cytoplasm. The CCV acquires Lamp1, but not Rab 5 and Rab 7, similar to S. 
Typimurium with the exception of Rab 7 that is needed in the case of S. 
Typimurium. This appears to render the bacteria protected or separated from 
the lysosome pathways.  
Cytoskeletal requirements for C. jejuni entry into host cells until now have not 
been finalised, but it is agreed different C. jejuni strains adapt to and employ 
different pathways that suit the environments, cells or assays used. Because of 
that, data from many different studies showed pathways dependent of both MFs 
and MTs (Biswas et al., 2003), others showed pathways dependent only on 
MFs (Monteville et al., 2003) or only on MTs (Oelschlaeger et al., 1993, 
Kopecko et al., 2001, Hu and Kopecko, 1999) whilst another showed pathways 
independent of both MFs and MTs (Biswas et al., 2003).  
In this chapter, the mechanisms employed by the 11168H wild-type, cadF 
mutant and flpA mutants expressing GFP to enter IECs appeared to be both 
MF- and lipid raft-dependent. However, confocal micrographs did not clearly 
show any reduction in invasion by the inhibitors cyto D, which inhibits G-actin 
polymerisation and disrupts F-actin actin filaments, or MβCD, which inhibits lipid 
rafts in the plasma membrane. In addition, in the same inhibitor treatment, no 
significant reduction of invasion was observed between treated IECs or non-
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treated IECs. For every assay on each strain, minimum of 50 to 100 cells were 
observed for every field.  
GFP allowed the visualisation of the association of C. jejuni with actin 
polymerisation specifically and with the actin cytoskeleton generally. This is 
because the host cytoskeleton structure is partly made of polymerised actin 
filaments, which are responsible for many active cell processes including cell 
movement, membrane ruffling and phagocytosis. In this study, internalised C. 
jejuni was observed demonstrating localised adherence. At the site of 
adherence, accumulation of actin was observed and it has previously been 
reported that infection of INT 407 monolayers with C. jejuni M21 produced the 
same effects (Konkel et al., 1992a) 
All the C. jejuni 11168H expressing GFP strains investigated in this study 
adhered to and invaded Caco-2 and T84 cells. Each strain also appeared to 
invade at the same rate judged by the micrographs observed. A previous study 
has also reported that there was no significant difference observed between the 
ability of slightly invasive and highly invasive C. jejuni strains to adhere to IECs 
(Biswas et al., 2000). Stimulation of membrane ruffling as a result of C. jejuni 
adhering to IECs proved to be a common phenomenon, although invasiveness 
may be C. jejuni strain specific (Biswas et al., 2000). Data from this study using 
confocal microscopy supports previous studies whereby the occurrence of 
pseudopod formation is stimulated by C. jejuni and this may play a key role in 
adherence to the target cell membrane (Konkel et al., 1992a).  
 
 
 
 
 
 
 
 
 
 
 
249 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
CHAPTER SIX: FINAL DISCUSSION 
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The aim of this study was to further investigate the roles played by the two highly 
conserved C. jejuni fibronectin binding proteins CadF and FlpA during bacterial 
interactions with IECs. Two C. jejuni 11168H and 81-176 strains were used for 
comparison to initially identify whether the functions of CadF and FlpA are 
species or strain specific. The two strains 11168 and 81-176 belong to specific 
MLST clonal complexes of ST-21 and ST-42 respectively. ST-21 represents 
livestock-associated linages whilst ST-42 represents livestock and water and 
wildlife-associated linages (Gundogdu et al., 2016). 
Although both cadF and flpA are highly conserved genes in C. jejuni strains, 
differences were identified in the transcription of both genes between the 
11168H and 81-176 wild-type strains. cadF is transcribed at a higher level 
(around 4-fold) in both wild-type strains compared to flpA (see Figure 3.11). 
However, transcription of cadF in the 81-176 wild-type strain is at a higher level 
than in the 11168H wild-type strain, under the growth conditions used in this 
study. In contrast, transcription of flpA was at the same level in both 81-176 and 
11168H. Bearing this information in mind, results from the different assays used 
in this study can be interpreted in relation to the predicted levels of CadF or 
FlpA in the particular strain. Bioinformatic analysis showed that CadF in NCTC 
11168 is similar to CadF in 81-176 (see Figure 3.1) and that FlpA in NCTC 
11168 is similar to FlpA in 81-176 (see Figure 3.2). This suggests that CadF 
function will be identical in both 11168H and 81-176 strains and FlpA function 
will be identical in both strains as well. However, the amino acid sequences of 
CadF and FlpA are quite divergent as shown by the amino acid alignments (see 
Figure 3.3) as well as by the 3-D ribbon diagrams (see Figure 3.4). This 
suggests that CadF and FlpA probably have some differences in function in C. 
jejuni.  
 
 
 
6.1 The role of CadF 
 
Studies with the 11168H and 81-176 cadF mutants indicated that C. jejuni uses 
CadF to bind to the IEC extracellular matrix protein fibronectin. The binding to 
fibronectin facilitates the adhesion of C. jejuni to IECs and the activation of 
downstream signal transduction pathways involving small Rho GTPases. The 
251 
 
hypothesises was that inactivation of cadF in C. jejuni would lead to a reduced 
level of binding to and invasion into IECs, which could also affect the activation 
of the IECs signal transduction pathways involving small Rho GTPases 
including the Rac1 pathway, which involves the initiation of signalling pathways 
such as integrin signalling for membrane ruffling and for focal adhesion. 
The inactivation of cadF in both the 11168H and 81-176 wild-type strains 
resulted in a reduction of adhesion to Caco-2 and T84 IECs. However, the 
binding of the cadF mutants to immobilised fibronectin in vitro was not 
dramatically reduced. This somewhat counter-intuitive result suggests that 
fibronectin is not the only extracellular receptor that C. jejuni binds to on the 
surface of IECs. The influence of other IECs factors, such as the presence of 
putative receptors in lipid rafts which C. jejuni uses to gain access to IECs to 
allow subsequent invasion to occur must also be considered. This finding is also 
in contrast to a study by Konkel et al. who reported that CadF has a higher 
binding affinity to immobilised fibronectin compared to FlpA in the F38011 strain 
(Konkel et al., 2010). The cadF mutants were less cytotoxic than the flpA 
mutants in the G. mellonella model of infection. This would suggest that higher 
levels of CadF have a more severe impact on host cells. Results from other 
assays demonstrated that CadF in 11168H is required for and played a role in 
the invasion of IECs, in translocating across IECs, in inducing IL-8 and in 
activating Rac1. However, the impact of CadF showed no significant difference 
to that of FlpA on those assays. 
While inactivation of cadF in both the 11168H and 81-176 wild-type strains is 
responsible for the reduced adhesion to IECs, it was evident that this is not 
statistically significant. This may be due to up-regulation of flpA as a redundant 
response as part of a compensation mechanism must also be considered. In 
addition, both the 11168H and 81-176 cadF mutant exhibited higher numbers 
of interacting bacteria than the respective flpA mutant. In contrast, in the 
invasion assays, the 11168H cadF mutant invades less than the 11168H flpA 
mutant. However, the 81-176 cadF and flpA mutants exhibited similar invasion 
abilities. These results may indicate that CadF has a more important role in 
invasion than in interaction with IECs compared to FlpA and also this may be 
strain-dependent. 
The use of inhibitors to investigate the pathways employed by C. jejuni to enter 
IECs has indicated that not all inhibitors have the same impact on the ability of 
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the 11168H cadF mutant to invade IECs. A reduction in the invasion ability of 
the 11168H cadF mutant was evident when IECs were pre-treated with MβCD, 
cyto D or colchicine. However, pre-treatment of IECs with wortmanin had less 
impact on the ability of 11168H cadF mutant to invade IECs compared to the 
other three inhibitors. Therefore, the invasion pathway of the 11168H cadF 
mutant involves components such as lipid rafts, MFs and MTs and is 
independent of PI3-kinases. This suggests that CadF is involved in C. jejuni 
binding to fibronectin which leads to subsequent IECs processes involving PI3 
activation to induce internalisation. 
 
 
 
6.2 The role of FlpA 
 
FlpA contains three domains similar to that of fibronectin type III binding 
domains (Konkel et al., 2010). In this study, both 11168H and 81-176 flpA 
mutants were shown to bind less to fibronectin in vitro compared to the 
respective cadF mutants. In the interaction assays with IECs, both 11168H and 
81-176 flpA mutants showed a reduction compared to the respective cadF 
mutants. This suggests that having three FnIII binding domains allows FlpA to 
play a more important role in binding to fibronectin in vitro and in adherence to 
IECs than CadF. FlpA was also shown to play A role in translocation across 
IECs, induction of IL-8 and activation of Rac1. In addition, FlpA showed a similar 
ability and efficiency compared to CadF in translocating across IECs. FlpA also 
able to induce IL-8 and Rac1 to a similar level compared to CadF. 
 The ability of the 11168H flpA mutant to invade T84 cells was inhibited by 
MβCD, cytochalasin D and wortmannin. However, colchicine not only did not 
inhibit invasion by the 11168H flpA mutant, but the invasion ability of the 
11168H flpA mutant was increased to a higher level than that of the 11168H 
wild-type strain when T84 IECs were pre-treated with colchicine. The 11168H 
flpA mutant expressed higher levels of cadF compared to the wild-type strain. 
The CadF-invasion pathway appears to involve PI3 activation and is 
independent of MFs and MTs, highlighting the multiple and the complex 
invasion mechanisms that C. jejuni employs to enter IECs. Cytochalasin D 
depolymerises IECs MFs whilst colchicine inhibits formation MTs. These results 
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indicate that the FlpA-invasion pathway may involve MTs. This finding also 
provides novel evidence that while both CadF and FlpA are required for C. jejuni 
invasion to IECs, C. jejuni induced MT depolymerisation reduced the invasion 
ability of cadF mutant while in flpA mutant MT depolymerisation of IECs was 
shown to increase the invasion to IECs.  
 
 
 
6.3 Roles of CadF and FlpA in C. jejuni pathogenesis  
 
This study has identified some similarities and some differences in the roles of 
CadF and FlpA in C. jejuni and provided preliminary evidence as to why C. jejuni 
strains possesses two fibronectin binding adhesins. This can be discussed in 
relation to progressive steps during C. jejuni interactions with host cells. 
First step: Pathogenesis of C. jejuni begins with adherence. Both CadF and 
FlpA are able to bind to fibronectin in vitro. However, the binding ability of a flpA 
mutant to IECs is reduced significantly compared to a cadF mutant. However, 
it was evident that both proteins play an important role in C. jejuni adherence to 
IECs. FlpA appears to have a more significant role in C. jejuni binding as the 
numbers of the flpA mutants binding to IECs were significantly reduced 
compared to the cadF mutants. This could be attributed to the fundamental 
difference between CadF and FlpA, particularly the presence of three FnIII 
domains in FlpA compared to CadF. However, both FlpA and CadF are known 
to bind to the same integrin α5β1 receptors.  
Second step: Both CadF and FlpA also play a role in C. jejuni invasion of IECs. 
However, the invasion ability of a cadF mutant is reduced significantly 
compared to a flpA mutant with T84 IECs but similar in Caco-2 IECs. Also 
invasion of both cadF and flpA mutants is dependent on lipid rafts while there 
is preferential difference to engage invasion pathways that are either MT- or 
MF-specific. This suggests that the invasion by cadF and flpA mutants involve 
the caveolin-mediated endocytosis pathway. Also that CadF plays a more 
important role in invasion of IECs compared to FlpA, supported by the higher 
transcription levels of cadF compared to flpA.  
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Third step: Once C. jejuni adheres to IECs, CadF and FlpA use separate and 
different pathways. Entry mediated via CadF is MT- and MF-dependent. In 
contrast, entry mediated via FlpA is MT-independent. This difference between 
CadF and FlpA involvement with MTs is probably responsible for the different 
roles of MFs and MTs during C. jejuni invasion as reported in many published 
studies. C. jejuni presumably is able to switch between entry mediated via CadF 
and entry mediated via FlpA resulting in invasion mechanisms requiring both 
MFs and MTs or either MFs or MTs. 
Fourth step: The end result however is similar, as evidenced by the fact that 
CadF and FlpA showed similar ability in activating Rac1, a member of small 
GTPases. Mutation of either cadF or flpA results in a decrease in Rac1 
activation compared to the wild-type strain. This suggests that both CadF and 
FlpA play a role in Rac1 activation. Rac1activation is a switch that turns on the 
chain of events such as the formation of focal adhesions, recruitment of other 
signalling molecules and relaying signals to cytoskeleton components such as 
MFs and MTs. As a result of this reaction, the host cell cytoskeleton will 
reorganise and induce membrane ruffles at the site of C. jejuni attachment. 
Actin cytoskeleton rearrangements include the formation of pseudopodia such 
as lamellipodia and filopodia and can be observed as actin concentration 
localised with C. jejuni internalisation.  
Collectively, the results from this study are in agreement to the invasion model 
proposed by O’Croinin & Backert (O Croinin and Backert, 2012). In relation to 
this invasion model, this demonstrates that CadF and FlpA work in co-operation 
through zipper or/and trigger mechanisms. Both CadF and FlpA mediate 
adherence and invasion through unique mechanisms and activate members of 
the small GTPases which play central roles in rearranging MFs and MTs in the 
host cytoskeleton. Thus through CadF and FlpA, C jejuni is fully equipped to 
trigger and activate signalling events that lead to the bacteria being internalised 
by the host cells. 
All taken into consideration, as with any other successful pathogen, C. jejuni 
demonstrates the complex and intricate pathogenesis mechanisms which are 
different from other enteric pathogens. These involve multiple factors with 
various and co-operative actions or independent and separate pathways that 
C. jejuni employ for any given cells line, to mediate successful interaction/s that 
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result in campylobacteriosis and establishing C. jejuni as one of the most 
successful human enteropathogens to date. 
Further investigation needs to be performed as a clearer understanding of the 
pathogenesis mechanisms will contribute to the development of innovative 
strategies for prevention and therapy in the future.  
 
 
 
6.4 Future work 
 
Future gene expression analysis should use RNA seq. Gene expression studies 
will benefit from RNA seq techniques because this method is excellent to 
investigate changes in gene expression under different conditions. The next 
study should investigate the expression of CadF and FlpA in media 
supplemented with bile salts. In the intestine, the presence of bile salts serves 
as a protection to host cells by bactericidal activity against pathogens (Urdaneta 
and Casadesus, 2017). However, it was reported that pathogens are able to 
survive and establish infection in the presence of bile salts in the intestine. This 
is because bile salts can activate different bacterial mechanisms for resistance, 
damage repair and protection (Urdaneta and Casadesus, 2017, Schubert et al., 
2017). In another study, bile salts were shown to increase resistance to 
antimicrobials and change gene expression in C. jejuni (Lertpiriyapong et al., 
2012). Further, it was reported that bile salts induced Cia expression in C. jejuni 
which enhanced the ability of C. jejuni to invade IECs (Rivera-Amill et al., 2001, 
Malik-Kale et al., 2008). Sodium taurocholate (ST) is a constituent of the bile 
salts in the caecum (Hamilton et al., 2007). Recently, bile salts have been 
shown to facilitate germination of Clostridium difficile (Kochan et al., 2017). This 
study will no doubt bring it closer to the natural niche of C. jejuni as in the gut 
environment which makes the result more relevant. Changes in the expression 
of CadF and FlpA under conditions that more closely mimic those in the human 
intestine may cast further light of the role of these two fibronectin binding 
proteins during C. jejuni infection. 
In this study, the assays were performed at two different time points. In the next 
study, the adhesion and invasion assay should be performed which include 
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more time points and longer time points so as to provide a complete picture of 
C. jejuni interaction with IECs. Attempts have been made to construct 
complements of cadF and flpA mutants, however with no success. It was noted 
by Konkel that in his group the construction of cadF and flpA complements 
posed significant challenges. However, without doubt, the availability of 
complementation will be useful to answer and clear any controversial results as 
complementation should restore the phenotypic changes. Construction of a 
double cadF flpA mutant may also show more clearly the role of CadF and FlpA. 
A double mutant could show whether CadF and FlpA function independently 
and/or different mechanisms and pathways are involved. Construction of 
complements and double mutants should be included in further studies. As with 
the cell lines employed, it will be also relevant to include cells that produce 
mucus such as HT29 MTXE-12, and an Homo sapiens colon ileocecal 
carcinoma cells (HCT8) (Alemka et al., 2010, Lindmark et al., 2009). Previously, 
a vertical diffusion chamber (VDC) model system was used to more closely 
mimic the human intestinal microenvironment in C. jejuni study. The VDC has 
two chambers, one, microaerobic environment to mimic apical surface of IECs 
and second, an aerobic environment to mimic the baso-lateral surfaced of 
cultured IECs (Mills et al., 2012, Naz et al., 2013). This system potentially will 
create a better condition for in vitro C. jejuni study compared to standard tissue 
culture methods. Various assays can be performed comparing different strains, 
different cell lines and gene expression studies, which would all benefit from 
using the VDC model system. Stem cell research could also be attempted as 
one of the technique to investigate pathogenesis, as an option has available to 
use a ‘miniguts’. The miniguts grow from a single stem cell isolated from the 
intestine that is able to form a complex organoid structure and has a similar 
identity with their original organ (Sato and Clevers, 2013). 
GFP expressing C. jejuni strains have contributed to following up interaction 
studies in vivo. As a fusion tag, the GFP can be utilised in many ways including 
protein localisation, movement and the dynamic of the compartments where the 
bacteria or protein targeted (Gerdes and Kaether, 1996). During visualisation 
with confocal microscopy, C. jejuni can be observed both in vacuoles and free 
in the cytoplasm. Therefore, further work is needed to clarify the different 
compartments where C. jejuni can be found, especially during infection in vivo. 
Defining the respective roles of these compartments will identify new routes as 
some usually represent dead-ends in pathogenesis. The interaction of the cadF 
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and flpA mutants expressing GFP also can be followed and tracked in vivo. As 
a visual marker, the GFP will allow not only enumeration of the bacteria but also 
the impact and the fate of the bacteria in the natural environment. A previous 
study has reported that expression of GFP has no impact on the interaction of 
pathogens with host cells (Valdivia et al., 1996). However, a recent study has 
reported that GFP may induce oxidative stress to cells, and this will have an 
impact on the results obtained in the study where the bacteria is tagged with 
GFP (Kalyanaraman and Zielonka, 2017).  
CadF and FlpA have also been identified among the proteins found in C. jejuni 
OMVs (Elmi et al., 2012). HtrA is also found in C. jejuni OMVs and has been 
shown to play a role in C. jejuni invasion through the ability to cleave E-cadherin 
(Elmi et al., 2016). Further studies are required to demonstrate the effect of C. 
jejuni OMVs in general and OMVs isolated from cadF and flpA mutants in 
specific, on damage to host cells such as on epithelial cells and immune cells 
in order to identify the role of CadF and FlpA in OMV interactions with host cells. 
As with live bacteria, OMVs entry mechanisms, intracellular localisation and 
activities will also require further studies. Investigations involving OMVs will 
result in a greater understanding of C. jejuni pathogenesis in humans.  
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Appendix 1 
 
ClustalW output for NCTC11168 CadF and FlpA alignment 
 
######################################## 
# Program: water 
# Rundate: Thu 27 Apr 2017 11:34:18 
# Commandline: water 
#    -auto 
#    -stdout 
#    -asequence emboss_water-I20170427-113417-0026-88836252-
oy.asequence 
#    -bsequence emboss_water-I20170427-113417-0026-88836252-
oy.bsequence 
#    -datafile EBLOSUM62 
#    -gapopen 10.0 
#    -gapextend 0.5 
#    -aformat3 pair 
#    -sprotein1 
#    -sprotein2 
# Align_format: pair 
# Report_file: stdout 
######################################## 
 
#======================================= 
# 
# Aligned_sequences: 2 
# 1: CadFNTCC11168(Cj1478c) 
# 2: FlpANCTC11168(Cj1279c) 
# Matrix: EBLOSUM62 
# Gap_penalty: 10.0 
# Extend_penalty: 0.5 
# 
# Length: 283 
# Identity:      55/283 (19.4%) 
# Similarity:    91/283 (32.2%) 
# Gaps:         101/283 (35.7%) 
# Score: 52.0 
#  
# 
#======================================= 
 
CadFNTCC11168     16 GADNNVK--
FEITPTLNYNYFEGNLDMDNRYAPGIRLGYHFDDFWLDQLE     63 
                     |.|...|  .|:...||..|.:.:|..:...:..| :...|:         
FlpANCTC11168    174 GDDKEFKKIAEVKNRLNAEYIDSDLKPNENSSYRI-
IAVSFN--------    214 
 
CadFNTCC11168     64 
FGLEHYSDVKYTNTNKTTDITRTYLSAIKGIDVGEKFYFYGLAGGGYEDF    
113 
                      |::..|....::|:|.......:|||  ..|...|......| ..|||| 
285 
 
FlpANCTC11168    215 -GIKSGSSQVVSSTSKALPPQVEHLSA--
STDGSSKIILTWDA-PTYEDF    260 
 
CadFNTCC11168    114 
SNAAYDNKSGGFGHYGAGVKFRLSDSLALRLETRDQINFNHANHNWVSTL    
163 
                     |.....:.|..|                                       
FlpANCTC11168    261 SYYKVYSTSSSF--------------------------------------    272 
 
CadFNTCC11168    164 GISFGFGGKKEK-
AVEEVADTRATPQAKCPVEPREGA---------LLDE    203 
                      :.|....|.:| :.|::.               |||         ::|: 
FlpANCTC11168    273 -LPFSVLAKTDKNSYEDIV---------------
EGAGKSKYYKVTMVDK    306 
 
CadFNTCC11168    204 
NGCEKTISLEGHFGFDKTTINPTFQEKIKEIAKVLDENERYDTILEGHTD    253 
                     :|.|..:..:|..|  ||..||        :|..:        ||...|  
FlpANCTC11168    307 DGLESPMPKDGVEG--KTLGNP--------LAPSI--------
ILAQST-    337 
 
CadFNTCC11168    254 NIGSRAYNQKLSERRAKSVANELEKYGVEKSRI    
286 
                        |...|.:.|:...::|..|:.:||.|::.: 
FlpANCTC11168    338 ---SEGINLEWSDNDTRAVEYEVRRYGGEQNAV    
367 
 
 
#--------------------------------------- 
#--------------------------------------- 
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Appendix 2 
 
ClustalW output for NCTC11168 and 81-176 FlpA alignment 
 
######################################## 
# Program: water 
# Rundate: Thu 27 Apr 2017 11:27:44 
# Commandline: water 
#    -auto 
#    -stdout 
#    -asequence emboss_water-I20170427-112743-0196-93760291-
oy.asequence 
#    -bsequence emboss_water-I20170427-112743-0196-93760291-
oy.bsequence 
#    -datafile EBLOSUM62 
#    -gapopen 10.0 
#    -gapextend 0.5 
#    -aformat3 pair 
#    -sprotein1 
#    -sprotein2 
# Align_format: pair 
# Report_file: stdout 
######################################## 
 
#======================================= 
# 
# Aligned_sequences: 2 
# 1: FlpANCTC11168 
# 2: FlpA81-176 
# Matrix: EBLOSUM62 
# Gap_penalty: 10.0 
# Extend_penalty: 0.5 
# 
# Length: 410 
# Identity:     403/410 (98.3%) 
# Similarity:   405/410 (98.8%) 
# Gaps:           0/410 ( 0.0%) 
# Score: 2057.0 
#  
# 
#======================================= 
 
FlpANCTC11168      2 
MKRFRLSFYLSFLTLLLSACSVSQMNSLASSKEPAVNESLPKVESLKSLS     
51 
                     ||||||.||||||||||||||||||||||||||||||||||||||||||| 
FlpA81-176         1 
MKRFRLGFYLSFLTLLLSACSVSQMNSLASSKEPAVNESLPKVESLKSLS     
50 
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FlpANCTC11168     52 
DMSNIAFEWEPLYNENIKGFYLYRSSDENPDFKLVGTIKDKFQTHYVDTK    
101 
                     ||||||||||.||||||||||||||||||||||||||||||||||||||| 
FlpA81-176        51 
DMSNIAFEWESLYNENIKGFYLYRSSDENPDFKLVGTIKDKFQTHYVDTK    
100 
 
FlpANCTC11168    102 
LEPGTKYRYMMKSFNEQGQISEDGKVIEVSTAPRLEAVPFVQAVTNLPNR    
151 
                     |||||||||||||||||||||||||||||||||||||||||||||||||| 
FlpA81-176       101 
LEPGTKYRYMMKSFNEQGQISEDGKVIEVSTAPRLEAVPFVQAVTNLPNR    
150 
 
FlpANCTC11168    152 
IKLIWRPHPDFRVDSYIIERTKGDDKEFKKIAEVKNRLNAEYIDSDLKPN    201 
                     |||||||||||||||||||||||||||||||||||||||||||||||||| 
FlpA81-176       151 
IKLIWRPHPDFRVDSYIIERTKGDDKEFKKIAEVKNRLNAEYIDSDLKPN    200 
 
FlpANCTC11168    202 
ENSSYRIIAVSFNGIKSGSSQVVSSTSKALPPQVEHLSASTDGSSKIILT    251 
                     |||||||||||||||||..|||||||||||||||||||||||||:||:|| 
FlpA81-176       201 
ENSSYRIIAVSFNGIKSEPSQVVSSTSKALPPQVEHLSASTDGSNKIMLT    
250 
 
FlpANCTC11168    252 
WDAPTYEDFSYYKVYSTSSSFLPFSVLAKTDKNSYEDIVEGAGKSKYYKV    
301 
                     |||||||||||||||||||||||||||||||||||||||||.|||||||| 
FlpA81-176       251 
WDAPTYEDFSYYKVYSTSSSFLPFSVLAKTDKNSYEDIVEGVGKSKYYKV    
300 
 
FlpANCTC11168    302 
TMVDKDGLESPMPKDGVEGKTLGNPLAPSIILAQSTSEGINLEWSDNDTR    
351 
                     |||||||||||||||||||||||||||||||||||||||||||||||||| 
FlpA81-176       301 
TMVDKDGLESPMPKDGVEGKTLGNPLAPSIILAQSTSEGINLEWSDNDTR    
350 
 
FlpANCTC11168    352 
AVEYEVRRYGGEQNAVFKGIKEKRLKDVKALPGVEYSYEVIAIDSAGLRS    
401 
                     |||||||||||||||||||||||||||||||||||||||||||||||||| 
FlpA81-176       351 
AVEYEVRRYGGEQNAVFKGIKEKRLKDVKALPGVEYSYEVIAIDSAGLRS    
400 
 
FlpANCTC11168    402 EPSSKVKAAQ    411 
                     |||||||||| 
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FlpA81-176       401 EPSSKVKAAQ    410 
 
 
#--------------------------------------- 
#--------------------------------------- 
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Appendix 3 
 
ClustalW output for NCTC11168 and 81-176 CadF alignment 
 
######################################## 
# Program: water 
# Rundate: Thu 27 Apr 2017 11:23:41 
# Commandline: water 
#    -auto 
#    -stdout 
#    -asequence emboss_water-I20170427-112335-0274-85685520-
oy.asequence 
#    -bsequence emboss_water-I20170427-112335-0274-85685520-
oy.bsequence 
#    -datafile EBLOSUM62 
#    -gapopen 10.0 
#    -gapextend 0.5 
#    -aformat3 pair 
#    -sprotein1 
#    -sprotein2 
# Align_format: pair 
# Report_file: stdout 
######################################## 
 
#======================================= 
# 
# Aligned_sequences: 2 
# 1: CadFNTCC11168 
# 2: CadF81-176 
# Matrix: EBLOSUM62 
# Gap_penalty: 10.0 
# Extend_penalty: 0.5 
# 
# Length: 319 
# Identity:     315/319 (98.7%) 
# Similarity:   315/319 (98.7%) 
# Gaps:           0/319 ( 0.0%) 
# Score: 1668.0 
#  
# 
#======================================= 
 
CadFNTCC11168      1 
MKKIFLCLGLASVLFGADNNVKFEITPTLNYNYFEGNLDMDNRYAPGIRL     
50 
                     ||||.||||||||||.|||||||||||||||||||||||||||||||||| 
CadF81-176         1 
MKKILLCLGLASVLFSADNNVKFEITPTLNYNYFEGNLDMDNRYAPGIRL     
50 
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CadFNTCC11168     51 
GYHFDDFWLDQLEFGLEHYSDVKYTNTNKTTDITRTYLSAIKGIDVGEKF    
100 
                     |||||||||||||||||||||||||||||||||||||||||||||||||| 
CadF81-176        51 
GYHFDDFWLDQLEFGLEHYSDVKYTNTNKTTDITRTYLSAIKGIDVGEKF    
100 
 
CadFNTCC11168    101 
YFYGLAGGGYEDFSNAAYDNKSGGFGHYGAGVKFRLSDSLALRLETRDQI    
150 
                     |||||||||||||||||||||||||||||||||||||||||||||||||| 
CadF81-176       101 
YFYGLAGGGYEDFSNAAYDNKSGGFGHYGAGVKFRLSDSLALRLETRDQI    
150 
 
CadFNTCC11168    151 
NFNHANHNWVSTLGISFGFGGKKEKAVEEVADTRATPQAKCPVEPREGAL    
200 
                     ||||||||||||||||||||||||||||||||||..|||||||||||||| 
CadF81-176       151 
NFNHANHNWVSTLGISFGFGGKKEKAVEEVADTRPAPQAKCPVEPREGAL    
200 
 
CadFNTCC11168    201 
LDENGCEKTISLEGHFGFDKTTINPTFQEKIKEIAKVLDENERYDTILEG    250 
                     |||||||||||||||||||||||||||||||||||||||||||||||||| 
CadF81-176       201 
LDENGCEKTISLEGHFGFDKTTINPTFQEKIKEIAKVLDENERYDTILEG    250 
 
CadFNTCC11168    251 
HTDNIGSRAYNQKLSERRAKSVANELEKYGVEKSRIKTVGYGQDNPRSSN    
300 
                     |||||||||||||||||||||||||||||||||||||||||||||||||| 
CadF81-176       251 
HTDNIGSRAYNQKLSERRAKSVANELEKYGVEKSRIKTVGYGQDNPRSSN    
300 
 
CadFNTCC11168    301 DTKEGRADNRRVDAKFILR    319 
                     ||||||||||||||||||| 
CadF81-176       301 DTKEGRADNRRVDAKFILR    319 
 
 
#--------------------------------------- 
#--------------------------------------- 
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